Cinemark Usa 10-K 2 Mar 18 2017 FY Annual report Financial data

Document and Entity Information

Document and Entity Information - USD ($)	12 Months Ended
	Dec. 31, 2017	Mar. 02, 2018	Jun. 30, 2017
Document Information [Line Items]
Document Type	10-K
Amendment Flag	false
Document Period End Date	Dec. 31, 2017
Document Fiscal Year Focus	2,017
Document Fiscal Period Focus	FY
Trading Symbol	ck0000885975
Entity Registrant Name	CINEMARK USA INC /TX
Entity Central Index Key	885,975
Current Fiscal Year End Date	--12-31
Entity Well-known Seasoned Issuer	No
Entity Current Reporting Status	Yes
Entity Voluntary Filers	No
Entity Filer Category	Non-accelerated Filer
Entity Public Float			$ 0
Class A common stock
Document Information [Line Items]
Entity Common Stock, Shares Outstanding		1,500
Class B common stock
Document Information [Line Items]
Entity Common Stock, Shares Outstanding		182,648

CONSOLIDATED BALANCE SHEETS

CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands		Dec. 31, 2017	Dec. 31, 2016
Current assets
Cash and cash equivalents		$ 522,415	$ 561,138
Inventories		17,507	16,961
Accounts receivable		89,248	74,993
Current income tax receivable		11,730	7,367
Prepaid expenses and other		16,536	15,754
Accounts receivable from parent		14,581	10,080
Total current assets		672,017	686,293
Theatre properties and equipment
Land		104,207	103,080
Buildings		490,394	474,453
Property under capital lease		430,764	383,826
Theatre furniture and equipment		1,199,702	1,089,040
Leasehold interests and improvements		1,103,522	1,009,355
Total		3,328,589	3,059,754
Less: accumulated depreciation and amortization		1,500,535	1,355,218
Theatre properties and equipment, net		1,828,054	1,704,536
Other assets
Goodwill	[1]	1,284,079	1,262,963
Intangible assets - net		336,761	334,899
Investments in and advances to affiliates		120,045	98,317
Long-term deferred tax asset		4,067	2,051
Deferred charges and other assets - net		39,767	37,555
Total other assets		1,985,269	1,925,780
Total assets		4,485,340	4,316,609
Current liabilities
Current portion of long-term debt		7,099	5,671
Current portion of capital lease obligations		25,511	21,139
Current income tax payable		5,509	5,071
Current liability for uncertain tax positions		11,873	10,085
Accounts payable		109,984	110,150
Accrued film rentals		106,738	97,504
Accrued payroll		50,349	49,707
Accrued property taxes		31,353	33,043
Accrued other current liabilities		119,870	110,432
Total current liabilities		468,286	442,802
Long-term liabilities
Long-term debt, less current portion		1,780,381	1,782,441
Capital lease obligations, less current portion		251,151	234,281
Long-term deferred tax liability		121,787	135,014
Long-term liability for uncertain tax positions		8,358	8,105
Deferred lease expenses		40,929	42,378
Other long-term liabilities		41,247	43,580
Total long-term liabilities		2,595,559	2,589,727
Commitments and contingencies (see Note 15)
Cinemark USA, Inc.'s stockholder's equity:
Common stock		49,543	49,543
Treasury stock, 57,245 Class B shares at cost		(24,233)	(24,233)
Additional paid-in-capital		1,264,505	1,252,715
Retained earnings		373,069	241,926
Accumulated other comprehensive loss		(253,282)	(247,013)
Total Cinemark USA, Inc.'s stockholder's equity		1,409,602	1,272,938
Noncontrolling interests		11,893	11,142
Total equity		1,421,495	1,284,080
Total liabilities and equity		4,485,340	4,316,609
NCM
Other assets
Investment in NCM		200,550	189,995
Long-term liabilities
Deferred revenue - NCM		351,706	343,928
Class A common stock
Cinemark USA, Inc.'s stockholder's equity:
Common stock		0	0
Class B common stock
Cinemark USA, Inc.'s stockholder's equity:
Common stock		49,543	49,543
Total equity		$ 49,543	$ 49,543
[1]	Balances are presented net of accumulated impairment losses of $214,031 for the U.S. operating segment and $27,622 for the international operating segment.

CONSOLIDATED BALANCE SHEETS (Pa

CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares	Dec. 31, 2017	Dec. 31, 2016
Treasury Stock, Shares	57,245	57,245
Class A common stock
Common stock, par value	$ 0.01	$ 0.01
Common stock, shares authorized	10,000,000	10,000,000
Common stock, shares issued	1,500	1,500
Common stock, shares outstanding	1,500	1,500
Class B common stock
Common stock, shares authorized	1,000,000	1,000,000
Common stock, shares issued	239,893	239,893
Common stock, shares outstanding	182,648	182,648
Common stock, par value	$ 0	$ 0

CONSOLIDATED STATEMENTS OF INCO

CONSOLIDATED STATEMENTS OF INCOME - USD ($) $ in Thousands		12 Months Ended
		Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Revenues
Admissions		$ 1,794,982	$ 1,789,137	$ 1,765,519
Concession		1,038,788	990,103	936,970
Other		157,777	139,525	150,120
Total revenues		2,991,547	2,918,765	2,852,609
Cost of operations
Film rentals and advertising		966,510	962,655	945,640
Concession supplies		166,320	154,469	144,270
Salaries and wages		354,510	325,765	301,099
Facility lease expense		328,197	321,294	319,761
Utilities and other		355,041	355,926	355,801
General and administrative expenses		150,911	140,637	154,052
Depreciation and amortization		237,513	209,071	189,206
Impairment of long-lived assets		15,084	2,836	8,801
Loss on sale of assets and other		22,812	20,459	8,143
Total cost of operations		2,596,898	2,493,112	2,426,773
Operating income		394,649	425,653	425,836
Other income (expense)
Interest expense	[1]	(105,918)	(108,313)	(112,741)
Loss on debt amendments and refinancing		(521)	(13,445)	(925)
Interest income		6,243	6,396	8,708
Foreign currency exchange gain (loss)		893	6,455	(16,793)
Distributions from NCM		16,407	14,656	18,140
Equity in income of affiliates		35,985	31,962	28,126
Total other income (expense)		(46,911)	(62,289)	(75,485)
Income before income taxes		347,738	363,364	350,351
Income taxes		80,256	104,851	129,960
Net income		267,482	258,513	220,391
Less: Net income attributable to noncontrolling interests		1,839	1,736	1,859
Net income attributable to Cinemark USA, Inc.		$ 265,643	$ 256,777	$ 218,532
[1]	Includes amortization of debt issue costs.

CONSOLIDATED STATEMENTS OF COMP

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Statement Of Income And Comprehensive Income [Abstract]
Net income	$ 267,482	$ 258,513	$ 220,391
Other comprehensive income (loss), net of tax
Unrealized gain due to fair value adjustments on interest rate swap agreements, net of taxes of $1,562, $138 and $0, net of settlements	0	234	2,636
Unrealized loss due to fair value adjustments on available-for-sale securities, net of taxes of $572, $0 and $0	0	0	(957)
Other comprehensive income (loss) in equity method investments	248	89	(3,119)
Foreign currency translation adjustments	(4,966)	26,394	(125,512)
Total other comprehensive income (loss), net of tax	(4,718)	26,717	(126,952)
Total comprehensive income, net of tax	262,764	285,230	93,439
Comprehensive income attributable to noncontrolling interests	(1,839)	(1,769)	(1,821)
Comprehensive income attributable to Cinemark USA, Inc.	$ 260,925	$ 283,461	$ 91,618

CONSOLIDATED STATEMENTS OF COM6

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (Parenthetical) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Statement Of Income And Comprehensive Income [Abstract]
Unrealized gain due to fair value adjustments on interest rate swap agreements, taxes	$ 0	$ 138	$ 1,562
Unrealized loss due to fair value adjustments on available-for-sale securities, taxes	$ 0	$ 0	$ 572

CONSOLIDATED STATEMENTS OF EQUI

CONSOLIDATED STATEMENTS OF EQUITY - USD ($) shares in Thousands, $ in Thousands	Total	Class A common stock	Class B common stock	Treasury Stock	Additional Paid-in- Capital	Retained Earnings	Accumulated Other Comprehensive Loss	Total Cinemark USA, Inc.'s Stockholder's Equity	Noncontrolling Interests
Balance at Dec. 31, 2014	$ 1,136,723		$ 49,543	$ (24,233)	$ 1,221,179	$ 24,677	$ (144,772)	$ 1,126,394	$ 10,329
Balance (in shares) at Dec. 31, 2014		2	240	(57)
Share based awards compensation expense	14,873				14,873			14,873
Tax benefit (expense) related to share based award vestings	2,421				2,421			2,421
Dividends paid to parent	(115,225)					(115,225)		(115,225)
Noncash dividends paid to parent	(17,935)					(17,935)		(17,935)
Dividends paid to noncontrolling interests	(1,045)								(1,045)
Net income	220,391					218,532		218,532	1,859
Other comprehensive income (loss)	(126,952)						(126,914)	(126,914)	(38)
Balance at Dec. 31, 2015	1,113,251		$ 49,543	$ (24,233)	1,238,473	110,049	(271,686)	1,102,146	11,105
Balance (in shares) at Dec. 31, 2015		2	240	(57)
Share based awards compensation expense	12,413				12,413			12,413
Tax benefit (expense) related to share based award vestings	1,856				1,856			1,856
Dividends paid to parent	(124,900)					(124,900)		(124,900)
Dividends paid to noncontrolling interests	(1,309)								(1,309)
Buyout of noncontrolling interests' share of Chilean subsidiary	(450)				(27)			(27)	(423)
Gain realized on available-for-sale securities, net of taxes	(2,011)						(2,011)	(2,011)
Net income	258,513					256,777		256,777	1,736
Other comprehensive income (loss)	26,717						26,684	26,684	33
Balance at Dec. 31, 2016	1,284,080		$ 49,543	$ (24,233)	1,252,715	241,926	(247,013)	1,272,938	11,142
Balance (in shares) at Dec. 31, 2016		2	240	(57)
Share based awards compensation expense	11,825				11,825			11,825
Tax benefit (expense) related to share based award vestings	(35)				(35)			(35)
Dividends paid to parent	(134,500)					(134,500)		(134,500)
Dividends paid to noncontrolling interests	(1,088)								(1,088)
Net income	267,482					265,643		265,643	1,839
Reclassification of cumulative translation adjustments for a former Canadian subsidiary	(1,551)						(1,551)	(1,551)
Other comprehensive income (loss)	(4,718)						(4,718)	(4,718)
Balance at Dec. 31, 2017	$ 1,421,495		$ 49,543	$ (24,233)	$ 1,264,505	$ 373,069	$ (253,282)	$ 1,409,602	$ 11,893
Balance (in shares) at Dec. 31, 2017		2	240	(57)

CONSOLIDATED STATEMENTS OF EQU8

CONSOLIDATED STATEMENTS OF EQUITY (Parenthetical) $ in Thousands	12 Months Ended
	Dec. 31, 2016USD ($)
Statement Of Stockholders Equity [Abstract]
Gain realized on available-for-sale securities, taxes	$ 1,180

CONSOLIDATED STATEMENTS OF CASH

CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands		12 Months Ended
		Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Operating activities
Net income		$ 267,482	$ 258,513	$ 220,391
Adjustments to reconcile net income to cash provided by operating activities:
Depreciation		235,093	207,091	186,898
Amortization of intangible and other assets and favorable/unfavorable leases		2,420	1,980	2,308
Amortization of long-term prepaid rents		2,274	1,826	2,361
Amortization of debt issue costs		6,197	5,492	5,151
Amortization of deferred revenues, deferred lease incentives and other		(16,211)	(16,731)	(17,163)
Impairment of long-lived assets		15,084	2,836	8,801
Share based awards compensation expense		11,825	12,413	14,873
Loss on sale of assets and other		22,812	20,459	8,143
Write-off of unamortized debt issue costs associated with early retirement of debt			2,369
Deferred lease expenses		(1,268)	(990)	(1,806)
Reclassification of cumulative translation adjustments for a former Canadian subsidiary		(1,551)
Equity in income of affiliates		(35,985)	(31,962)	(28,126)
Deferred income tax expenses		(15,015)	(5,467)	11,095
Distributions from equity investees	[1]	25,973	21,916	19,027
Changes in assets and liabilities and other
Inventories		(541)	(1,007)	(2,535)
Accounts receivable		(14,753)	(2,781)	(28,069)
Income tax receivable		(4,363)	15,510	(3,527)
Prepaid expenses and other		(782)	(2,260)	(2,612)
Deferred charges and other assets - net		(4,956)	(1,619)	8,126
Accounts payable and accrued expenses		23,355	(30,250)	43,859
Income tax payable		438	(2,261)	936
Liabilities for uncertain tax positions		2,041	1,182	1,315
Other long-term liabilities		8,294	(5,076)	5,779
Net cash provided by operating activities		527,863	451,183	455,225
Investing activities
Additions to theatre properties and equipment and other		(380,862)	(326,908)	(331,726)
Proceeds from sale of theatre properties and equipment and other		15,098	3,570	9,966
Acquisitions of theatres in the U.S. and international markets, net of cash acquired		(40,997)	(15,300)	(2,651)
Acquisition of screen advertising business			(1,450)
Proceeds from sale of marketable securities			13,451
Investment in joint ventures and other		(3,715)	(1,132)	(3,711)
Net cash used for investing activities		(410,476)	(327,769)	(328,122)
Financing activities
Dividends paid to parent		(134,500)	(124,900)	(115,225)
Payroll taxes paid as a result of restricted stock withholdings		(2,943)	(6,834)	(4,770)
Proceeds from issuance of Senior Notes, net of discount			222,750
Retirement of Senior Subordinated Notes			(200,000)
Repayments of long-term debt		(5,671)	(16,605)	(8,420)
Payment of debt issue costs		(1,146)	(7,217)	(6,957)
Payments on capital leases		(21,725)	(19,343)	(16,513)
Proceeds from financing lease		10,200
Purchases of non-controlling interests			(450)
Other		(1,123)	554	1,376
Net cash used for financing activities		(156,908)	(152,045)	(150,509)
Effect of exchange rate changes on cash and cash equivalents		798	1,266	(26,932)
Increase (decrease) in cash and cash equivalents		(38,723)	(27,365)	(50,338)
Cash and cash equivalents:
Beginning of period		561,138	588,503	638,841
End of period		$ 522,415	$ 561,138	$ 588,503
[1]	Includes distributions received from equity investees that were recorded as a reduction of the respective investment balances.

SUMMARY OF SIGNIFICANT ACCOUNTI

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	12 Months Ended
	Dec. 31, 2017
Accounting Policies [Abstract]
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	1. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Business — Cinemark USA, Inc. and subsidiaries (the “Company”), a wholly-owned subsidiary of Cinemark Holdings, Inc., operates in the motion picture exhibition industry, with theatres in the United States (“U.S.”), Brazil, Argentina, Chile, Colombia, Peru, Ecuador, Honduras, El Salvador, Nicaragua, Costa Rica, Panama, Guatemala, Bolivia, Curaçao and Paraguay. Principles of Consolidation — The consolidated financial statements include the accounts of Cinemark USA, Inc. and its subsidiaries. Majority-owned subsidiaries that the Company has control of are consolidated while those affiliates of which the Company owns between 20% and 50% and does not control are accounted for under the equity method. Those affiliates of which the Company owns less than 20% are generally accounted for under the cost method, unless the Company is deemed to have the ability to exercise significant influence over the affiliate, in which case the Company would account for its investment under the equity method. The results of these equity method investees are included in the consolidated financial statements effective with their formation or from their dates of acquisition. Intercompany balances and transactions are eliminated in consolidation. Cash and Cash Equivalents — Cash and cash equivalents consist of operating funds held in financial institutions, petty cash held by the theatres and highly liquid investments with original maturities of three months or less when purchased. Cash investments are primarily in money market funds or other similar funds. Accounts Receivable – Accounts receivable, which are recorded at net realizable value, consist primarily of receivables related to screen advertising, receivables related to discounted tickets sold to retail locations, receivables from landlords related to theatre construction and remodels, rebates earned from the Company’s concession vendors and value-added and other non-income tax receivables. Inventories — Concession and theatre supplies inventories are stated at the lower of cost (first-in, first-out method) or market. Theatre Properties and Equipment — Theatre properties and equipment are stated at cost less accumulated depreciation and amortization. Depreciation is provided using the straight-line method over the estimated useful lives of the assets as follows: Category Useful Life Buildings on owned land 40 years Buildings on leased land Lesser of lease term or useful life Land and buildings under capital lease (1) Lesser of lease term or useful life Theatre furniture and equipment 3 to 15 years Leasehold improvements Lesser of lease term or useful life (1) The Company reviews long-lived assets for impairment indicators on a quarterly basis or whenever events or changes in circumstances indicate the carrying amount of the assets may not be fully recoverable. The Company also performs a full quantitative impairment evaluation on an annual basis. The Company considers actual theatre level cash flows, budgeted theatre level cash flows, theatre property and equipment carrying values, amortizing intangible asset carrying values, the age of a recently built theatre, competitive theatres in the marketplace, the impact of recent ticket price changes, the impact of recent theatre remodels or other substantial improvements, available lease renewal options and other factors considered relevant in its assessment of impairment of individual theatre assets. Long-lived assets are evaluated for impairment on an individual theatre basis, which the Company believes is the lowest applicable level for which there are identifiable cash flows. The impairment evaluation is based on the estimated undiscounted cash flows from continuing use through the remainder of the theatre’s useful life. The remainder of the theatre’s useful life correlates with the available remaining lease period, which includes the probability the exercise of available renewal periods or extensions, for leased properties and the lesser of twenty years or the building’s remaining useful life for fee-owned properties. If the estimated undiscounted cash flows are not sufficient to recover a long-lived asset’s carrying value, the Company then compares the carrying value of the asset group (theatre) with its estimated fair value. When the estimated fair value is determined to be lower than the carrying value of the asset group, the asset group is written down to its estimated fair value. Significant judgment is involved in estimating cash flows and fair value. Management’s estimates, which fall under Level 3 of the U.S. GAAP fair value hierarchy as defined by Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 820-10-35, are based on historical and projected operating performance, recent market transactions and current industry trading multiples. Fair value is determined based on a multiple of cash flows, which was six and a half times for the evaluations performed during 2015, 2016 and 2017. The long-lived asset impairment charges recorded during each of the periods presented are specific to theatres that were directly and individually impacted by increased competition, adverse changes in market demographics, or adverse changes in the development or the conditions of the areas surrounding the theatre. See Note 6. Goodwill and Other Intangible Assets — The Company evaluates goodwill for impairment annually during the fourth quarter or whenever events or changes in circumstances indicate the carrying value of the goodwill may not be fully recoverable. The Company evaluates goodwill for impairment at the reporting unit level. Management considers the reporting unit to be each of its nineteen regions in the U.S. and seven countries internationally with Honduras, El Salvador, Nicaragua, Costa Rica, Panama and Guatemala considered one reporting unit (the Company does not have goodwill recorded for all of its international locations). Significant judgment is involved in estimating cash flows and fair value. Management’s estimates, which fall under Level 3 of the U.S. GAAP fair value hierarchy as defined by FASB ASC Topic 820-10-35, are based on historical and projected operating performance, recent market transactions and current industry trading multiples. Fair value is determined based on a multiple of estimated cash flows, which was eight times, for the evaluations performed during 2015 and 2017. During the year ended December 31, 2015, the Company performed a qualitative goodwill impairment assessment on all reporting units except one, in accordance with ASU 2011-08 Testing Goodwill for Impairment During the year ended December 31, 2016, the Company performed a qualitative goodwill impairment assessment on all reporting units. Based on the qualitative assessment performed, the Company determined that it was not more likely than not that the fair value of the reporting units were less than their carrying values. During the year ended December 31, 2017, the Company performed a quantitative goodwill impairment assessment for all reporting units. As of December 31, 2017, the estimated fair value of the Company’s goodwill exceeded their carrying values by more than 10%. Tradename intangible assets are tested for impairment at least annually during the fourth quarter or whenever events or changes in circumstances indicate the carrying value may not be fully recoverable. The Company estimates the fair value of its tradenames by applying an estimated market royalty rate that could be charged for the use of its tradename to forecasted future revenues, with an adjustment for the present value of such royalties. If the estimated fair value is less than the carrying value, the tradename intangible asset is written down to its estimated fair value. Significant judgment is involved in estimating market royalty rates and long-term revenue forecasts. Management’s estimates, which fall under Level 3 of the U.S. GAAP fair value hierarchy as defined by FASB ASC Topic 820-10-35, are based on historical and projected revenue performance and industry trends. During the year ended December 31, 2015, the Company performed a qualitative tradename intangible asset impairment assessment in accordance with ASU 2011-08. The qualitative assessments included consideration of the Company’s historical and forecasted revenues and estimated royalty rates for each tradename intangible asset. Based on the qualitative assessment performed, the Company determined that it was not more likely than not that the fair values of the tradename assets were less than their carrying values as of December 31, 2015. During the year ended December 31, 2016, the Company performed a qualitative assessment for all indefinite-lived tradename assets other than our tradename in Ecuador, for which the Company performed a quantitative assessment. The qualitative assessments included consideration of the Company’s historical and forecasted revenues and estimated royalty rates for each tradename intangible asset. The quantitative test for our tradename in Ecuador included estimating the fair value of the tradename based on forecasted revenues for our Ecuador theatres multiplied by an estimated market royalty rate that could be charged for the use of the tradename, with an adjustment for the present value of such royalties. Based on the qualitative and quantitative assessments performed, the Company determined that it was not more likely than not that the fair values of tradename intangible assets were less than their carrying values as of December 31, 2016. During the year ended December 31, 2016, the Company also performed a quantitative test on its definite-lived tradename associated with the Rave theatres acquired in 2013. During the year ended December 31, 2016, the Company rebranded certain of these theatres with Cinemark signage as part of recliner conversions and other renovations. The Company estimated the fair value of the Rave tradename by applying an estimated market royalty rate that could be charged for the use of the tradename to forecasted future revenues for the theatres using the Rave tradename, with an adjustment for the present value of such royalties. As of December 31, 2016, the estimated fair value of the Rave tradename intangible asset exceeded their carrying value by more than 10%. During the year ended 2017, the Company performed a quantitative test on all indefinite and definite-lived tradename assets. As of December 31, 2017, the estimated fair value of the Company’s tradename assets exceeded their carrying values by more than 10% The table below summarizes the Company’s intangible assets and the amortization method used for each type of intangible asset: Intangible Asset Amortization Method Goodwill Indefinite-lived Tradename Indefinite-lived Vendor contracts Straight-line method over the terms of the underlying contracts. The remaining terms of the underlying contracts range from one to three years. Favorable/unfavorable leases Based on the pattern in which the economic benefits are realized over the terms of the lease agreements. The remaining terms of the lease agreements range from approximately two to nineteen years. Other intangible assets Straight-line method over the terms of the underlying agreement or the expected useful life of the intangible asset. The remaining useful lives of these intangible assets range from one to twelve years. Deferred Charges and Other Assets — Deferred charges and other assets consist of long-term prepaid rents, construction and other deposits, equipment to be placed in service, and other assets of a long-term nature. Long-term prepaid rents represent prepayments of rent on operating leases. These payments are recognized as facility lease expense over the period for which the rent was paid in advance as outlined in the lease agreements. The remaining amortization periods generally range from one to fifteen years. Lease Accounting — The Company evaluates each lease for classification as either a capital lease or an operating lease. The Company records the lease as a capital lease at its inception if 1) the present value of future minimum lease payments exceeds 90% of the leased property’s estimated fair value; 2) the lease term exceeds 75% of the property’s estimated useful life; 3) the lease contains a bargain purchase option; or 4) ownership transfers to the Company at the end of the lease. The Company performs this evaluation at the inception of the lease and when a modification is made to a lease. If the lease agreement calls for a scheduled rent increase during the lease term, the Company recognizes the lease expense on a straight-line basis over the lease term. The Company determines the straight-line rent expense impact of an operating lease upon inception of the lease. For some new build theatres, the landlord is responsible for constructing a theatre using guidelines and specifications agreed to by the Company and assumes substantially all of the risk of construction. For other theatres, the Company is responsible for managing construction of the theatre and the landlord contributes an agreed upon amount to the costs of construction. If the Company concludes that it has substantially all of the construction period risks, it records a construction asset and related liability for the amount of total project costs incurred during the construction period. At the end of the construction period, the Company determines if the transaction qualifies for sale-leaseback accounting treatment in regards to lease classification. If the Company receives a lease incentive payment from a landlord, the Company records the proceeds as a deferred lease incentive liability and amortizes the liability as a reduction in rent expense over the initial term of the respective lease if a new theatre, or over the remaining lease term if an existing theatre. Deferred Revenues — Advances collected on long-term screen advertising, concession and other contracts are recorded as deferred revenues. In accordance with the terms of the agreements, the advances collected on such contracts are recognized during the period in which the advances are earned, which may differ from the period in which the advances are collected. These advances are recognized on either a straight-line basis over the term of the contracts or as such revenues are earned in accordance with the terms of the contracts. The remaining amortization periods generally range from one to twenty years. See Note 2 for discussion of impact of new revenue recognition accounting pronouncement and Note 3 for discussion of deferred revenue – NCM. Self-Insurance Reserves — The Company is self-insured for general liability claims subject to an annual cap. For the years ended December 31, 2015, 2016 and 2017, general liability claims were capped at $100, $100 and $250, respectively, per occurrence with annual caps of approximately $2,900, $3,350 and $3,900, respectively. The Company was fully insured for workers compensation claims during the years ended December 31, 2015 and 2016. During 2017, the Company implemented a fully-funded deductible workers compensation insurance plan under which the Company is responsible for pre-funding claims and is responsible for claims up to $250 per occurrence, with an annual cap of $5,000. The Company was also self-insured for medical claims up to $125, $150 and $250 per occurrence for the years ended December 31, 2015, 2016 and 2017, respectively. As of December 31, 2016 and 2017, the Company’s insurance reserves were $7,837 and $8,252, respectively, and are reflected in accrued other current liabilities in the consolidated balance sheets. Revenue and Expense Recognition — Revenues are recognized when admissions and concession sales are received at the box office. Other revenues include screen advertising and other ancillary revenues such as vendor marketing promotions, meeting rentals and electronic video games located in the Company’s theatres. Screen advertising revenues are recognized over the period that the related advertising is delivered on-screen or in-theatre. The Company records proceeds from the sale of gift cards and other advanced sale-type certificates in current liabilities and recognizes admissions or concession revenue when a holder redeems the card or certificate. The Company recognizes unredeemed gift cards and other advanced sale-type certificates as revenue only after such a period of time indicates, based on historical experience, the likelihood of redemption is remote, and based on applicable laws and regulations. In evaluating the likelihood of redemption, the Company considers the period outstanding, the level and frequency of activity, and the period of inactivity. As of December 31, 2016 and 2017, the Company’s liabilities for advanced sale-type certificates were approximately $70,247 and $77,623, respectively, and are reflected in accrued other current liabilities on the consolidated balance sheets. The Company recognized unredeemed gift cards and other advanced sale-type certificates as revenues in the amount of $11,786, $11,522 and $11,861 during the years ended December 31, 2015, 2016 and 2017, respectively. See Note 2 for discussion of impact of new revenue recognition accounting pronouncements. Film rental costs are accrued based on the applicable box office receipts and either firm terms or a sliding scale formula, which are generally established prior to the opening of the film, or estimates of the final settlement rate, which occurs at the conclusion of the film run, subject to the film licensing arrangement. Under a firm terms formula, the Company pays the distributor a percentage of box office receipts, which reflects either an aggregate rate for the life of the film or rates that decline over the term of the run. Under a sliding scale formula, film rental is paid as a percentage of box office revenues using a pre-determined matrix based upon box office performance of the film. The settlement process allows for negotiation of film rental fees upon the conclusion of the film run based upon how the film performs. Estimates are based on the expected success of a film. The success of a film can typically be determined a few weeks after a film is released when initial box office performance of the film is known. Accordingly, final settlements typically approximate estimates since box office receipts are known at the time the estimate is made and the expected success of a film can typically be estimated early in the film’s run. If actual settlements are different than those estimates, film rental costs are adjusted at the time of settlement. Loyalty Programs — The Company launched its app-based Connections loyalty program for its domestic markets in February 2016. Customers earn points for initial sign-up and for various transactions as tracked within the app. Points may be redeemed for concessions items, concession discounts and experiential rewards, each of which are offered for limited periods of time and at varying times during the year. The Company has determined that the values of the rewards offered to the customer are insignificant to the original transactions required to earn such rewards and has applied the incremental cost approach to accounting for the rewards earned. The Company also has loyalty programs in certain of its international markets, which generally consist of the customer paying a membership fee in exchange for discounts during the membership period. The Company had approximately $5,527 recorded in accrued other current liabilities for its loyalty programs as of December 31, 2017. See Note 2 for discussion of impact of new revenue recognition accounting pronouncements. Accounting for Share Based Awards — The Company measures the cost of employee services received in exchange for an equity award based on the fair value of the award on the date of the grant. The grant date fair value is estimated using a market observed price. Such costs are recognized over the period during which an employee is required to provide service in exchange for the award (which is usually the vesting period). At the time of the grant, the Company also estimates the number of awards that will ultimately be forfeited. See Note 12 for discussion of the Company’s share based awards and related compensation expense. Income Taxes — The Company participates in the consolidated return of Cinemark Holdings, Inc. However, the Company’s provision for income taxes is computed on a stand-alone basis. The Company uses an asset and liability approach to financial accounting and reporting for income taxes. Deferred income taxes are provided when tax laws and financial accounting standards differ with respect to the amount of income for a year and the basis of assets and liabilities. A valuation allowance is recorded to reduce the carrying amount of deferred tax assets unless it is more likely than not that such assets will be realized. Income taxes are provided on unremitted earnings from foreign subsidiaries unless such earnings are expected to be indefinitely reinvested. Income taxes have also been provided for potential tax assessments. The evaluation of an uncertain tax position is a two-step process. The first step is recognition: The Company determines whether it is more likely than not that a tax position will be sustained upon examination, including resolution of any related appeals or litigation processes, based on the technical merits of the position. In evaluating whether a tax position has met the more-likely-than-not recognition threshold, the Company should presume that the position would be examined by the appropriate taxing authority that would have full knowledge of all relevant information. The second step is measurement: A tax position that meets the more-likely-than-not recognition threshold is measured to determine the amount of benefit to recognize in the financial statements. The tax position is measured as the largest amount of benefit that is greater than 50 percent likely of being realized upon ultimate settlement. Differences between tax positions taken in a tax return and amounts recognized in the financial statements result in (1) a change in a liability for income taxes payable or (2) a change in an income tax refund receivable, a deferred tax asset or a deferred tax liability or both (1) and (2). The Company accrues interest and penalties on its uncertain tax positions as a component of income tax expense. Segments — For the years ended December 31, 2015, 2016 and 2017, the Company managed its business under two reportable operating segments, U.S. markets and international markets. See Note 16. Use of Estimates — The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires the use of estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the periods presented. The Company’s consolidated financial statements include amounts that are based on management’s best estimates and judgments. Actual results could differ from those estimates. Foreign Currency Translations — The assets and liabilities of the Company’s foreign subsidiaries are translated into U.S. dollars at current exchange rates as of the balance sheet date, and revenues and expenses are translated at average monthly exchange rates. The resulting translation adjustments are recorded in the consolidated balance sheets in accumulated other comprehensive loss. See Note 10 for a summary of the translation adjustments recorded in accumulated other comprehensive loss for the years ended December 31, 2015, 2016 and 2017. The Company recognizes foreign currency transaction gains and losses when changes in exchange rates impact transactions, other than intercompany transactions of a long-term investment nature, that have been denominated in a currency other than the functional currency. Fair Value Measurements — According to authoritative guidance, inputs used in fair value measurements fall into three different categories; Level 1, Level 2 and Level 3. Level 1 inputs are quoted prices (unadjusted) in active markets for identical assets or liabilities that the reporting entity has the ability to access at the measurement date. Level 2 inputs are inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly. Level 3 inputs are unobservable inputs for the asset or liability. The Company had an interest rate swap agreement and investments in marketable securities that were adjusted to fair value on a recurring basis (quarterly). With respect to its interest rate swap agreement, the Company used the income approach to determine the fair value of its interest rate swap agreement and under this approach, the Company used projected future interest rates as provided by the counterparties to the interest rate swap agreement and the fixed rate that the Company was obligated to pay under the agreement. Therefore, the Company’s fair value measurements for its interest rate swap used significant unobservable inputs, which fall in Level 3. The interest rate swap agreement expired in April 2016. With respect to its investments in marketable securities, the Company used quoted market prices, which fall under Level 1 of the hierarchy. There were no changes in valuation techniques during the period and no transfers in or out of Level 1, Level 2 or Level 3 during the years ended December 31, 2015, 2016 and 2017. See Note 9 for further discussion of the Company’s fair value measurements. The Company also uses fair value measurements on a nonrecurring basis, primarily in the impairment evaluations for goodwill, intangible assets and other long-lived assets. See and included above for discussion of such fair value measurements. Acquisitions — The Company accounts for acquisitions under the acquisition method of accounting. The acquisition method requires that the acquired assets and liabilities, including contingencies, be recorded at fair value determined on the acquisition date and changes thereafter reflected in income. For significant acquisitions, the Company obtains independent third party valuation studies for certain of the assets acquired and liabilities assumed to assist the Company in determining fair value. The estimation of the fair values of the assets acquired and liabilities assumed involves a number of estimates and assumptions that could differ materially from the actual amounts realized. The Company provides assumptions, including both quantitative and qualitative information, about the specified asset or liability to the third party valuation firms. The Company primarily utilizes the third parties to accumulate comparative data from multiple sources and assemble a report that summarizes the information obtained. The Company then uses the information to record estimated fair value. The third party valuation firms are supervised by Company personnel who are knowledgeable about valuations and fair value. The Company evaluates the appropriateness of the assumptions and valuation methodologies utilized by the third party valuation firm.

New Accounting Pronouncements

New Accounting Pronouncements	12 Months Ended
	Dec. 31, 2017
Accounting Changes And Error Corrections [Abstract]
New Accounting Pronouncements	2. NEW ACCOUNTING PRONOUNCEMENTS Impact of New Revenue Recognition Standard In May 2014, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2014-09, Revenue from Contracts with Customers (Topic 606) ASC 606 permits two methods of adoption: retrospectively to each prior reporting period presented (full retrospective method), or retrospectively with the cumulative effect of initially applying the guidance recognized at the date of initial application (modified retrospective method). The Company adopted ASC 606 as of January 1, 2018 using the modified retrospective method. The new standard will therefore be applied to all contracts not completed as of January 1, 2018. While the Company does not believe the adoption of ASC 606 will have a material impact to its results of operations or cash flows, it does expect ASC 606 to have an impact on the classification of certain revenues and related expenses, as summarized below. Quantitative amounts included below are estimates of the expected effects of the Company’s adoption of ASC 606 and represent management’s best estimates of the impact of adopting ASC 606 at the time of the preparation of this Annual Report on Form 10-K. The actual impact of ASC 606 is subject to change from these estimates, pending the completion of the Company’s assessment during the first quarter of 2018. • The Company believes its Exhibitor’s Services Agreement (“ESA”) with National CineMedia, LLC (“NCM”) includes a significant financing component due to the length of time necessary to fulfill the performance obligations under the ESA as compared to the timing of receipt of the advanced payment. Similarly, the Company believes its Common Unit Adjustment (“CUA”) Agreement with NCM includes a significant financing component due to the receipt of common units in advance of the fulfillment of the performance obligations. As a result, the Company expects other revenues, specifically screen advertising revenues, will increase with a similar offsetting increase in noncash interest expense, but will not have a material impact on the Company’s results of operations. • In addition to recording the impact of significant financing components associated with its NCM ESA and CUA agreement, the Company has determined that based on how the performance obligations are fulfilled under these agreements, the related deferred revenues will be amortized on a straight-line basis under ASC 606 versus the units of revenue method followed prior to adoption of ASC 606. As a result of the change in amortization method, the Company expects to record a cumulative effect of accounting change adjustment of no more than $55,000 in retained earnings effective January 1, 2018, with an offsetting decrease in deferred revenue - NCM. • The Company currently records online surcharges net of service fees as amounts have been immaterial. The Company has determined that it is the principal in the arrangement, and therefore, in accordance with ASC 606 guidance, the Company will recognize online surcharges in revenues on a gross basis and record all related service fees as an operating expense. As a result of this change, the Company’s other revenues and utilities and other costs will increase on a prospective basis, but will not have a material impact on the Company’s results of operations. • The Company currently has a domestic loyalty program that awards points to its members upon completion of various purchases and other transactions. Under ASC 606, the Company will have to defer a portion of the proceeds received from each purchase as a liability to provide future goods and services (or rewards in exchange for points) to program members. The Company expects this will result in slight reductions in admissions and concessions revenues with an offsetting increase in other long-term liabilities, but will not have a material impact on the consolidated financial statements. The timing of revenue recognition for other revenue streams, including revenues for unredeemed gift cards and other advanced sales-type certificates, will also be impacted by the adoption of ASC 606, but we do not expect such changes to be material. Other New Accounting Pronouncements In February 2016, the FASB issued Accounting Standards Update 2016-02, Leases (Topic 842) In March 2016, the FASB issued Accounting Standards Update 2016-09, Compensation – Stock Compensation (Topic 718): Improvements to Employee Share-Based Payment Accounting In August 2016, the FASB issued Accounting Standards Update 2016-15, Statement of Cash Flows (Topic 230): Classification of Certain Cash Receipts and Cash Payments – a consensus of the FASB Emerging Issues Task Force In January 2017, the FASB issued Accounting Standards Update 2017-04, Intangibles – Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment In May 2017, the FASB issued Accounting Standards Update 2017-09, Compensation – Stock Compensation (Topic 718): Scope Modification Accounting In August 2017, the FASB issued Accounting Standards Update 2017-12, Derivatives and Hedging (Topic 815): Targeted Improvements to Accounting for Hedging Activities

Investment in National CineMedi

Investment in National CineMedia LLC	12 Months Ended
	Dec. 31, 2017
NCM
Investment in National CineMedia LLC	3. INVESTMENT IN NATIONAL CINEMEDIA LLC The Company has an investment in National CineMedia, LLC (“NCM”). NCM operates a digital in-theatre network in the U.S. for providing cinema advertising and non-film events. Upon joining NCM, the Company entered into an Exhibitor Services Agreement, or the ESA, with NCM, pursuant to which NCM provides advertising, promotion and event services to our theatres. On February 13, 2007, The ESA modification reflected a shift from circuit share expense under the prior ESA, which obligated NCM to pay the Company a percentage of revenue, to a monthly theatre access fee, which significantly reduced the contractual amounts paid to us by NCM. The Company recorded the proceeds related to the ESA modification as deferred revenue, which is being amortized into other revenues over the life of the agreement using the units of revenue method. As a result of the application of a portion of the proceeds it received from the NCMI initial public offering, the Company had a negative basis in its original membership units in NCM, which is referred to herein as the Company’s Tranche 1 Investment. Following the NCMI IPO, the Company does not recognize undistributed equity in the earnings on its Tranche 1 Investment until NCM's net earnings, less distributions received, surpass the amount of the excess distribution. The Company recognizes equity in earnings on its Tranche 1 Investment only to the extent it receives cash distributions from NCM. The Company The Company believes that the accounting model provided by ASC 323-10-35-22 for recognition of equity investee losses in excess of an investor's basis is analogous to the accounting for equity income subsequent to recognizing an excess distribution. Common Unit Adjustments Pursuant to a Common Unit Adjustment Agreement dated as of February 13, 2007 between NCMI and the Company, AMC and Regal, which we refer to collectively as the Founding Members, annual adjustments to the common membership units are made primarily based on increases or decreases in the number of theatre screens operated and theatre attendance generated by each Founding Member. To account for the receipt of additional common units under the Common Unit Adjustment Agreement, we follow the guidance in FASB ASC 323-10-35-29 (formerly EITF 02-18, “Accounting for Subsequent Investments in an Investee after Suspension of Equity Loss Recognition” Below is a summary of common units received by the Company under the Common Unit Adjustment Agreement during the years ended December 31, 2015, 2016 and 2017: Date Number Fair Value Common Units of Common Units of Common Units Event Received Received Received 2015 Annual common unit adjustment 3/31/2015 1,074,910 $ 15,421 2016 Annual common unit adjustment 3/31/2016 753,598 $ 11,111 2017 Annual common unit adjustment 3/31/2017 1,487,218 $ 18,363 Each common unit received by the Company is convertible into one share of NCMI common stock. The fair value of the common units received was estimated based on the market price of NCMI stock at the time that the common units were received, adjusted for volatility associated with the estimated period of time it would take to convert the common units and register the respective shares. The fair value measurement used for the common units falls under Level 2 of the U.S. GAAP fair value hierarchy as defined by ASC Topic 820-10-35. The Company records additional common units it receives as part of its Tranche 2 Investment at estimated fair value with a corresponding adjustment to deferred revenue. As of December 31, 2017, the Company owned a total of 27,871,862 common units of NCM, which represented an interest of approximately 18%. Each common unit is convertible into one share of NCMI common stock. The estimated fair value of the Company’s investment in NCM was approximately $191,201 based on NCM, Inc.’s stock price as of December 31, 2017 of $6.86 per share (Level 1 input as defined in FASB ASC Topic 820), which was less than the Company’s carrying value of $200,550. The Company does not believe that the decline in NCM, Inc.’s stock price is other than temporary and therefore, no impairment of the Company’s investment in NCM was recorded during the year ended December 31, 2017. The market value of NCM, Inc.’s stock price may continue to vary due to the performance of the business, industry trends, general and economic conditions and other factors. Summary of Activity with NCM Below is a summary of activity with NCM included in the Company’s consolidated financial statements for the periods indicated. See Note 2 for discussion of impact of new revenue recognition accounting pronouncements. Investment Deferred Distributions from Equity in Other Other Comprehensive Cash in NCM Revenue NCM Earnings Revenue Loss Received Balance as of January 1, 2015 $ 178,939 $ (335,219 ) Receipt of common units due to annual common unit adjustment 15,421 (15,421 ) $ — $ — $ — $ — $ — Revenues earned under ESA (1) — — — — (11,330 ) — 11,330 Receipt of excess cash distributions (14,072 ) — (15,396 ) — — — 29,468 Receipt under tax receivable agreement (2,308 ) — (2,744 ) — — — 5,052 Equity in earnings 8,510 — — (8,510 ) — — — Equity in other comprehensive loss (2,735 ) — — — — 2,735 Amortization of deferred revenue — 8,506 — — (8,506 ) — — Balance as of and for the twelve months ended December 31, 2015 $ 183,755 $ (342,134 ) $ (18,140 ) $ (8,510 ) $ (19,836 ) $ 2,735 $ 45,850 Receipt of common units due to annual common unit adjustment 11,111 (11,111 ) $ — $ — $ — $ — $ — Revenues earned under ESA (1) — — — — (11,048 ) — 11,048 Receipt of excess cash distributions (11,233 ) — (11,483 ) — — — 22,716 Receipt under tax receivable agreement (2,985 ) — (3,173 ) — — — 6,158 Equity in earnings 9,347 — — (9,347 ) — — — Amortization of deferred revenue — 9,317 — — (9,317 ) — — Balance as of and for the twelve months ended December 31, 2016 $ 189,995 $ (343,928 ) $ (14,656 ) $ (9,347 ) $ (20,365 ) $ — $ 39,922 Receipt of common units due to annual common unit adjustment 18,363 (18,363 ) $ — $ — $ — $ — $ — Revenues earned under ESA (1) — — — — (11,274 ) — 11,274 Receipt of excess cash distributions (15,093 ) — (14,158 ) — — — 29,251 Receipt under tax receivable agreement (2,265 ) — (2,249 ) — — — 4,514 Equity in earnings 9,550 — — (9,550 ) — — — Amortization of deferred revenue — 10,585 — — (10,585 ) — — Balance as of and for the twelve months ended December 31, 2017 $ 200,550 $ (351,706 ) $ (16,407 ) $ (9,550 ) $ (21,859 ) $ — $ 45,039 (1) Amounts include the per patron and per digital screen theatre access fees due to the Company, net of amounts due to NCM for on-screen advertising time provided to the Company’s beverage concessionaire. The amounts due to NCM for on-screen advertising time provided to the Company’s beverage concessionaire were approximately $9,819, $10,523 and $11,110 for the years ended December 31, 2015, 2016 and 2017, respectively. The Company made payments to NCM of approximately $50, $49 and $102 during the years ended December 31, 2015, 2016 and 2017, respectively, related to installation of certain equipment used for digital advertising, which is included in theatre furniture and equipment on the consolidated balance sheets. The tables below present summary financial information for NCM for the periods indicated (financial information for NCM’s fiscal year ended December 29, 2017 is not yet available): Year Ended Year Ended Nine Months Ended December 31, 2015 December 29, 2016 September 28, 2017 Revenues $ 446,500 $ 447,600 $ 285,400 Operating income $ 140,500 $ 173,000 $ 83,700 Net income $ 87,500 $ 109,300 $ 44,800 As of As of December 29, 2016 September 28, 2017 Current assets $ 180,900 $ 130,100 Noncurrent assets $ 607,600 $ 776,900 Current liabilities $ 121,100 $ 96,700 Noncurrent liabilities $ 924,300 $ 910,800 Members' deficit $ (256,900 ) $ (100,500 )

Other Investments

Other Investments	12 Months Ended
	Dec. 31, 2017
Financial Support For Nonconsolidated Legal Entity [Abstract]
Other Investments	4. OTHER INVESTMENTS Below is a summary of activity for each of the Company’s other investments for the periods indicated: DCIP RealD AC LLC DCDC Other Total Balance at December 31, 2014 $ 51,277 $ 14,429 $ 7,899 $ 2,438 $ 1,615 $ 77,658 Cash contributions 3,211 — — — 500 3,711 Equity in income 18,522 — 970 124 — 19,616 Equity in comprehensive loss (384 ) — — — — (384 ) Unrealized holding loss — (1,529 ) — — — (1,529 ) Sale of investment in Taiwan (1) — — — — (1,383 ) (1,383 ) Cash distributions received (1,047 ) — (1,600 ) — — (2,647 ) Other — — — — (69 ) (69 ) Balance at December 31, 2015 $ 71,579 $ 12,900 $ 7,269 $ 2,562 $ 663 $ 94,973 Cash contributions 717 — — — 415 1,132 Equity in income 21,434 — 311 870 — 22,615 Equity in comprehensive income 89 — — — — 89 Sale of investment (2) — (12,900 ) — — — (12,900 ) Cash distributions received (6,000 ) — (1,600 ) (98 ) — (7,698 ) Other — — — (584 ) 690 106 Balance at December 31, 2016 $ 87,819 $ — $ 5,980 $ 2,750 $ 1,768 $ 98,317 Cash contributions 1,112 — — — 2,603 3,715 Equity in income 22,900 — 2,336 1,199 — 26,435 Equity in comprehensive income 248 — — — — 248 Cash distributions received (5,864 ) — (2,400 ) (351 ) — (8,615 ) Other — — — — (55 ) (55 ) Balance at December 31, 2017 $ 106,215 $ — $ 5,916 $ 3,598 $ 4,316 $ 120,045 (1) (2) RealD, Inc Digital Cinema Implementation Partners LLC (“DCIP”) On February 12, 2007, the Company, AMC and Regal entered into a joint venture known as DCIP to facilitate the implementation of digital cinema in the Company’s theatres and to establish agreements with major motion picture studios for the financing of digital cinema. As of December 31, 2017, the Company had a 33% voting interest in DCIP and a 24.3% economic interest in DCIP. The Company accounts for its investment in DCIP and its subsidiaries under the equity method of accounting. Below is summary financial information for DCIP as of and for the years ended December 31, 2015, 2016 and 2017. Year ended December 31, 2015 2016 2017 Revenues $ 171,203 $ 178,836 $ 177,382 Operating income $ 103,449 $ 107,919 $ 106,687 Net income $ 79,255 $ 89,152 $ 93,103 As of December 31, 2016 December 31, 2017 Current assets $ 45,087 $ 56,296 Noncurrent assets $ 861,290 $ 772,438 Current liabilities $ 44,771 $ 59,153 Noncurrent liabilities $ 464,246 $ 296,889 Members' equity $ 397,360 $ 472,692 The digital projection systems are being leased from Kasima LLC (“Kasima”), which is an indirect subsidiary of DCIP and a related party to the Company, under an operating lease with an initial term of twelve years that contains ten one-year fair value renewal options. The equipment lease agreement also contains a fair value purchase option. Under the equipment lease agreement, the Company pays annual rent of one thousand dollars per digital projection system. The Company may also be subject to various types of other rent if such digital projection systems do not meet minimum performance requirements as outlined in the agreements. Certain of the other rent payments are subject to either a monthly or an annual maximum. As of December 31, 2017, the Company had 3,805 digital projection systems being leased under the master equipment lease agreement with Kasima. The Company had the following transactions with DCIP during the years ended December 31, 2015, 2016 and 2017: Year Ended December 31, 2015 2016 2017 Equipment lease payments $ 4,474 $ 5,217 $ 5,743 Warranty reimbursements from DCIP $ (4,329 ) $ (6,091 ) $ (8,511 ) Management services fees $ 825 $ 825 $ 823 RealD, Inc. (“RealD”) The Company licenses 3-D systems from RealD. Under its license agreement with RealD, the Company earned options to purchase shares of RealD common stock as it installed a certain number of 3-D systems as outlined in the license agreement. During 2010 and 2011, the Company vested in a total of 1,222,780 RealD options. Upon vesting in these options, the Company recorded an investment in RealD and a deferred lease incentive liability using the estimated fair value of the RealD options at the time of vesting. During March 2011, the Company exercised all of its options to purchase shares of common stock in RealD for $0.00667 per share. The Company owned 1,222,780 shares of RealD and accounted for its investment in RealD as a marketable security, specifically an available-for-sale security, in accordance with ASC Topic 320-10-35-1, therefore unrealized holding gains and losses were reported as a component of accumulated other comprehensive loss until realized. On March 22, 2016, an affiliate of Rizvi Traverse Management, LLC acquired RealD for $11.00 per share. As a result of the transaction, the Company sold its shares for approximately $13,451 and recognized a gain of $3,742, which included the recognition of a cumulative unrealized holding gain of $3,191 previously recorded in accumulated other comprehensive loss. The gain is reflected within loss on sale of assets and other on the consolidated statement of income for the year ended December 31, 2016. The Company used the proceeds to make a pre-payment on its term loan in accordance with the terms of its senior secured credit facility (see Note 8). AC JV, LLC During December 2013, the Company, Regal, AMC (the “AC Founding Members”) and NCM entered into a series of agreements that resulted in the formation of AC JV, LLC (“AC”), a new joint venture that now owns “Fathom Events” (consisting of Fathom Events and Fathom Consumer Events) formerly operated by NCM. The Fathom Events business focuses on the marketing and distribution of live and pre-recorded entertainment programming to various theatre operators to provide additional programs to augment their feature film schedule. The Fathom Consumer Events business includes live and pre-recorded concerts featuring contemporary music, opera and symphony, DVD product releases and marketing events, theatrical premieres, Broadway plays, live sporting events and other special events. The Company paid event fees to AC of $11,440, $10,871 and $13,950 for the years ended December 31, 2015, 2016 and 2017, respectively, which are included in film rentals and advertising costs on the consolidated statements of income. AC was formed by the AC Founding Members and NCM. NCM, under a contribution agreement, contributed the assets associated with its Fathom Events division to AC in exchange for 97% ownership of the Class A Units of AC. Under a separate contribution agreement, the Founding Members each contributed cash of approximately $268 to AC in exchange for 1% of the Class A Units of AC. Subsequently, NCM and the Founding Members entered into a Membership Interest Purchase Agreement, under which NCM sold each of the Founding Members 31% of its Class A Units in AC, the aggregate value of which was determined to be $25,000, in exchange for a six-year Promissory Note. Each of the Founding Members’ Promissory Notes were originally for $8,333, bear interest at 5% per annum and require annual principal and interest payments. The remaining outstanding balance of the note payable from the Company to NCM as of December 31, 2017 was $2,778. Digital Cinema Distribution Coalition The Company is a party to a joint venture with certain exhibitors and distributors called Digital Cinema Distribution Coalition (“DCDC”). DCDC operates a satellite distribution network that distributes all digital content to U.S. theatres via satellite. The Company has an approximate 14.6% ownership in DCDC. The Company paid approximately $807, $939 and $848 to DCDC during the years ended December 31, 2015, 2016 and 2017, respectively, related to content delivery services, which is included in film rentals and advertising costs on the consolidated statements of income.

GOODWILL AND OTHER INTANGIBLE A

GOODWILL AND OTHER INTANGIBLE ASSETS - NET	12 Months Ended
	Dec. 31, 2017
Goodwill And Intangible Assets Disclosure [Abstract]
GOODWILL AND OTHER INTANGIBLE ASSETS - NET	5. GOODWILL AND OTHER INTANGIBLE ASSETS — NET The Company’s goodwill was as follows: U.S. Operating Segment International Operating Segment Total Balance at December 31, 2015 (1) $ 1,156,556 $ 90,992 $ 1,247,548 Acquisitions of theatres 7,607 — 7,607 Other acquisitions (2) — 1,410 1,410 Foreign currency translation adjustments — 6,398 6,398 Balance at December 31, 2016 (1) $ 1,164,163 $ 98,800 $ 1,262,963 Acquisitions of theatres (3) 9,878 13,211 23,089 Foreign currency translation adjustments — (1,973 ) (1,973 ) Balance at December 31, 2017 (1) $ 1,174,041 $ 110,038 $ 1,284,079 (1) Balances are presented net of accumulated impairment losses of $214,031 for the U.S. operating segment and $27,622 for the international operating segment. (2) (3) Acquisition of theatres in the U.S. and international markets. As of December 31, intangible assets-net, consisted of the following: Balance at Balance at January 1, December 31, 2016 Additions (1) Amortization Other (2) 2016 Intangible assets with finite lives: Gross carrying amount $ 99,968 $ 503 $ — $ (675 ) $ 99,796 Accumulated amortization (59,706 ) ― (5,538 ) 638 (64,606 ) Total net intangible assets with finite lives $ 40,262 $ 503 $ (5,538 ) $ (37 ) $ 35,190 Intangible assets with indefinite lives: Tradename 299,382 ― ― 327 299,709 Total intangible assets — net $ 339,644 $ 503 $ (5,538 ) $ 290 $ 334,899 Balance at Balance at January 1, December 31, 2017 Additions (3) Amortization Other (2) 2017 Intangible assets with finite lives: Gross carrying amount $ 99,796 $ 11,584 $ — $ (5,485 ) $ 105,895 Accumulated amortization (64,606 ) — (5,563 ) 1,300 (68,869 ) Total net intangible assets with finite lives $ 35,190 $ 11,584 $ (5,563 ) $ (4,185 ) $ 37,026 Intangible assets with indefinite lives: Tradename 299,709 — — 26 299,735 Total intangible assets — net $ 334,899 $ 11,584 $ (5,563 ) $ (4,159 ) $ 336,761 (1) Activity for 2016 reflects addition of non-compete agreement and favorable lease associated with theatres acquired in the U.S. (2) Amounts represent foreign currency translation adjustments and the write-off of certain lease intangibles for theatre closures and lease amendments. (3) Amounts represent fair values allocated to intangible assets acquired as part of acquisitions of theatres in the U.S. and international markets. Estimated aggregate future amortization expense for intangible assets is as follows: For the year ended December 31, 2018 $ 5,725 For the year ended December 31, 2019 5,267 For the year ended December 31, 2020 5,535 For the year ended December 31, 2021 3,685 For the year ended December 31, 2022 3,280 Thereafter 13,534 Total $ 37,026

IMPAIRMENT OF LONG-LIVED ASSETS

IMPAIRMENT OF LONG-LIVED ASSETS	12 Months Ended
	Dec. 31, 2017
Impairment Or Disposal Of Tangible Assets Disclosure [Abstract]
IMPAIRMENT OF LONG-LIVED ASSETS	6. IMPAIRMENT OF LONG-LIVED ASSETS The Company reviews long-lived assets for impairment indicators on a quarterly basis or whenever events or changes in circumstances indicate the carrying amount of the assets may not be fully recoverable. See Note 1 for discussion of the Company’s impairment policy. The Company’s long-lived asset impairment losses are summarized in the following table: Year Ended December 31, 2015 2016 2017 U.S. theatre properties $ 7,052 $ 1,929 $ 5,227 International theatre properties 757 907 9,857 Subtotal 7,809 2,836 15,084 Intangible assets (1) 992 — — Impairment of long-lived assets $ 8,801 $ 2,836 $ 15,084 (1) Activity for 2015 was related to the impairment of a favorable lease for one theatre. The long-lived asset impairment charges recorded during each of the years presented are specific to theatres that were directly and individually impacted by increased competition, adverse changes in market demographics, or adverse changes in the development or the conditions of the areas surrounding the theatre. As of December 31, 2017, the estimated aggregate remaining fair value of the long-lived assets impaired during the year ended December 31, 2017 was approximately $8,953.

Deferred Charges and Other Ass

Deferred Charges and Other Assets - Net	12 Months Ended
	Dec. 31, 2017
Deferred Costs Capitalized Prepaid And Other Assets Disclosure [Abstract]
Deferred Charges and Other Assets - Net	7. DEFERRED CHARGES AND OTHER ASSETS — NET As of December 31, deferred charges and other assets — net consisted of the following: December 31, 2016 2017 Long-term prepaid rents $ 5,996 $ 7,762 Construction and other deposits 10,881 12,167 Equipment to be placed in service 12,856 13,868 Other 7,822 5,970 Total $ 37,555 $ 39,767

LONG-TERM DEBT

LONG-TERM DEBT	12 Months Ended
	Dec. 31, 2017
Debt Disclosure [Abstract]
LONG-TERM DEBT	8. LONG-TERM DEBT As of December 31, long-term debt consisted of the following: December 31, 2016 2017 Cinemark USA, Inc. term loan $ 663,799 $ 659,517 Cinemark USA, Inc. 4.875% senior notes due 2023 755,000 755,000 Cinemark USA, Inc. 5.125% senior notes due 2022 400,000 400,000 Other (1) 4,167 2,778 Total long-term debt 1,822,966 1,817,295 Less current portion 5,671 7,099 Less debt issuance costs, net of accumulated amortization of $19,364 and $25,549, respectively 34,854 29,815 Long-term debt, less current portion $ 1,782,441 $ 1,780,381 (1) Primarily represents debt owed to NCM in relation to the recently-formed joint venture AC JV, LLC. See Note 4. Senior Secured Credit Facility Cinemark USA, Inc. has a senior secured credit facility that includes a seven year $700,000 term loan and a five year $100,000 revolving credit line (the “Credit Agreement”). On May 8, 2015, Cinemark USA, Inc. amended its Credit Agreement to extend the maturity of the $700,000 term loan from December 2019 to May 2022. After the amendment, quarterly principal payments in the amount of $1,750 were due on the term loan through March 31, 2022, with the remaining principal of $635,250 due on May 8, 2022. The Company incurred debt issue costs of approximately $6,957 in connection with the amendment, which is reflected as a reduction of long-term debt on the consolidated balance sheets. In addition, the Company incurred approximately $925 in legal and other fees that are reflected as loss on debt amendments and refinancing on the consolidated statement of income for the year ended December 31, 2015. On May 16, 2016, Cinemark USA, Inc. made a pre-payment of $13,451 on its term loan using the net proceeds received from the sale of shares of RealD (see Note 4). In accordance with the terms of the Credit Agreement, the pre-payment was applied first to the next four principal installments, and second, to the remaining installments pro-rata based on the remaining outstanding principal amount of such installments. Therefore, subsequent to the prepayment, quarterly payments in the amount of $1,427 are due on the term loan beginning June 30, 2017 through March 31, 2022, with the remaining principal of $635,250 due on May 8, 2022. The Company did not incur any fees as a result of the pre-payment. Cinemark USA, Inc. amended its Credit Agreement as follows during 2016 and 2017: Debt Issue Loss on Debt Effective Date Nature of Amendment Costs Paid (1) Amendment (2) June 13, 2016 Reduced term loan interest rate by 0.25% $ 783 $ 249 December 15, 2016 Reduced term loan interest rate by 0.50% $ 2,446 $ 161 June 16, 2017 Reduced term loan interest rate by 0.25%; modified certain definitions and other provisions in the Credit Agreement $ 521 $ 190 November 28, 2017 Extended maturity of revolving credit line to December 2022; reduced the interest rate applicable to borrowings under the credit line $ 330 $ 331 (1) Reflected as a reduction of long term debt on the consolidated balance sheet as of December 31, 2016 and 2017. (2) Reflected as a loss on debt amendments and refinancing on the consolidated statement of income for the year in which the amendments were effective. Subsequent to the amendments noted above, interest on the term loan accrues at Cinemark USA, Inc.’s option at: (A) the base rate equal to the greater of (1) the US “Prime Rate” as quoted in The Wall Street Journal or if no such rate is quoted therein, in a Federal Reserve Board statistical release, (2) the federal funds effective rate plus 0.50%, and (3) a one-month Eurodollar-based rate plus 1.0%, plus, in each case, a margin of 1.00% per annum, or (B) a Eurodollar-based rate for a period of 1, 2, 3, 6, 9 or 12 months plus a margin of 2.00% per annum. Interest on the revolving credit line accrues, at our option, at: (A) a base rate equal to the greater of (1) the US “Prime Rate” as quoted in The Wall Street Journal or if no such rate is quoted therein, in a Federal Reserve Board statistical release, (2) the federal funds effective rate plus 0.50%, and (3) a one-month Eurodollar-based rate plus 1.0%, plus, in each case, a margin that ranges from 0.50% to 1.25% per annum, or (B) a Eurodollar-based rate for a period of 1, 2, 3, 6, 9 or 12 months plus a margin that ranges from 1.50% to 2.25% per annum. The margin of the revolving credit line is determined by the consolidated net senior secured leverage ratio as defined in the Credit Agreement. At December 31, 2017, there was $ 659,517 Cinemark USA, Inc.’s obligations under the Credit Agreement are guaranteed by Cinemark Holdings, Inc. and certain of Cinemark USA, Inc.’s domestic subsidiaries and are secured by mortgages on certain fee and leasehold properties and security interests in substantially all of Cinemark USA, Inc.’s and the guarantors’ personal property, including, without limitation, pledges of all of Cinemark USA, Inc.’s capital stock, all of the capital stock of certain of Cinemark USA, Inc.’s domestic subsidiaries and 65% of the voting stock of certain of its foreign subsidiaries. The Credit Agreement contains usual and customary negative covenants for agreements of this type, including, but not limited to, restrictions on Cinemark USA, Inc.’s ability, and in certain instances, its subsidiaries’ and our ability, to consolidate or merge or liquidate, wind up or dissolve; substantially change the nature of its business; sell, transfer or dispose of assets; create or incur indebtedness; create liens; pay dividends or repurchase stock; and make capital expenditures and investments. If Cinemark USA, Inc. has borrowings outstanding on the revolving credit line, it is required to satisfy a consolidated net senior secured leverage ratio covenant as defined in the Credit Agreement. The dividend restriction contained in the Credit Agreement prevents the Company and any of its subsidiaries from paying a dividend or otherwise distributing cash to its stockholders unless (1) the Company is not in default, and the distribution would not cause Cinemark USA, Inc. to be in default, under the Credit Agreement; and (2) the aggregate amount of certain dividends, distributions, investments, redemptions and capital expenditures made since December 18, 2012, including dividends declared by the board of directors, is less than the sum of (a) the aggregate amount of cash and cash equivalents received by Cinemark Holdings, Inc. or Cinemark USA, Inc. as common equity since December 18, 2012, (b) Cinemark USA, Inc.’s consolidated EBITDA minus 1.75 times its consolidated interest expense, each as defined in the Credit Agreement, and (c) certain other defined amounts. As of December 31, 2017, Cinemark USA, Inc. could have distributed up to approximately $2,620,026 to its parent company and sole stockholder, Cinemark Holdings, Inc. 4.875% Senior Notes On May 24, 2013, Cinemark USA, Inc. issued $530,000 aggregate principal amount of 4.875% senior notes due 2023, at par value, (the “4.875% Senior Notes”). Interest on the 4.875% Senior Notes is payable on June 1 and December 1 of each year. The 4.875% Senior Notes mature on June 1, 2023. On March 21, 2016, Cinemark USA, Inc. issued an additional $225,000 aggregate principal amount of the 4.875% Senior Notes, at 99.0% of the principal amount plus accrued and unpaid interest from December 1, 2015. Proceeds, after payment of fees, were used to finance the redemption of Cinemark, USA, Inc.’s previously outstanding $200,000 7.375% senior subordinated notes due 2021 (the “7.375% Senior Subordinated Notes”), as discussed below. These additional notes have identical terms, other than the issue date, the issue price and the first interest payment date, and constitute part of the same series as Cinemark USA, Inc.’s existing 4.875% Senior Notes. The aggregate principal amount of $755,000 of 4.875% Senior Notes mature on June 1, 2023. The Company incurred debt issue costs of approximately $3,702 in connection with the issuance of the additional notes, which, along with the discount of $2,250, are reflected as a reduction of long term debt, net of accumulated amortization, on the consolidated balance sheets as of December 31, 2016 and 2017. The 4.875% Senior Notes are fully and unconditionally guaranteed on a joint and several senior unsecured basis by certain of Cinemark USA, Inc.’s subsidiaries that guarantee, assume or become liable with respect to any of Cinemark USA, Inc.’s or a guarantor’s debt. The 4.875% Senior Notes and the guarantees are senior unsecured obligations and rank equally in right of payment with all of Cinemark USA, Inc.’s and its guarantor’s existing and future senior unsecured debt and senior in right of payment to all of Cinemark USA, Inc.’s and its guarantor’s existing and future senior subordinated debt. The 4.875% Senior Notes and the guarantees are effectively subordinated to all of Cinemark USA, Inc.’s and its guarantor’s existing and future secured debt to the extent of the value of the assets securing such debt, including all borrowings under Cinemark USA, Inc.’s Credit Agreement. The 4.875% Senior Notes and the guarantees are structurally subordinated to all existing and future debt and other liabilities of Cinemark USA, Inc.’s subsidiaries that do not guarantee the 4.875% Senior Notes. The indenture to the 4.875% Senior Notes contains covenants that limit, among other things, the ability of Cinemark USA, Inc. and certain of its subsidiaries to (1) make investments or other restricted payments, including paying dividends, making other distributions or repurchasing subordinated debt or equity, (2) incur additional indebtedness and issue preferred stock, (3) enter into transactions with affiliates, (4) enter new lines of business, (5) merge or consolidate with, or sell all or substantially all of its assets to, another person and (6) create liens. As of December 31, 2017, Cinemark USA, Inc. could have distributed up to approximately $2,608,237 to its parent company and sole stockholder, Cinemark Holdings, Inc., under the terms of the indenture to the 4.875% Senior Notes, subject to its available cash and other borrowing restrictions outlined in the indenture. The required minimum coverage ratio is 2 to 1 and our actual ratio as of December 31, 2017 was approximately 6.1 to 1. 5.125% Senior Notes On December 18, 2012, Cinemark USA, Inc. issued $400,000 aggregate principal amount of 5.125% senior notes due 2022, at par value (the “5.125% Senior Notes”). Interest on the 5.125% Senior Notes is payable on June 15 and December 15 of each year. The 5.125% Senior Notes mature on December 15, 2022. The 5.125% Senior Notes are fully and unconditionally guaranteed on a joint and several senior unsecured basis by certain of Cinemark USA, Inc.’s subsidiaries that guarantee, assume or become liable with respect to any of Cinemark USA, Inc.’s or a guarantor’s debt. The 5.125% Senior Notes and the guarantees are senior unsecured obligations and rank equally in right of payment with all of Cinemark USA, Inc.’s and its guarantor’s existing and future senior unsecured debt and senior in right of payment to all of Cinemark USA, Inc.’s and its guarantor’s existing and future subordinated debt. The 5.125% Senior Notes and the guarantees are effectively subordinated to all of Cinemark USA, Inc.’s and its guarantor’s existing and future secured debt to the extent of the value of the assets securing such debt, including all borrowings under Cinemark USA, Inc.’s Credit Agreement. The 5.125% Senior Notes and the guarantees are structurally subordinated to all existing and future debt and other liabilities of Cinemark USA, Inc.’s subsidiaries that do not guarantee the 5.125% Senior Notes. The indenture to the 5.125% Senior Notes contains covenants that limit, among other things, the ability of Cinemark USA, Inc. and certain of its subsidiaries to (1) make investments or other restricted payments, including paying dividends, making other distributions or repurchasing subordinated debt or equity, (2) incur additional indebtedness and issue preferred stock, (3) enter into transactions with affiliates, (4) enter new lines of business, (5) merge or consolidate with, or sell all or substantially all of its assets to, another person and (6) create liens. As of December 31, 2016, Cinemark USA, Inc. could have distributed up to approximately $2,613,268 to its parent company and sole stockholder, Cinemark Holdings, Inc., under the terms of the indenture to the 5.125% Senior Notes, subject to its available cash and other borrowing restrictions outlined in the indenture. The required minimum coverage ratio is 2 to 1 and our actual ratio as of December 31, 2017 was approximately 6.1 to 1. 7. 375 On June 3, 2011, Cinemark USA, Inc. issued $200,000 aggregate principal amount of 7.375% senior subordinated notes due 2021, at par value (the “Senior Subordinated Notes”). On March 21, 2016, Cinemark USA, Inc. redeemed its Senior Subordinated Notes at a make-whole premium of approximately 104% plus accrued and unpaid interest, utilizing the proceeds from the issuance of the additional $225,000 Cinemark USA, Inc. 4.875% Senior Notes discussed above. As a result of the redemption, the Company wrote-off approximately $2,369 in unamortized debt issue costs, paid a make-whole premium of $9,444 and paid other fees of $1,222, all of which are reflected in loss on debt amendments and refinancing during the year ended December 31, 2016. Fair Value of Long Term Debt The Company estimates the fair value of its long-term debt primarily using quoted market prices, which fall under Level 2 of the U.S. GAAP fair value hierarchy as defined by FASB ASC Topic 820-10-35. The carrying value of the Company’s long term debt was $1,822,966 and $1,817,295 as of December 31, 2016 and 2017, respectively, excluding debt issuance costs of $34,854 and $29,815, respectively. The fair value of the Company’s long term debt was $1,850,212 and $1,840,918 as of December 31, 2016 and 2017, respectively. Covenant Compliance and Debt Maturity As of December 31, 2017, the Company believes it was in full financial compliance with all agreements, including related covenants, governing its outstanding debt. The Company’s long-term debt, excluding unamortized debt issuance costs, at December 31, 2017 matures as follows: 2018 $ 7,099 2019 7,099 2020 5,710 2021 5,710 2022 1,036,677 Thereafter 755,000 Total $ 1,817,295

Fair Value Measurements

Fair Value Measurements	12 Months Ended
	Dec. 31, 2017
Fair Value Disclosures [Abstract]
Fair Value Measurements	9. FAIR VALUE MEASUREMENTS The Company determines fair value measurements in accordance with FASB ASC Topic 820, which establishes a fair value hierarchy under which an asset or liability is categorized based on the lowest level of input significant to its fair value measurement. The levels of input defined by FASB ASC Topic 820 are as follows: Level 1 – quoted market prices in active markets for identical assets or liabilities that are accessible at the measurement date; Level 2 – other than quoted market prices included in Level 1 that are observable for the asset or liability, either directly or indirectly; and Level 3 – unobservable and should be used to measure fair value to the extent that observable inputs are not available. As of December 31, 2017, the Company did not have any assets or liabilities measured at fair value on a recurring basis under FASB ASC Topic 820. Below is a reconciliation of the beginning and ending balance for liabilities measured at fair value on a recurring basis using significant unobservable inputs (Level 3): Liabilities Liabilities 2016 2017 Beginning balance - January 1 $ 373 $ — Total loss included in accumulated other comprehensive loss 71 — Settlements included in interest expense (444 ) — Ending balance - December 31 $ — $ — The Company also uses the market approach for fair value measurements on a nonrecurring basis in the impairment evaluations of its long-lived assets (see Note 5 and Note 6). Additionally, the Company uses the market approach to estimate the fair value of its long-term debt (see Note 8). There were no changes in valuation techniques during the period. There were no transfers in or out of Level 1, Level 2 or Level 3 during the years ended December 31, 2015, 2016 and 2017.

FOREIGN CURRENCY TRANSLATION

FOREIGN CURRENCY TRANSLATION	12 Months Ended
	Dec. 31, 2017
Foreign Currency [Abstract]
FOREIGN CURRENCY TRANSLATION	10. FOREIGN CURRENCY TRANSLATION The accumulated other comprehensive loss account in stockholder’s equity of $247,013 and $253,282 at December 31, 2016 and 2017, respectively, includes the cumulative foreign currency losses of $247,046 and $253,565, respectively, from translating the financial statements of the Company’s international subsidiaries, the change in fair values of the Company’s interest rate swap agreements that were designated as hedges and the changes in fair value of the Company’s previously held available-for-sale securities. All foreign countries where the Company has operations are non-highly inflationary and the local currency is the same as the functional currency in all of the locations. Thus, any fluctuation in the currency results in a cumulative foreign currency translation adjustment recorded to accumulated other comprehensive loss. A highly inflationary economy is defined as an economy with a cumulative inflation rate of approximately 100 percent or more over a three-year period. If a country’s economy is classified as highly inflationary, the financial statements of the foreign entity operating in that country must be remeasured to the functional currency of the reporting entity. There has been a steady devaluation of the Argentine peso relative to the U.S. dollar in recent years. As of December 31, 2017, the Company has not designated Argentina as highly inflationary for accounting purposes. The Company will continue to monitor the inflation on a quarterly basis to determine whether remeasurement is necessary. Below is a summary of the impact of translating the financial statements of the Company’s international subsidiaries as of and for the years ended December 31, 2015, 2016 and 2017. Other Comprehensive Income (Loss) Exchange Rate as of December 31, For the Year Ended December 31, Country 2015 2016 2017 2015 2016 2017 Brazil 3.96 3.26 3.31 $ (74,559 ) $ 37,286 $ (4,567 ) Argentina 12.95 16.04 18.65 (30,520 ) (13,362 ) (8,200 ) Colombia 3,149.47 3,000.71 2,936.67 (8,043 ) 1,278 246 Chile 709.16 679.09 615.97 (6,572 ) 1,855 5,672 Peru 3.46 3.45 3.24 (4,882 ) 87 2,752 All other (898 ) (783 ) (869 ) $ (125,474 ) $ 26,361 $ (4,966 ) During the year ended December 31, 2017, the Company reclassified $1,551 of cumulative foreign currency translation adjustments, related to a Canadian subsidiary that was liquidated, from accumulated other comprehensive loss to foreign currency exchange gain on the consolidated statement of income.

NONCONTROLLING INTERESTS IN SUB

NONCONTROLLING INTERESTS IN SUBSIDIARIES	12 Months Ended
	Dec. 31, 2017
Noncontrolling Interest [Abstract]
NONCONTROLLING INTERESTS IN SUBSIDIARIES	11. NONCONTROLLING INTERESTS IN SUBSIDIARIES Noncontrolling interests in subsidiaries of the Company were as follows at December 31: December 31, 2016 2017 Cinemark Partners II — 24.6% interest (in one theatre) $ 8,249 $ 8,795 Laredo Theatres – 25% interest (in two theatres) 1,695 1,746 Greeley Ltd. — 49% interest (in one theatre) 689 843 Other 509 509 Total $ 11,142 $ 11,893 During December 2016 the Company purchased the remaining 25% noncontrolling interest of one of its Chilean subsidiaries, Flix Impirica S.A. (“Flix Impirica”), for approximately $450 in cash. The increase in the Company’s ownership interest in the Chilean subsidiary was accounted for as an equity transaction in accordance with ASC Topic 810-10-45-23. The Company recorded a decrease in additional paid-in-capital of approximately $27, which represented the difference between the cash paid and the book value of the Chilean subsidiary’s noncontrolling interest account, which was approximately $423. As a result of this transaction, the Company now owns 100% of the shares in Flix Impirica. Below is a summary of the impact of changes in the Company’s ownership interest in its subsidiaries on its equity: Year ended December 31, 2015 2016 2017 Net income attributable to Cinemark USA, Inc. $ 218,532 $ 256,777 $ 265,643 Transfers from noncontrolling interests Decrease in Cinemark USA, Inc. additional paid-in-capital for the buyout of Flix Impirica non-controlling interest — (27 ) — Net transfers from non-controlling interests — (27 ) — Change from net income attributable to Cinemark USA, Inc. and transfers from noncontrolling interests $ 218,532 $ 256,750 $ 265,643

CAPITAL STOCK

CAPITAL STOCK	12 Months Ended
	Dec. 31, 2017
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]
CAPITAL STOCK	12. CAPITAL STOCK Common and Preferred Stock — Cinemark USA, Inc. has 1,500 shares of Class A common stock and 182,648 shares of Class B common stock outstanding, all of which are held by Cinemark Holdings, Inc. Holders of Class A common stock have exclusive voting rights. Holders of Class B common stock have no voting rights except upon any proposed amendments to the articles of incorporation. However, they may convert their Class B common stock, at their option, to Class A common stock. In the event of any liquidation, holders of the Class A and Class B common stock will be entitled to their pro-rata share of assets remaining after any holders of preferred stock have received their preferential amounts based on their respective shares held. The Company has 1,000,000 shares of preferred stock, $1.00 par value, authorized with none issued or outstanding. The rights and preferences of preferred stock will be determined by the Board of Directors at the time of issuance. The Company’s ability to pay dividends is effectively limited by the terms of its senior notes indentures, its senior notes indentures and its senior secured credit facility, which also significantly restricts the ability of certain of the Company’s subsidiaries to pay dividends directly or indirectly to it. See Note 8. Furthermore, certain of the Company’s foreign subsidiaries currently have a deficit in retained earnings which prevents the Company from declaring and paying dividends from those subsidiaries. Restricted Stock — Below is a summary of restricted stock activity for Cinemark Holdings, Inc. for the years ended December 31, 2015, 2016 and 2017: Year Ended Year Ended Year Ended December 31, 2015 December 31, 2016 December 31, 2017 Shares of Restricted Stock Weighted Average Grant Date Fair Value Shares of Restricted Stock Weighted Average Grant Date Fair Value Shares of Restricted Stock Weighted Average Grant Date Fair Value Outstanding at January 1 878,897 $ 24.92 757,775 $ 30.73 606,618 $ 33.51 Granted 226,212 $ 42.79 335,707 $ 30.98 246,534 $ 41.70 Vested (329,437 ) $ 23.72 (430,056 ) $ 26.60 (192,230 ) $ 36.26 Forfeited (17,897 ) $ 27.58 (56,808 ) $ 33.81 (10,341 ) $ 33.48 Outstanding at December 31 757,775 $ 30.73 606,618 $ 33.51 650,581 $ 35.81 During the year ended December 31, 2017, Cinemark Holdings, Inc. granted 246,534 shares of restricted stock to its directors and employees of the Company. The fair value of the restricted stock granted was determined based on the market value of Cinemark Holdings, Inc.’s common stock on the date of grant, which ranged from $34.82 to $42.37 per share. The Company assumed forfeiture rates ranging from 0% to 10% for the restricted stock awards. Restricted stock granted to directors vests over a one-year period. Restricted stock granted to employees vests over periods ranging from one year to four years based on continued service. The recipients of restricted stock are entitled to receive dividends and to vote their respective shares, however, the sale and transfer of the restricted shares is prohibited during the restriction period. Below is a summary of restricted stock award activity recorded for the periods indicated. Year Ended December 31, 2015 2016 2017 Compensation expense recognized by the Company during the period $ 8,715 $ 7,269 $ 7,528 Additional compensation expense recognized by Cinemark Holdings, Inc. during the period $ 885 $ 981 $ 856 Fair value of restricted shares held by Company employees that vested during the period $ 13,276 $ 13,739 $ 7,255 Fair value of restricted shares held by Cinemark Holdings, Inc.’s directors that vested during the period $ 1,148 $ 923 $ 917 Income tax benefit recognized upon vesting of restricted stock awards held by Company employees $ 3,341 $ 5,167 $ 2,281 Additional income tax benefit recognized upon vesting of restricted stock awards held by Cinemark Holdings, Inc.'s directors $ 482 $ 388 $ 386 As of December 31, 2017, the remaining unrecognized compensation expense related to these restricted stock awards was approximately $13,049, of which $12,633 will be recognized by the Company and $416 of which will be recognized by Cinemark Holdings, Inc. The weighted average period over which this remaining compensation expense will be recognized is approximately two years. Restricted Stock Units — During the years ended December 31, 2015, 2016 and 2017, Cinemark Holdings, Inc. granted restricted stock units representing 142,917, 253,661 and 175,634 hypothetical shares of Cinemark Holdings, Inc.’s common stock, respectively, to employees of the Company. The restricted stock units vest based on a combination of financial performance factors and continued service. The financial performance factors are based on an implied equity value concept that determines an internal rate of return (“IRR”) for a two year measurement period, as defined in the award agreement, based on a formula utilizing a multiple of Adjusted EBITDA subject to certain specified adjustments (as defined in the restricted stock unit award agreement). The financial performance factors for the restricted stock units have a threshold, target and maximum level of payment opportunity and vest on a prorata basis according to the IRR achieved by the Company during the performance period. As an example, if the Company achieves an IRR equal to 11.0% for the 2015 grant, the number of restricted stock units that shall vest will be greater than the target but less than the maximum number that would have vested had the Company achieved the highest IRR. All payouts of restricted stock units that vest will be subject to an additional service requirement and will be paid in the form of Cinemark Holdings, Inc.’s common stock if the participant continues to provide services through the fourth anniversary of the grant date. The financial performance factors and respective vesting rates for each of the 2015, 2016 and 2017 grants are as follows: Year Ended December 31, Percentage of Shares Vesting 2015 2016 2017 Threshold IRR 7.5% 6.0% 7.0% 33.3% Target IRR 9.5% 8.0% 9.5% 66.6% Maximum IRR 11.5% 10.0% 13.0% 100.0% At the time of each of the restricted stock unit grants, the Company assumes the IRR level to be reached for the defined measurement period will be the mid-point IRR level in determining the amount of compensation expense to record for such grants. If and when additional information becomes available to indicate that something other than the mid-point IRR level will be achieved, the Company adjusts compensation expense on a prospective basis over the remaining service period. The Company assumed a forfeiture rate of 5% for the restricted stock unit awards granted during 2017. Restricted stock unit award participants are eligible to receive dividend equivalent payments if and at the time the restricted stock unit awards vest. Below is a table summarizing the potential number of units that could vest under restricted stock unit awards granted during the years ended December 31, 2015, 2016 and 2017 at each of the three levels of financial performance (excluding forfeitures): Granted During the Year Ended December 31, 2015 2016 2017 Number of Value at Number of Value at Number of Value at Units Grant (1) Units Grant (1) Units Grant (1) at threshold IRR 47,640 $ 2,057 84,554 $ 2,522 58,545 $ 2,481 at target IRR 95,282 $ 4,115 169,107 $ 5,044 117,089 $ 4,961 at maximum IRR 142,917 $ 6,173 253,661 $ 7,568 175,634 $ 7,442 (1) The grant date fair values for units issued during the years ended December 31, 2015, 2016, and 2017 were $43.19, $29.83 and $42.37, respectively. Below is a summary of activity for restricted stock unit awards for Cinemark Holdings, Inc. for the periods indicated: Year Ended December 31, 2015 2016 2017 Number of restricted stock unit awards that vested during the period 123,769 213,984 97,115 Fair value of restricted stock unit awards that vested during the period $ 5,483 $ 7,260 $ 4,155 Accumulated dividends paid upon vesting of restricted stock unit awards $ 442 $ 662 $ 558 Income tax benefit recognized upon vesting of restricted stock unit awards $ 2,303 $ 3,049 $ 1,745 Compensation expense recognized during the period $ 6,158 $ 5,144 $ 4,297 During the year ended December 31, 2015, the Compensation Committee of Cinemark Holdings, Inc.’s Board of Directors approved a modification to each of the 2013 and 2014 restricted stock unit grants. The modifications resulted in a cap on the foreign currency exchange rate devaluation impact to be used in calculating the IRR for the respective measurement periods. The Company revalued each of the grants based on Cinemark Holdings, Inc.’s stock price at the date of modification, which was $33.02. The modifications resulted in incremental compensation expense of approximately $2,460 for the year ended December 31, 2015. During the year ended December 31, 2016, the Compensation Committee of Cinemark Holdings, Inc.’s Board of Directors approved a modification to the 2015 restricted stock unit grants. The modification resulted in a cap on the foreign currency exchange rate devaluation impact to be used in calculating the IRR for the respective measurement periods. The Company revalued each of the grants based on Cinemark Holdings, Inc.’s stock price at the date of modification, which was $37.98. The modifications resulted in incremental compensation expense of approximately $562 for the year ended December 31, 2016. As of December 31, 2017, the Company had restricted stock units outstanding that represented a total 628,189 hypothetical shares of Cinemark Holdings, Inc.’s common stock, net of actual cumulative forfeitures of 7,407 units, assuming the maximum IRR is achieved for all of the outstanding restricted stock unit awards. As of December 31, 2017, the remaining unrecognized compensation expense related to the outstanding restricted stock unit awards was $6,820, which reflects the maximum IRR level that was achieved for the 2014 and 2015 grants, an IRR level of 8.0% that is estimated for the 2016 grants and an IRR level of 9.5% that is estimated for the 2017 grants. The weighted average period over which this remaining compensation expense will be recognized is approximately two years.

SUPPLEMENTAL CASH FLOW INFORMAT

SUPPLEMENTAL CASH FLOW INFORMATION	12 Months Ended
	Dec. 31, 2017
Supplemental Cash Flow Elements [Abstract]
SUPPLEMENTAL CASH FLOW INFORMATION	13. SUPPLEMENTAL CASH FLOW INFORMATION The following is provided as supplemental information to the consolidated statements of cash flows: Year Ended December 31, 2015 2016 2017 Cash paid for interest $ 105,155 $ 108,101 $ 99,232 Cash paid for income taxes, net of refunds received $ 108,435 $ 93,368 $ 95,043 Noncash investing and financing activities: Change in accounts payable and accrued expenses for the acquisition of theatre properties and equipment (1) $ 2,491 $ (29,471 ) $ 9,349 Theatre properties and equipment acquired under capital lease $ 36,544 $ 33,282 $ 46,727 Investment in NCM - receipt of common units (see Note 3) $ 15,421 $ 11,111 $ 18,363 Noncash distributions to Cinemark Holdings, Inc. $ (17,935 ) $ — $ — Receipt of promissory note related to sale of investment in a Taiwan joint venture $ 2,304 $ — $ — (1) Additions to theatre properties and equipment included in accounts payable as of December 31, 2016 and 2017 were $40,625 and $31,276, respectively.

INCOME TAXES

INCOME TAXES	12 Months Ended
	Dec. 31, 2017
Income Tax Disclosure [Abstract]
INCOME TAXES	14. INCOME TAXES On December 22, 2017, the President signed the Tax Cuts and Jobs Act (the “Tax Act”). The Tax Act, among other things, lowered the U.S. corporate income tax rate from 35% to 21% effective January 1, 2018. The Company recorded a net one-time benefit of $44,889, all non-cash, related to enactment of the Tax Act, including a re-measurement of deferred tax liabilities using the lower U.S. corporate income tax rate, a reassessment of permanently reinvested earnings, a deemed repatriation tax, and a reduction in a deferred tax asset with regard to foreign tax credit carryforwards. The adjustments to deferred tax assets and liabilities and the liability related to the transition tax are provisional amounts based on information available as of December 31, 2017. These amounts may change due to, among other things, further refinement of the Company’s calculations, changes in interpretations and assumptions that the Company has made, and additional guidance that may be issued by the U.S. government. The Company will complete its analysis over a one-year measurement period ending December 22, 2018, and any adjustments during this measurement period will be included in net income from continuing operations as an adjustment to income tax expense in the reporting period when such adjustments are determined. The Company’s provision for federal and foreign income tax expense for continuing operations consisted of the following: Year Ended December 31, 2015 2016 2017 Income before income taxes: U.S. $ 262,336 $ 277,474 $ 282,896 Foreign 88,015 85,890 64,842 Total $ 350,351 $ 363,364 $ 347,738 Current and deferred income taxes were as follows: Year Ended December 31, 2015 2016 2017 Current: Federal $ 72,185 $ 66,210 $ 55,224 Foreign 35,874 32,047 29,306 State 10,806 12,061 10,741 Total current expense $ 118,865 $ 110,318 $ 95,271 Deferred: Federal $ 10,420 $ (13,667 ) $ (14,046 ) Foreign (3,339 ) 1,674 (4,270 ) State 4,014 6,526 3,301 Total deferred taxes $ 11,095 $ (5,467 ) $ (15,015 ) Income taxes $ 129,960 $ 104,851 $ 80,256 A reconciliation between income tax expense and taxes computed by applying the applicable statutory federal income tax rate to income before income taxes follows: Year Ended December 31, 2015 2016 2017 Computed statutory tax expense $ 122,623 $ 127,176 $ 121,708 Foreign inflation adjustments (1,295 ) (281 ) — State and local income taxes, net of federal income tax impact 9,640 12,081 12,857 Foreign losses not benefited and changes in valuation allowance (2,408 ) (34,757 ) 249 Foreign tax rate differential (2,660 ) (942 ) (245 ) Foreign dividends — 68,684 13,662 Foreign tax credits — (62,815 ) (21,647 ) Impacts related to 2017 Tax Act (1) — — (44,889 ) Changes in uncertain tax positions 3,717 921 983 Other — net 343 (5,216 ) (2,422 ) Income taxes $ 129,960 $ 104,851 $ 80,256 (1) Includes one-time benefit due to re-measurement of net deferred tax liabilities using a lower U.S. corporate tax rate and a reassessment of permanently reinvested earnings of ($79,834), a deemed repatriation tax of $14,512, and a reduction in deferred tax assets with regard to foreign tax credit carryforwards of $20,433. U.S. income taxes have been provided on deemed repatriated earnings of $352,632 related to the Company’s non-U.S. companies as of December 31, 2017 as a result of the enactment of the Tax Act. The Company recorded a net transition tax of $14,512 on the deemed repatriated earnings during the year ended December 31, 2017. Before the Tax Act, U.S. income taxes and foreign withholding taxes had not been provided on earnings of $316,346 and $251,439 that had not been distributed by the Company’s non-U.S. companies as of December 31, 2015 and 2016, respectively. The Company’s intention before enactment of the Tax Act was to permanently reinvest these earnings, thereby indefinitely postponing their remittance to the U.S. While the Company’s investment in foreign subsidiaries continues to be permanent in duration, the Company may periodically repatriate a portion of these earnings to the extent that it does not incur additional U.S. tax liability. The Company considers any excess of the amount for financial reporting over the tax basis of its investment in its foreign subsidiaries to be indefinitely reinvested. At this time, the determination of deferred tax liabilities on this amount is not practicable. Deferred Income Taxes The tax effects of significant temporary differences and tax loss and tax credit carryforwards comprising the net long-term deferred income tax liabilities as of December 31, 2016 and 2017 consisted of the following: December 31, 2016 2017 Deferred liabilities: Theatre properties and equipment $ 176,781 $ 147,208 Intangible asset — other 36,052 30,770 Intangible asset — tradenames 112,747 72,967 Investment in partnerships 107,066 67,449 Total deferred liabilities 432,646 318,394 Deferred assets: Deferred lease expenses 24,026 14,714 Exchange (gain) loss (731 ) 220 Deferred revenue - NCM 130,005 85,816 Capital lease obligations 85,721 67,369 Other tax loss carryforwards 15,883 15,564 Other tax credit carryforwards 48,033 38,436 Other expenses, not currently deductible for tax purposes 11,270 13,801 Total deferred assets 314,207 235,920 Net deferred income tax liability before valuation allowance 118,439 82,474 Valuation allowance against deferred assets – non-current 14,524 35,246 Net deferred income tax liability $ 132,963 $ 117,720 Net deferred tax liability — Foreign $ 7,571 $ 3,073 Net deferred tax liability — U.S. 125,392 114,647 Total $ 132,963 $ 117,720 A significant portion of our foreign tax credit carryforwards expire in 2024. Some foreign net operating losses will expire in the next reporting period; however, some losses may be carried forward indefinitely. State net operating losses may be carried forward for periods of between five and twenty years with the last expiring year being 2037. The Company’s valuation allowance changed from $14,524 at December 31, 2016 to $35,246 at December 31, 2017 (See Note 18). The increase was a result of the Tax Act and its impact on the estimated usage of foreign tax credit carryforwards before their expiration. Uncertain Tax Positions The following is a reconciliation of the total amounts of unrecognized tax benefits excluding interest and penalties, for the years ended December 31, 2015, 2016 and 2017: Year Ended December 31, 2015 2016 2017 Balance at January 1, $ 16,515 $ 17,133 $ 17,403 Gross increases - tax positions in prior periods 40 13 92 Gross decreases - tax positions in prior periods — — (12 ) Gross increases - current period tax positions 2,112 923 265 Settlements (871 ) (924 ) (177 ) Foreign currency translation adjustments (663 ) 258 695 Balance at December 31, $ 17,133 $ 17,403 $ 18,266 The Company had $18,190 and $20,232 of unrecognized tax benefits, including interest and penalties, as of December 31, 2016 and 2017, respectively. Of these amounts, $18,190 and $20,232 represent the amount of unrecognized tax benefits that if recognized would impact the effective income tax rate for the years ended December 31, 2016 and 2017, respectively. The Company had $4,111 and $5,288 accrued for interest and penalties as of December 31, 2016 and 2017, respectively. The Company participates in the consolidated income tax return of Cinemark Holdings, Inc. in the U.S. federal jurisdiction and in certain state and foreign jurisdictions, and is routinely under audit by many different tax authorities. The Company believes that its accrual for tax liabilities is adequate for all open audit years based on its assessment of many factors including past experience and interpretations of tax law. This assessment relies on estimates and assumptions and may involve a series of complex judgments about future events. The Company is no longer subject to income tax audits from the Internal Revenue Service for years before 2014. The Company is no longer subject to state income tax examinations by tax authorities in its major state jurisdictions for years before 2013. The Company is no longer subject to non-U.S. income tax examinations by tax authorities in its major non-U.S. tax jurisdictions for years before 2005. The Company is currently under audit in the non-U.S. tax jurisdictions of Brazil and Chile. The Company believes that it is reasonably possible that the Chile audit will be completed within the next twelve months.

COMMITMENTS AND CONTINGENCIES

COMMITMENTS AND CONTINGENCIES	12 Months Ended
	Dec. 31, 2017
Commitments And Contingencies Disclosure [Abstract]
COMMITMENTS AND CONTINGENCIES	15. COMMITMENTS AND CONTINGENCIES Leases — The Company conducts a significant part of its theatre operations in leased properties under noncancelable operating and capital leases with terms generally ranging from 10 to 25 years. In addition to the minimum annual lease payments, some of the leases provide for contingent rentals based on operating results of the theatre and most require the payment of taxes, insurance and other costs applicable to the property. The Company can renew, at its option, a substantial portion of the leases at defined or then market rental rates for various periods. Some leases also provide for escalating rent payments throughout the lease term. A liability for deferred lease expenses of $42,378 and $40,929 at December 31, 2016 and 2017, respectively, has been provided to account for lease expenses on a straight-line basis, where lease payments are not made on such a basis. Theatre rent expense was as follows: Year Ended December 31, 2015 2016 2017 Fixed rent expense $ 240,057 $ 242,927 $ 247,908 Contingent rent and other facility lease expenses 79,704 78,367 80,289 Total facility lease expense $ 319,761 $ 321,294 $ 328,197 Future minimum lease payments under noncancelable operating and capital leases that have initial or remaining terms in excess of one year at December 31, 2017 are due as follows: Operating Capital Leases Leases 2018 $ 253,835 $ 42,832 2019 233,606 42,363 2020 215,265 41,543 2021 197,779 34,584 2022 171,486 32,383 Thereafter 675,567 182,027 Total $ 1,747,538 375,732 Amounts representing interest payments (99,070 ) Present value of future minimum payments 276,662 Current portion of capital lease obligations (25,511 ) Capital lease obligations, less current portion $ 251,151 Employment Agreements — On August 20, 2015, Cinemark Holdings, Inc.’s board of directors announced Mr. Mark Zoradi as the Company’s Chief Executive Officer. Cinemark Holdings, Inc. and Mr. Zoradi entered into an employment agreement effective as of August 24, 2015. Effective March 4, 2016, the Company’s former President and Chief Operating Officer, Robert Copple, resigned with good reason as defined within his employment agreement. The Company paid Mr. Copple the payments and benefits pursuant to the terms set forth in his employment agreement. The Company’s post-termination obligations, such as providing continued participation in the Company’s welfare benefit plans and insurance programs, remain in effect for a limited period of time under the employment agreement. All expenses incurred by the Company in relation to the resignation are reflected in general and administrative expenses for the year ended December 31, 2016. The Company’s employment agreement with Mr. Tim Warner, the Company’s former CEO, terminated on April 1, 2016. As of December 31, 2017, the Company had employment agreements with Lee Roy Mitchell, Mark Zoradi, Sean Gamble, Valmir Fernandes, Michael Cavalier and Rob Carmony. The employment agreements are subject to automatic extensions for a one year period, unless the employment agreements are terminated. The base salaries stipulated in the employment agreements are subject to review at least annually during the term of the agreements for increase (but not decrease) by the Company’s Compensation Committee. Management personnel subject to these employment agreements are eligible to receive annual cash incentive bonuses upon the Company meeting certain performance targets established by the Compensation Committee within the first 90 days of the fiscal year. Effective January 2, 2018, Robert Carmony retired from the Company and his employment agreement was terminated as of that date. Retirement Savings Plan — The Company has a 401(k) retirement savings plan (“401(k) Plan”) for the benefit of all eligible employees and makes matching contributions as determined annually in accordance with the 401(k) Plan. Employer matching contribution payments of $3,187 and $6,380 were made during 2016 (for plan year 2015) and 2017 (for plan years 2016 and 2017), respectively. A liability of approximately $999 has been recorded at December 31, 2017 for employer contribution payments to be made in 2018 for the remaining amounts owed for plan year 2017. Legal Proceedings — The case presents putative class action claims for damages and attorney’s fees arising from employee wage and hour claims under California law for alleged meal period, rest break, reporting time pay, unpaid wages, pay upon termination, and wage statements violations. The claims are also asserted as a representative action under the California Private Attorney General Act (“PAGA”). The Company denies the claims, denies that class certification is appropriate and denies that a PAGA representative action is appropriate, and is vigorously defending against the claims. The Company denies any violation of law and plans to vigorously defend against all claims. The Court determined that class certification is not appropriate and determined that a PAGA representative action is not appropriate. The plaintiff has appealed these rulings. The Ninth Circuit Court of Appeal reversed portions of the ruling and remanded it back to the District Court. The Company is unable to predict the outcome of the litigation or the range of potential loss. Flagship Theatres of Palm Desert, LLC d/b/a Cinemas Palme D’Or v. Century Theatres, Inc., and Cinemark USA, Inc.; Superior Court of the State of California, County of Los Angeles . Plaintiff in this case alleges that the Company violated California antitrust and unfair competition laws by engaging in “circuit dealing” with various motion picture distributors and tortuously interfered with Plaintiff’s business relationships. Plaintiff seeks compensatory damages, trebling of those damages under California law, punitive damages, injunctive relief, attorneys’ fees, costs and interest. Plaintiff also alleges that the Company’s conduct ultimately resulted in closure of its theatre in June 2016. The Company denied the allegations. In 2008, the Company moved for summary judgment on Plaintiff’s claims, arguing primarily that clearances between the theatres at issue were lawful and that Plaintiff lacked proof sufficient to support certain technical elements of its antitrust claims. The trial court granted that motion and dismissed Plaintiff’s claims. Plaintiff appealed and, in 2011, the Court of Appeal reversed, holding, among other things, that Plaintiff’s claims were not about the illegality of clearances but were focused, instead, on “circuit dealing.” Having re-framed the claims in that manner, the Court of Appeal held that the trial court’s decision to limit discovery to the market where the theatres at issue operated was an error, as “circuit dealing” necessarily involves activities in different markets. Upon return to the trial court, the parties engaged in additional, broadened discovery related to Plaintiff’s “circuit dealing” claim. Thereafter, the Company moved again for summary judgment on all of Plaintiff’s claims. That new motion for summary judgment was pending when, on or about April 11, 2014, the trial court granted the Company’s motion for terminating sanctions and entered a judgment dismissing the case with prejudice. Plaintiff then appealed that second dismissal, seeking to have the judgment reversed and the case remanded to the trial court. The Court of Appeal issued a ruling on May 24, 2016, reversing the granting of terminating sanctions and instead imposed a lesser evidentiary and damages preclusion sanction. The case returned to the trial court on October 6, 2016. The Company has denied Plaintiff’s allegations and is vigorously defending these claims. The Company is unable to predict the outcome of this litigation or the range of potential loss. The Company received a Civil Investigative Demand (“CID”) from the Antitrust Division of the United States Department of Justice. The CID relates to an investigation under Sections 1 and 2 of the Sherman Act. The Company also received CIDs from the Antitrust Section of the Office of the Attorney General of the State of Ohio and later from other states regarding similar inquiries under state antitrust laws. The CIDs request the Company to answer interrogatories, and produce documents, or both, related to the investigation of matters including film clearances, potential coordination and/or communication with other major theatre circuits and related joint ventures. The Company intends to fully cooperate with all federal and state government agencies. Although the Company does not believe that it has violated any federal or state antitrust or competition laws, it cannot predict the ultimate scope, duration or outcome of these investigations. From time to time, the Company is involved in other various legal proceedings arising from the ordinary course of its business operations, such as personal injury claims, employment matters, landlord-tenant disputes, patent claims and contractual disputes, some of which are covered by insurance or by indemnification from vendors. The Company believes its potential liability with respect to these types of proceedings currently pending is not material, individually or in the aggregate, to the Company’s financial position, results of operations and cash flows.

SEGMENTS

SEGMENTS	12 Months Ended
	Dec. 31, 2017
Segment Reporting [Abstract]
SEGMENTS	16. SEGMENTS The Company manages its international market and its U.S. market as separate reportable operating segments, with the international segment consisting of operations in Brazil, Argentina, Chile, Colombia, Peru, Ecuador, Honduras, El Salvador, Nicaragua, Costa Rica, Panama, Guatemala, Bolivia, Curacao and Paraguay. Each segment’s revenue is derived from admissions and concession sales and other ancillary revenues. The Company uses Adjusted EBITDA, as shown in the reconciliation table below, as the primary measure of segment profit and loss to evaluate performance and allocate its resources. The Company does not report asset information by segment because that information is not used to evaluate the performance or allocate resources between segments. Below is a breakdown of select financial information by reportable operating segment: Year Ended December 31, 2015 2016 2017 Revenues U.S. $ 2,137,733 $ 2,230,693 $ 2,236,237 International 728,735 701,573 769,436 Eliminations (13,859 ) (13,501 ) (14,126 ) Total revenues $ 2,852,609 $ 2,918,765 $ 2,991,547 Adjusted EBITDA (1) U.S. $ 518,165 $ 550,150 $ 559,693 International 166,416 157,690 165,576 Total Adjusted EBITDA $ 684,581 $ 707,840 $ 725,269 Capital expenditures U.S. $ 223,213 $ 242,271 $ 321,040 International 108,513 84,637 59,822 Total capital expenditures $ 331,726 $ 326,908 $ 380,862 (1) Distributions from equity investees are reported entirely within the U.S. operating segment The following table sets forth a reconciliation of net income to Adjusted EBITDA: Year Ended December 31, 2015 2016 2017 Net income $ 220,391 $ 258,513 $ 267,482 Add (deduct): Income taxes 129,960 104,851 80,256 Interest expense (1) 112,741 108,313 105,918 Loss on debt amendments and refinancing 925 13,445 521 Other income (2) (20,041 ) (44,813 ) (43,121 ) Other cash distributions from equity investees (3) 19,027 21,916 25,973 Depreciation and amortization 189,206 209,071 237,513 Impairment of long-lived assets 8,801 2,836 15,084 Loss on sale of assets and other 8,143 20,459 22,812 Deferred lease expenses (1,806 ) (990 ) (1,268 ) Amortization of long-term prepaid rents 2,361 1,826 2,274 Share based awards compensation expense 14,873 12,413 11,825 Adjusted EBITDA $ 684,581 $ 707,840 $ 725,269 (1) Includes amortization of debt issue costs. (2) Includes interest income, foreign currency exchange gain (loss), and equity in income of affiliates and excludes distributions from NCM. (3) Includes distributions received from equity investees that were recorded as a reduction of the respective investment balances. Financial Information About Geographic Area Below is a breakdown of select financial information by geographic area: Year Ended December 31, 2015 2016 2017 Revenues U.S. $ 2,137,733 $ 2,230,693 $ 2,236,237 Brazil 291,959 304,407 341,485 Other international countries 436,776 397,166 427,951 Eliminations (13,859 ) (13,501 ) (14,126 ) Total $ 2,852,609 $ 2,918,765 $ 2,991,547 December 31, 2016 December 31, 2017 Theatre Properties and Equipment-net U.S. $ 1,306,643 $ 1,439,168 Brazil 197,896 179,669 Other international countries 199,997 209,217 Total $ 1,704,536 $ 1,828,054

RELATED PARTY TRANSACTIONS

RELATED PARTY TRANSACTIONS	12 Months Ended
	Dec. 31, 2017
Related Party Transactions [Abstract]
RELATED PARTY TRANSACTIONS	17. RELATED PARTY TRANSACTIONS The Company manages theatres for Laredo Theatres, Ltd. (“Laredo”). The Company is the sole general partner and owns 75% of the limited partnership interests of Laredo. Lone Star Theatres, Inc. owns the remaining 25% of the limited partnership interests in Laredo and is 100% owned by Mr. David Roberts, Lee Roy Mitchell’s son-in-law. Lee Roy Mitchell is Cinemark Holdings, Inc.’s Chairman of the Board and directly and indirectly owns approximately 8% of Cinemark Holdings, Inc.’s common stock. Under the agreement, management fees are paid by Laredo to the Company at a rate of 5% of annual theatre revenues up to $50,000 and 3% of annual theatre revenues in excess of $50,000. The Company recorded $567, $506 and $586 of management fee revenues during the years ended December 31, 2015, 2016 and 2017, respectively. All such amounts are included in the Company’s consolidated financial statements with the intercompany amounts eliminated in consolidation. The Company has an Aircraft Time Sharing Agreement with Copper Beech Capital, LLC to use, on occasion, a private aircraft owned by Copper Beech Capital, LLC. Copper Beech Capital, LLC is owned by Mr. Mitchell and his wife, Tandy Mitchell. The private aircraft is used by Mr. Mitchell and other executives who accompany Mr. Mitchell to business meetings for the Company. The Company reimburses Copper Beech Capital, LLC the actual costs of fuel usage and the expenses of the pilots, landing fees, storage fees and similar expenses incurred during the trip. For the years ended December 31, 2015, 2016 and 2017, the aggregate amounts paid to Copper Beech Capital, LLC for the use of the aircraft was approximately $410, $110 and $131, respectively. The Company held an event for its employees and their families at Pinstack in December of 2016. Pinstack is majority-owned by Mr. Mitchell and his wife, Tandy Mitchell. In connection with the event, the Company paid Pinstack approximately $70. The Company currently leases 14 theatres and one parking facility from Syufy Enterprises, LP (“Syufy”) or affiliates of Syufy. Raymond Syufy is one of Cinemark Holdings, Inc.’s directors and is an officer of the general partner of Syufy. Of these 15 leases, 14 have fixed minimum annual rent. The one lease without minimum annual rent has rent based upon a specified percentage of gross sales as defined in the lease. For the years ended December 31, 2015, 2016 and 2017, the Company paid total rent of approximately $20,581, $21,124 and $22,483, respectively, to Syufy. The Company has paid certain fees and expenses on behalf of its parent, Cinemark Holdings, Inc. and Cinemark Holdings, Inc. has paid income taxes on behalf of the Company. The Company paid cash dividends to Cinemark Holdings, Inc. of $115,225, $124,900 and $134,500 during the years ended December 31, 2015, 2016 and 2017, respectively. Additionally, the Company made a noncash distribution to Cinemark Holdings, Inc. of $17,935 during the year ended December 31, 2015 related to expenses paid on behalf of Cinemark Holdings, Inc. The Company had a receivable from Cinemark Holdings, Inc. of $10,080 and $14,581 as of December 31, 2016 and 2017, respectively.

VALUATION AND QUALIFYING ACCOUN

VALUATION AND QUALIFYING ACCOUNTS	12 Months Ended
	Dec. 31, 2017
Valuation And Qualifying Accounts [Abstract]
VALUATION AND QUALIFYING ACCOUNTS	18. VALUATION AND QUALIFYING ACCOUNTS The Company’s valuation allowance for deferred tax assets for the years ended December 31, 2015, 2016 and 2017 were as follows: Valuation Allowance for Deferred Taxes Balance at January 1, 2015 $ 52,873 Additions 437 Deductions (2,674 ) Balance at December 31, 2015 $ 50,636 Additions 483 Deductions (36,595 ) Balance at December 31, 2016 $ 14,524 Additions ( 1 ) 21,347 Deductions (625 ) Balance at December 31, 2017 $ 35,246 (1) A valuation allowance was provided against certain deferred tax assets arising from carryforwards of unused foreign tax credit benefits.

Condensed Consolidating Financi

Condensed Consolidating Financial Information of Subsidiary Guarantors	12 Months Ended
	Dec. 31, 2017
Statement Of Financial Position [Abstract]
Condensed Consolidating Financial Information of Subsidiary Guarantors	19. Condensed Consolidating Financial Information of Subsidiary Guarantors As of December 31, 2017, the Company had outstanding $400,000 aggregate principal amount of 5.125% senior notes due 2022, or the 5.125% Senior Notes, and $755,000 aggregate principal amount of 4.875% senior notes due 2023, or the 4.875% Senior Notes, (collectively the “Notes”). These Notes are fully and unconditionally guaranteed on a joint and several senior unsecured basis by the following subsidiaries of Cinemark USA, Inc.: Sunnymead Cinema Corp., Cinemark Properties, Inc., Greeley Holdings, Inc., Cinemark Partners I, Inc., CNMK Investments, Inc., CNMK Texas Properties, LLC., Cinemark Concessions LLC, Century Theatres, Inc., Marin Theatre Management, LLC, Century Theatres NG, LLC, Cinearts LLC, Cinearts Sacramento, LLC, Corte Madera Theatres, LLC, Novato Theatres, LLC, San Rafael Theatres, LLC, Northbay Theatres, LLC, Century Theatres Summit Sierra, LLC and Century Theatres Seattle, LLC. The following supplemental condensed consolidating financial information presents: a. Condensed consolidating balance sheet information as of December 31, 2016 and December 31, 2017 and condensed consolidating statements of income information, condensed consolidating statements of comprehensive income information and condensed consolidating statements of cash flows information for the years ended December 31, 2015, 2016 and 2017. b. Cinemark USA, Inc. (the “Parent” and “Issuer”), combined Guarantor Subsidiaries and combined Non-Guarantor Subsidiaries with their investments in subsidiaries accounted for using the equity method of accounting and therefore, the Parent column reflects the equity income of its Guarantor Subsidiaries and Non-Guarantor Subsidiaries, which are also separately reflected in the stand-alone Guarantor Subsidiaries and Non-Guarantor Subsidiaries column. Additionally, the Guarantor Subsidiaries column reflects the equity income (loss) of its Non-Guarantor Subsidiaries, which are also separately reflected in the stand-alone Non-Guarantor Subsidiaries column. c. Elimination entries necessary to consolidate the Parent and all of its Subsidiaries CONDENSED CONSOLIDATING BALANCE SHEET INFORMATION DECEMBER 31, 2016 Parent Subsidiary Subsidiary Company Guarantors Non-Guarantors Eliminations Consolidated (In thousands) Assets Current assets Cash and cash equivalents $ 146,855 $ 281,023 $ 133,260 $ — $ 561,138 Other current assets 62,425 15,098 71,706 (34,154 ) 115,075 Accounts receivable from parent or subsidiaries 76,550 121,478 (187,948 ) 10,080 Total current assets 285,830 417,599 204,966 (222,102 ) 686,293 Theatre properties and equipment - net 604,506 678,984 421,046 — 1,704,536 Investment in subsidiaries 1,570,592 132,892 — (1,703,484 ) — Other assets 1,409,320 134,284 488,535 (106,359 ) 1,925,780 Total assets $ 3,870,248 $ 1,363,759 $ 1,114,547 $ (2,031,945 ) $ 4,316,609 Liabilities and equity Current liabilities Current portion of long-term debt $ 4,282 $ — $ 1,409 $ (20 ) $ 5,671 Current portion of capital lease obligations 7,903 9,541 3,695 — 21,139 Accounts payable and accrued expenses 197,789 121,640 113,020 (16,457 ) 415,992 Accounts payable to parent or subsidiaries — — 187,948 (187,948 ) — Total current liabilities 209,974 131,181 306,072 (204,425 ) 442,802 Long-term liabilities Long-term debt, less current portion 1,879,663 — 12,600 (109,822 ) 1,782,441 Capital lease obligations, less current portion 124,944 71,228 38,109 — 234,281 Other long-term liabilities and deferrals 382,729 84,429 120,061 (14,214 ) 573,005 Total long-term liabilities 2,387,336 155,657 170,770 (124,036 ) 2,589,727 Commitments and contingencies Equity Cinemark USA, Inc.'s stockholder's equity: Common stock 49,543 457,368 10,239 (467,607 ) 49,543 Other stockholder's equity 1,223,395 619,553 616,324 (1,235,877 ) 1,223,395 Total Cinemark USA, Inc. stockholder's equity 1,272,938 1,076,921 626,563 (1,703,484 ) 1,272,938 Noncontrolling interests — — 11,142 — 11,142 Total equity 1,272,938 1,076,921 637,705 (1,703,484 ) 1,284,080 Total liabilities and equity $ 3,870,248 $ 1,363,759 $ 1,114,547 $ (2,031,945 ) $ 4,316,609 CONDENSED CONSOLIDATING BALANCE SHEET INFORMATION DECEMBER 31, 2017 Parent Subsidiary Subsidiary Company Guarantors Non-Guarantors Eliminations Consolidated (In thousands) Assets Current assets Cash and cash equivalents $ 130,590 $ 180,623 $ 211,202 $ — $ 522,415 Other current assets 59,661 17,841 76,789 (19,270 ) 135,021 Accounts receivable from parent or subsidiaries 117,972 119,616 — (223,007 ) 14,581 Total current assets 308,223 318,080 287,991 (242,277 ) 672,017 Theatre properties and equipment - net 650,783 765,500 411,771 — 1,828,054 Investment in subsidiaries 1,691,626 121,795 — (1,813,421 ) — Other assets 1,427,328 134,845 536,816 (113,720 ) 1,985,269 Total assets $ 4,077,960 $ 1,340,220 $ 1,236,578 $ (2,169,418 ) $ 4,485,340 Liabilities and equity Current liabilities Current portion of long-term debt $ 5,710 $ — $ 1,389 $ — $ 7,099 Current portion of capital lease obligations 9,532 11,124 4,855 — 25,511 Accounts payable and accrued expenses 215,580 116,409 110,089 (6,402 ) 435,676 Accounts payable to parent or subsidiaries — — 223,007 (223,007 ) — Total current liabilities 230,822 127,533 339,340 (229,409 ) 468,286 Long-term liabilities Long-term debt, less current portion 1,878,992 — 11,211 (109,822 ) 1,780,381 Capital lease obligations, less current portion 132,189 75,767 43,195 — 251,151 Other long-term liabilities and deferrals 426,355 60,567 93,871 (16,766 ) 564,027 Total long-term liabilities 2,437,536 136,334 148,277 (126,588 ) 2,595,559 Commitments and contingencies Equity Cinemark USA, Inc.'s stockholder's equity: Common stock 49,543 457,368 10,238 (467,606 ) 49,543 Other stockholder's equity 1,360,059 618,985 726,830 (1,345,815 ) 1,360,059 Total Cinemark USA, Inc. stockholder's equity 1,409,602 1,076,353 737,068 (1,813,421 ) 1,409,602 Noncontrolling interests — — 11,893 — 11,893 Total equity 1,409,602 1,076,353 748,961 (1,813,421 ) 1,421,495 Total liabilities and equity $ 4,077,960 $ 1,340,220 $ 1,236,578 $ (2,169,418 ) $ 4,485,340 CONDENSED CONSOLIDATING STATEMENT OF INCOME INFORMATION YEAR ENDED DECEMBER 31, 2015 Parent Subsidiary Subsidiary Company Guarantors Non-Guarantors Eliminations Consolidated (In thousands) Revenues $ 959,347 $ 1,178,873 $ 764,631 $ (50,242 ) $ 2,852,609 Cost of operations Theatre operating expenses 767,446 804,236 545,131 (50,242 ) 2,066,571 General and administrative expenses 16,152 81,240 56,660 — 154,052 Depreciation and amortization 59,759 73,708 55,739 — 189,206 Impairment of long-lived assets 6,445 1,600 756 — 8,801 (Gain) loss on sale of assets and other 6,191 3,728 (1,776 ) — 8,143 Total cost of operations 855,993 964,512 656,510 (50,242 ) 2,426,773 Operating income 103,354 214,361 108,121 — 425,836 Other income (expense) Interest expense (100,608 ) (8,500 ) (4,009 ) 376 (112,741 ) Loss on debt amendments and refinancing (925 ) — — — (925 ) Distributions from NCM 2,116 — 16,024 — 18,140 Equity in income of affiliates 217,567 55,082 27,262 (271,785 ) 28,126 Other income (expense) 200 20 (7,929 ) (376 ) (8,085 ) Total other income 118,350 46,602 31,348 (271,785 ) (75,485 ) Income before income taxes 221,704 260,963 139,469 (271,785 ) 350,351 Income taxes 3,172 79,131 47,657 — 129,960 Net income 218,532 181,832 91,812 (271,785 ) 220,391 Less: Net income attributable to noncontrolling interests — — 1,859 — 1,859 Net income attributable to Cinemark USA, Inc. $ 218,532 $ 181,832 $ 89,953 $ (271,785 ) $ 218,532 CONDENSED CONSOLIDATING STATEMENT OF INCOME INFORMATION YEAR ENDED DECEMBER 31, 2016 Parent Subsidiary Subsidiary Company Guarantors Non-Guarantors Eliminations Consolidated (In thousands) Revenues $ 1,014,713 $ 1,219,218 $ 737,981 $ (53,147 ) $ 2,918,765 Cost of operations Theatre operating expenses 804,041 828,905 540,310 (53,147 ) 2,120,109 General and administrative expenses 13,085 84,453 43,099 — 140,637 Depreciation and amortization 70,654 79,139 59,278 — 209,071 Impairment of long-lived assets 1,929 — 907 — 2,836 Loss on sale of assets and other 5,613 13,759 1,087 20,459 Total cost of operations 895,322 1,006,256 644,681 (53,147 ) 2,493,112 Operating income 119,391 212,962 93,300 — 425,653 Other income (expense) Interest expense (96,442 ) (7,538 ) (5,642 ) 1,309 (108,313 ) Loss on debt amendments and refinancing (13,445 ) — — — (13,445 ) Distributions from NCM 1,414 — 13,242 — 14,656 Equity in income of affiliates 245,010 58,528 30,370 (301,946 ) 31,962 Other income 351 19 13,790 (1,309 ) 12,851 Total other income (expense) 136,888 51,009 51,760 (301,946 ) (62,289 ) Income before income taxes 256,279 263,971 145,060 (301,946 ) 363,364 Income taxes (498 ) 52,277 53,072 — 104,851 Net income 256,777 211,694 91,988 (301,946 ) 258,513 Less: Net income attributable to noncontrolling interests — — 1,736 — 1,736 Net income attributable to Cinemark USA, Inc. $ 256,777 $ 211,694 $ 90,252 $ (301,946 ) $ 256,777 CONDENSED CONSOLIDATING STATEMENT OF INCOME INFORMATION YEAR ENDED DECEMBER 31, 2017 Parent Subsidiary Subsidiary Company Guarantors Non-Guarantors Eliminations Consolidated (In thousands) Revenues $ 1,013,960 $ 1,220,993 $ 807,350 $ (50,756 ) $ 2,991,547 Cost of operations Theatre operating expenses 795,976 834,135 591,223 (50,756 ) 2,170,578 General and administrative expenses 13,176 82,955 54,780 — 150,911 Depreciation and amortization 79,676 87,463 70,374 — 237,513 Impairment of long-lived assets 3,725 1,502 9,857 — 15,084 Loss on sale of assets and other 16,895 3,372 2,545 — 22,812 Total cost of operations 909,448 1,009,427 728,779 (50,756 ) 2,596,898 Operating income 104,512 211,566 78,571 — 394,649 Other income (expense) Interest expense (94,229 ) (7,675 ) (5,447 ) 1,433 (105,918 ) Loss on debt amendments and refinancing (521 ) — — — (521 ) Distributions from NCM — — 16,407 — 16,407 Equity in income of affiliates 255,594 16,838 33,742 (270,189 ) 35,985 Other income 2,475 1,040 5,054 (1,433 ) 7,136 Total other income 163,319 10,203 49,756 (270,189 ) (46,911 ) Income before income taxes 267,831 221,769 128,327 (270,189 ) 347,738 Income taxes 2,188 69,770 8,298 — 80,256 Net income 265,643 151,999 120,029 (270,189 ) 267,482 Less: Net income attributable to noncontrolling interests — — 1,839 — 1,839 Net income attributable to Cinemark USA, Inc. $ 265,643 $ 151,999 $ 118,190 $ (270,189 ) $ 265,643 CONDENSED CONSOLIDATING STATEMENT OF COMPREHENSIVE INCOME INFORMATION YEAR ENDED DECEMBER 31, 2015 Parent Subsidiary Subsidiary Company Guarantors Non-Guarantors Eliminations Consolidated (In thousands) Net income $ 218,532 $ 181,832 $ 91,812 $ (271,785 ) $ 220,391 Other comprehensive income (loss), net of tax Unrealized gain due to fair value adjustments on interest rate swap agreements, net of settlements, net of taxes of $1,562 2,636 — — — 2,636 Unrealized loss due to fair value adjustments on available-for-sale securities, net of taxes of $572 (957 ) — — — (957 ) Other comprehensive loss of equity method investments (3,119 ) — (3,086 ) 3,086 (3,119 ) Foreign currency translation adjustments (125,474 ) — (125,512 ) 125,474 (125,512 ) Total other comprehensive income, net of tax (126,914 ) — (128,598 ) 128,560 (126,952 ) Total comprehensive income, net of tax $ 91,618 $ 181,832 $ (36,786 ) $ (143,225 ) $ 93,439 Comprehensive income attributable to noncontrolling interests — — (1,821 ) — (1,821 ) Comprehensive income attributable to Cinemark USA, Inc. $ 91,618 $ 181,832 $ (38,607 ) $ (143,225 ) $ 91,618 CONDENSED CONSOLIDATING STATEMENT OF COMPREHENSIVE INCOME INFORMATION YEAR ENDED DECEMBER 31, 2016 Parent Subsidiary Subsidiary Company Guarantors Non-Guarantors Eliminations Consolidated (In thousands) Net income $ 256,777 $ 211,694 $ 91,988 $ (301,946 ) $ 258,513 Other comprehensive income, net of tax Unrealized gain due to fair value adjustments on interest rate swap agreements, net of settlements, net of taxes of $138 234 — — — 234 Other comprehensive income of equity method investments 89 — 89 (89 ) 89 Foreign currency translation adjustments 26,361 — 26,394 (26,361 ) 26,394 Total other comprehensive income, net of tax 26,684 — 26,483 (26,450 ) 26,717 Total comprehensive income, net of tax $ 283,461 $ 211,694 $ 118,471 $ (328,396 ) $ 285,230 Comprehensive income attributable to noncontrolling interests — — (1,769 ) — (1,769 ) Comprehensive income attributable to Cinemark USA, Inc. $ 283,461 $ 211,694 $ 116,702 $ (328,396 ) $ 283,461 CONDENSED CONSOLIDATING STATEMENT OF COMPREHENSIVE INCOME INFORMATION YEAR ENDED DECEMBER 31, 2017 Parent Subsidiary Subsidiary Company Guarantors Non-Guarantors Eliminations Consolidated (In thousands) Net income $ 265,643 $ 151,999 $ 120,029 $ (270,189 ) $ 267,482 Other comprehensive income (loss), net of tax Other comprehensive income of equity method investments 248 — 248 (248 ) 248 Foreign currency translation adjustments (4,966 ) — (4,966 ) 4,966 (4,966 ) Total other comprehensive loss, net of tax (4,718 ) — (4,718 ) 4,718 (4,718 ) Total comprehensive income, net of tax $ 260,925 $ 151,999 $ 115,311 $ (265,471 ) $ 262,764 Comprehensive income attributable to noncontrolling interests — — (1,839 ) — (1,839 ) Comprehensive income attributable to Cinemark USA, Inc. $ 260,925 $ 151,999 $ 113,472 $ (265,471 ) $ 260,925 CONDENSED CONSOLIDATING STATEMENT OF CASH FLOWS INFORMATION YEAR ENDED DECEMBER 31, 2015 Parent Subsidiary Subsidiary Company Guarantors Non-Guarantors Eliminations Consolidated (In thousands) Operating activities Net income $ 218,532 $ 181,832 $ 91,812 $ (271,785 ) $ 220,391 Adjustments to reconcile net income to cash provided by operating activities (142,602 ) 39,156 43,223 271,785 211,562 Changes in assets and liabilities 67,253 (67,850 ) 23,869 — 23,272 Net cash provided by operating activities 143,183 153,138 158,904 — 455,225 Investing activities Additions to theatre properties and equipment (98,193 ) (121,605 ) (111,928 ) — (331,726 ) Proceeds from sale of theatre properties and equipment and other 2,737 5,264 1,965 — 9,966 Acquisition of theatre in Brazil — — (2,651 ) — (2,651 ) Dividends received from subsidiaries 1,685 15 — (1,700 ) Intercompany note issuances (3,500 ) — (100,000 ) 103,500 — Investment in joint ventures and other (518 ) — (3,211 ) 18 (3,711 ) Net cash used for investing activities (97,789 ) (116,326 ) (215,825 ) 101,818 (328,122 ) Financing activities Dividends paid to parent (115,225 ) (1,700 ) — 1,700 (115,225 ) Repayments of long-term debt (8,385 ) — (35 ) — (8,420 ) Payments of debt issue costs (6,957 ) — — — (6,957 ) Payments on capital leases (5,389 ) (9,120 ) (2,004 ) — (16,513 ) Intercompany loan proceeds 100,000 — 3,518 (103,518 ) Other 2,421 (4,770 ) (1,045 ) — (3,394 ) Net cash provided by (used for) financing activities (33,535 ) (15,590 ) 434 (101,818 ) (150,509 ) Effect of exchange rate changes on cash and cash equivalents — — (26,932 ) — (26,932 ) Increase (decrease) in cash and cash equivalents 11,859 21,222 (83,419 ) — (50,338 ) Cash and cash equivalents: Beginning of year 129,505 74,643 434,693 — 638,841 End of year $ 141,364 $ 95,865 $ 351,274 $ — $ 588,503 CONDENSED CONSOLIDATING STATEMENT OF CASH FLOWS INFORMATION YEAR ENDED DECEMBER 31, 2016 Parent Subsidiary Subsidiary Company Guarantors Non-Guarantors Eliminations Consolidated (In thousands) Operating activities Net income $ 256,777 $ 211,694 $ 91,988 $ (301,946 ) $ 258,513 Adjustments to reconcile net income to cash provided by operating activities (189,223 ) 55,128 53,381 301,946 221,232 Changes in assets and liabilities 154,085 (164,005 ) (18,642 ) — (28,562 ) Net cash provided by operating activities 221,639 102,817 126,727 — 451,183 Investing activities Additions to theatre properties and equipment (108,439 ) (130,843 ) (87,626 ) — (326,908 ) Acquisition of theatres in the U.S. (15,300 ) — — — (15,300 ) Acquisition of screen advertising business — — (1,450 ) — (1,450 ) Proceeds from sale of theatre properties and equipment and other 2,912 374 284 — 3,570 Proceeds from sale of marketable securities 13,451 — — — 13,451 Intercompany note issuances (4,455 ) — — 4,455 Dividends received from subsidiaries 26,033 229,649 — (255,682 ) — Investment in joint ventures and other (1,000 ) — (132 ) — (1,132 ) Net cash provided by (used for) investing activities (86,798 ) 99,180 (88,924 ) (251,227 ) (327,769 ) Financing activities Dividends paid to parent (124,900 ) — (255,682 ) 255,682 (124,900 ) Proceeds from issuance of Senior Notes, net of discount 222,750 — — — 222,750 Retirement of Senior Subordinated Notes (200,000 ) — — — (200,000 ) Repayments of long-term debt (15,201 ) — (1,404 ) — (16,605 ) Payments of debt issue costs (7,217 ) — — — (7,217 ) Intercompany loan proceeds — — 4,455 (4,455 ) Payments on capital leases (6,645 ) (10,005 ) (2,693 ) — (19,343 ) Other 1,863 (6,834 ) (1,759 ) — (6,730 ) Net cash used for financing activities (129,350 ) (16,839 ) (257,083 ) 251,227 (152,045 ) Effect of exchange rate changes on cash and cash equivalents — — 1,266 — 1,266 Increase (decrease) in cash and cash equivalents 5,491 185,158 (218,014 ) — (27,365 ) Cash and cash equivalents: Beginning of year 141,364 95,865 351,274 — 588,503 End of year $ 146,855 $ 281,023 $ 133,260 $ — $ 561,138 CONDENSED CONSOLIDATING STATEMENT OF CASH FLOWS INFORMATION YEAR ENDED DECEMBER 31, 2017 Parent Subsidiary Subsidiary Company Guarantors Non-Guarantors Eliminations Consolidated (In thousands) Operating activities Net income $ 265,643 $ 151,999 $ 120,029 $ (270,189 ) $ 267,482 Adjustments to reconcile net income to cash provided by operating activities (123,080 ) 71,023 33,515 270,189 251,647 Changes in assets and liabilities 18,223 (35,138 ) 25,649 — 8,734 Net cash (used for) provided by operating activities 160,786 187,884 179,193 — 527,863 Investing activities Additions to theatre properties and equipment (146,385 ) (172,874 ) (61,603 ) — (380,862 ) Acquisition of theatres in the U.S. and international markets, net of cash acquired (12,500 ) — (28,497 ) — (40,997 ) Proceeds from sale of theatre properties and equipment and other 2,149 12,271 678 — 15,098 Dividends received from subsidiaries 127,600 1,873 — (129,473 ) — Investment in joint ventures and other — (104 ) (3,611 ) — (3,715 ) Net cash provided by (used for) investing activities (29,136 ) (158,834 ) (93,033 ) (129,473 ) (410,476 ) Financing activities Dividends paid to parent (134,500 ) (127,000 ) (2,473 ) 129,473 (134,500 ) Repayments of long-term debt (4,282 ) — (1,389 ) — (5,671 ) Payments on capital leases (7,952 ) (9,707 ) (4,066 ) — (21,725 ) Proceeds from financing lease — 10,200 — — 10,200 Other (1,181 ) (2,943 ) (1,088 ) — (5,212 ) Net cash used for financing activities (147,915 ) (129,450 ) (9,016 ) 129,473 (156,908 ) Effect of exchange rate changes on cash and cash equivalents — — 798 — 798 Increase (decrease) in cash and cash equivalents (16,265 ) (100,400 ) 77,942 — (38,723 ) Cash and cash equivalents: Beginning of year 146,855 281,023 133,260 — 561,138 End of year $ 130,590 $ 180,623 $ 211,202 $ — $ 522,415

Unaudited Supplemental Schedule

Unaudited Supplemental Schedules	12 Months Ended
	Dec. 31, 2017
Supplemental Financial Information For Indentures [Abstract]
Unaudited Supplemental Schedules	UNAUDITED SUPPLEMENTAL SCHEDULES As required by the indentures governing the Company’s 5.125% Senior Notes and 4.875% Senior Notes (collectively the “Notes”), the Company has included in this filing, financial information for its subsidiaries that have been designated as unrestricted subsidiaries as defined by the indentures. As required by the indentures governing the Notes, the Company has included a condensed consolidating balance sheet and condensed consolidating statements of income, comprehensive income and cash flows for the Company and its subsidiaries. These supplementary schedules separately identify the Company’s restricted subsidiaries and unrestricted subsidiaries as required by the indentures. CINEMARK USA, INC. AND SUBSIDIARIES UNAUDITED CONDENSED CONSOLIDATING BALANCE SHEET INFORMATION DECEMBER 31, 2017 (In thousands) Restricted Unrestricted Group Group Eliminations Consolidated Assets Current assets Cash and cash equivalents $ 461,518 $ 60,897 $ — $ 522,415 Other current assets 276,373 (126,494 ) (277 ) 149,602 Total current assets 737,891 (65,597 ) (277 ) 672,017 Theatre properties and equipment, net 1,828,054 — — 1,828,054 Other assets 1,823,787 488,501 (327,019 ) 1,985,269 Total assets $ 4,389,732 $ 422,904 $ (327,296 ) $ 4,485,340 Liabilities and equity Current liabilities Current portion of long-term debt $ 5,710 $ 1,389 $ — $ 7,099 Current portion of capital lease obligations 25,511 — — 25,511 Accounts payable and accrued expenses 435,951 2 (277 ) 435,676 Total current liabilities 467,172 1,391 (277 ) 468,286 Long-term liabilities Long-term debt, less current portion 1,998,992 1,389 (220,000 ) 1,780,381 Capital lease obligations, less current portion 251,151 — — 251,151 Other long-term liabilities and deferrals 501,030 62,997 — 564,027 Total long-term liabilities 2,751,173 64,386 (220,000 ) 2,595,559 Commitments and contingencies Equity 1,171,387 357,127 (107,019 ) 1,421,495 Total liabilities and equity $ 4,389,732 $ 422,904 $ (327,296 ) $ 4,485,340 Note: "Restricted Group" and "Unrestricted Group" are defined in the indentures for the senior notes. CINEMARK USA, INC. AND SUBSIDIARIES UNAUDITED CONDENSED CONSOLIDATING STATEMENT OF INCOME INFORMATION YEAR ENDED DECEMBER 31, 2017 (In thousands) Restricted Unrestricted Group Group Eliminations Consolidated Revenues $ 2,991,547 $ — $ — $ 2,991,547 Cost of operations — Theatre operating costs 2,170,578 — — 2,170,578 General and administrative expenses 150,896 15 — 150,911 Depreciation and amortization 237,513 — — 237,513 Impairment of long-lived assets 15,084 — — 15,084 Loss on sale of assets and other 22,812 — — 22,812 Total cost of operations 2,596,883 15 — 2,596,898 Operating income (loss) 394,664 (15 ) — 394,649 Other income (expense) (123,960 ) 77,049 — (46,911 ) Income before income taxes 270,704 77,034 — 347,738 Income taxes 88,618 (8,362 ) — 80,256 Net income 182,086 85,396 — 267,482 Less: Net income attributable to noncontrolling interests 1,839 — — 1,839 Net income attributable to Cinemark USA, Inc. $ 180,247 $ 85,396 $ — $ 265,643 Note: "Restricted Group" and "Unrestricted Group" are defined in the indentures for the senior notes. CINEMARK USA, INC. AND SUBSIDIARIES UNAUDITED CONDENSED CONSOLIDATING STATEMENT OF COMPREHENSIVE INCOME INFORMATION YEAR ENDED DECEMBER 31, 2017 (In thousands) Restricted Unrestricted Group Group Eliminations Consolidated Net income $ 182,086 $ 85,396 $ — $ 267,482 Other comprehensive income, net of tax Other comprehensive income in equity method investments — 248 — 248 Foreign currency translation adjustments (4,966 ) — — (4,966 ) Total other comprehensive income (loss), net of tax (4,966 ) 248 — (4,718 ) Total comprehensive income, net of tax 177,120 85,644 — 262,764 Comprehensive income attributable to noncontrolling interests (1,839 ) — — (1,839 ) Comprehensive income attributable to Cinemark USA, Inc. $ 175,281 $ 85,644 $ — $ 260,925 Note: "Restricted Group" and "Unrestricted Group" are defined in the indentures for the senior notes. CINEMARK USA, INC. AND SUBSIDIARIES UNAUDITED CONDENSED CONSOLIDATING STATEMENT OF CASH FLOWS INFORMATION YEAR ENDED DECEMBER 31, 2017 (In thousands) Restricted Unrestricted Group Group Eliminations Consolidated Operating activities Net income $ 182,086 $ 85,396 $ — $ 267,482 Adjustments to reconcile net income to cash provided by operating activities 246,820 4,827 — 251,647 Changes in assets and liabilities 34,233 (25,499 ) — 8,734 Net cash provided by operating activities 463,139 64,724 — 527,863 Investing activities Additions to theatre properties and equipment and other (380,862 ) — — (380,862 ) Acquisition of theatres in the U.S. and international markets, net of cash acquired (40,997 ) — — (40,997 ) Proceeds from sale of theatre properties and equipment and other 15,098 — — 15,098 Investment in joint ventures and other (103 ) (3,612 ) — (3,715 ) Net cash used for investing activities (406,864 ) (3,612 ) — (410,476 ) Financing activities Dividends paid to parent (134,500 ) — — (134,500 ) Repayments of long-term debt (4,282 ) (1,389 ) — (5,671 ) Payments on capital leases (21,725 ) — — (21,725 ) Other 4,988 — — 4,988 Net cash used for financing activities (155,519 ) (1,389 ) — (156,908 ) Effect of exchange rate changes on cash and cash equivalents 798 — — 798 Increase (decrease) in cash and cash equivalents (98,446 ) 59,723 — (38,723 ) Cash and cash equivalents: Beginning of year 559,964 1,174 — 561,138 End of year $ 461,518 $ 60,897 $ — $ 522,415 Note: "Restricted Group" and "Unrestricted Group" are defined in the indentures for the senior notes.

SUMMARY OF SIGNIFICANT ACCOUN30

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)	12 Months Ended
	Dec. 31, 2017
Accounting Policies [Abstract]
Business	Business — Cinemark USA, Inc. and subsidiaries (the “Company”), a wholly-owned subsidiary of Cinemark Holdings, Inc., operates in the motion picture exhibition industry, with theatres in the United States (“U.S.”), Brazil, Argentina, Chile, Colombia, Peru, Ecuador, Honduras, El Salvador, Nicaragua, Costa Rica, Panama, Guatemala, Bolivia, Curaçao and Paraguay.
Principles of Consolidation	Principles of Consolidation — The consolidated financial statements include the accounts of Cinemark USA, Inc. and its subsidiaries. Majority-owned subsidiaries that the Company has control of are consolidated while those affiliates of which the Company owns between 20% and 50% and does not control are accounted for under the equity method. Those affiliates of which the Company owns less than 20% are generally accounted for under the cost method, unless the Company is deemed to have the ability to exercise significant influence over the affiliate, in which case the Company would account for its investment under the equity method. The results of these equity method investees are included in the consolidated financial statements effective with their formation or from their dates of acquisition. Intercompany balances and transactions are eliminated in consolidation.
Cash and Cash Equivalents	Cash and Cash Equivalents — Cash and cash equivalents consist of operating funds held in financial institutions, petty cash held by the theatres and highly liquid investments with original maturities of three months or less when purchased. Cash investments are primarily in money market funds or other similar funds.
Accounts Receivable	Accounts Receivable – Accounts receivable, which are recorded at net realizable value, consist primarily of receivables related to screen advertising, receivables related to discounted tickets sold to retail locations, receivables from landlords related to theatre construction and remodels, rebates earned from the Company’s concession vendors and value-added and other non-income tax receivables.
Inventories	Inventories — Concession and theatre supplies inventories are stated at the lower of cost (first-in, first-out method) or market.
Theatre Properties and Equipment	Theatre Properties and Equipment — Theatre properties and equipment are stated at cost less accumulated depreciation and amortization. Depreciation is provided using the straight-line method over the estimated useful lives of the assets as follows: Category Useful Life Buildings on owned land 40 years Buildings on leased land Lesser of lease term or useful life Land and buildings under capital lease (1) Lesser of lease term or useful life Theatre furniture and equipment 3 to 15 years Leasehold improvements Lesser of lease term or useful life (1) The Company reviews long-lived assets for impairment indicators on a quarterly basis or whenever events or changes in circumstances indicate the carrying amount of the assets may not be fully recoverable. The Company also performs a full quantitative impairment evaluation on an annual basis. The Company considers actual theatre level cash flows, budgeted theatre level cash flows, theatre property and equipment carrying values, amortizing intangible asset carrying values, the age of a recently built theatre, competitive theatres in the marketplace, the impact of recent ticket price changes, the impact of recent theatre remodels or other substantial improvements, available lease renewal options and other factors considered relevant in its assessment of impairment of individual theatre assets. Long-lived assets are evaluated for impairment on an individual theatre basis, which the Company believes is the lowest applicable level for which there are identifiable cash flows. The impairment evaluation is based on the estimated undiscounted cash flows from continuing use through the remainder of the theatre’s useful life. The remainder of the theatre’s useful life correlates with the available remaining lease period, which includes the probability the exercise of available renewal periods or extensions, for leased properties and the lesser of twenty years or the building’s remaining useful life for fee-owned properties. If the estimated undiscounted cash flows are not sufficient to recover a long-lived asset’s carrying value, the Company then compares the carrying value of the asset group (theatre) with its estimated fair value. When the estimated fair value is determined to be lower than the carrying value of the asset group, the asset group is written down to its estimated fair value. Significant judgment is involved in estimating cash flows and fair value. Management’s estimates, which fall under Level 3 of the U.S. GAAP fair value hierarchy as defined by Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 820-10-35, are based on historical and projected operating performance, recent market transactions and current industry trading multiples. Fair value is determined based on a multiple of cash flows, which was six and a half times for the evaluations performed during 2015, 2016 and 2017. The long-lived asset impairment charges recorded during each of the periods presented are specific to theatres that were directly and individually impacted by increased competition, adverse changes in market demographics, or adverse changes in the development or the conditions of the areas surrounding the theatre. See Note 6.
Goodwill and Other Intangible Assets	Goodwill and Other Intangible Assets — The Company evaluates goodwill for impairment annually during the fourth quarter or whenever events or changes in circumstances indicate the carrying value of the goodwill may not be fully recoverable. The Company evaluates goodwill for impairment at the reporting unit level. Management considers the reporting unit to be each of its nineteen regions in the U.S. and seven countries internationally with Honduras, El Salvador, Nicaragua, Costa Rica, Panama and Guatemala considered one reporting unit (the Company does not have goodwill recorded for all of its international locations). Significant judgment is involved in estimating cash flows and fair value. Management’s estimates, which fall under Level 3 of the U.S. GAAP fair value hierarchy as defined by FASB ASC Topic 820-10-35, are based on historical and projected operating performance, recent market transactions and current industry trading multiples. Fair value is determined based on a multiple of estimated cash flows, which was eight times, for the evaluations performed during 2015 and 2017. During the year ended December 31, 2015, the Company performed a qualitative goodwill impairment assessment on all reporting units except one, in accordance with ASU 2011-08 Testing Goodwill for Impairment During the year ended December 31, 2016, the Company performed a qualitative goodwill impairment assessment on all reporting units. Based on the qualitative assessment performed, the Company determined that it was not more likely than not that the fair value of the reporting units were less than their carrying values. During the year ended December 31, 2017, the Company performed a quantitative goodwill impairment assessment for all reporting units. As of December 31, 2017, the estimated fair value of the Company’s goodwill exceeded their carrying values by more than 10%. Tradename intangible assets are tested for impairment at least annually during the fourth quarter or whenever events or changes in circumstances indicate the carrying value may not be fully recoverable. The Company estimates the fair value of its tradenames by applying an estimated market royalty rate that could be charged for the use of its tradename to forecasted future revenues, with an adjustment for the present value of such royalties. If the estimated fair value is less than the carrying value, the tradename intangible asset is written down to its estimated fair value. Significant judgment is involved in estimating market royalty rates and long-term revenue forecasts. Management’s estimates, which fall under Level 3 of the U.S. GAAP fair value hierarchy as defined by FASB ASC Topic 820-10-35, are based on historical and projected revenue performance and industry trends. During the year ended December 31, 2015, the Company performed a qualitative tradename intangible asset impairment assessment in accordance with ASU 2011-08. The qualitative assessments included consideration of the Company’s historical and forecasted revenues and estimated royalty rates for each tradename intangible asset. Based on the qualitative assessment performed, the Company determined that it was not more likely than not that the fair values of the tradename assets were less than their carrying values as of December 31, 2015. During the year ended December 31, 2016, the Company performed a qualitative assessment for all indefinite-lived tradename assets other than our tradename in Ecuador, for which the Company performed a quantitative assessment. The qualitative assessments included consideration of the Company’s historical and forecasted revenues and estimated royalty rates for each tradename intangible asset. The quantitative test for our tradename in Ecuador included estimating the fair value of the tradename based on forecasted revenues for our Ecuador theatres multiplied by an estimated market royalty rate that could be charged for the use of the tradename, with an adjustment for the present value of such royalties. Based on the qualitative and quantitative assessments performed, the Company determined that it was not more likely than not that the fair values of tradename intangible assets were less than their carrying values as of December 31, 2016. During the year ended December 31, 2016, the Company also performed a quantitative test on its definite-lived tradename associated with the Rave theatres acquired in 2013. During the year ended December 31, 2016, the Company rebranded certain of these theatres with Cinemark signage as part of recliner conversions and other renovations. The Company estimated the fair value of the Rave tradename by applying an estimated market royalty rate that could be charged for the use of the tradename to forecasted future revenues for the theatres using the Rave tradename, with an adjustment for the present value of such royalties. As of December 31, 2016, the estimated fair value of the Rave tradename intangible asset exceeded their carrying value by more than 10%. During the year ended 2017, the Company performed a quantitative test on all indefinite and definite-lived tradename assets. As of December 31, 2017, the estimated fair value of the Company’s tradename assets exceeded their carrying values by more than 10% The table below summarizes the Company’s intangible assets and the amortization method used for each type of intangible asset: Intangible Asset Amortization Method Goodwill Indefinite-lived Tradename Indefinite-lived Vendor contracts Straight-line method over the terms of the underlying contracts. The remaining terms of the underlying contracts range from one to three years. Favorable/unfavorable leases Based on the pattern in which the economic benefits are realized over the terms of the lease agreements. The remaining terms of the lease agreements range from approximately two to nineteen years. Other intangible assets Straight-line method over the terms of the underlying agreement or the expected useful life of the intangible asset. The remaining useful lives of these intangible assets range from one to twelve years.
Deferred Charges and Other Assets	Deferred Charges and Other Assets — Deferred charges and other assets consist of long-term prepaid rents, construction and other deposits, equipment to be placed in service, and other assets of a long-term nature. Long-term prepaid rents represent prepayments of rent on operating leases. These payments are recognized as facility lease expense over the period for which the rent was paid in advance as outlined in the lease agreements. The remaining amortization periods generally range from one to fifteen years.
Lease Accounting	Lease Accounting — The Company evaluates each lease for classification as either a capital lease or an operating lease. The Company records the lease as a capital lease at its inception if 1) the present value of future minimum lease payments exceeds 90% of the leased property’s estimated fair value; 2) the lease term exceeds 75% of the property’s estimated useful life; 3) the lease contains a bargain purchase option; or 4) ownership transfers to the Company at the end of the lease. The Company performs this evaluation at the inception of the lease and when a modification is made to a lease. If the lease agreement calls for a scheduled rent increase during the lease term, the Company recognizes the lease expense on a straight-line basis over the lease term. The Company determines the straight-line rent expense impact of an operating lease upon inception of the lease. For some new build theatres, the landlord is responsible for constructing a theatre using guidelines and specifications agreed to by the Company and assumes substantially all of the risk of construction. For other theatres, the Company is responsible for managing construction of the theatre and the landlord contributes an agreed upon amount to the costs of construction. If the Company concludes that it has substantially all of the construction period risks, it records a construction asset and related liability for the amount of total project costs incurred during the construction period. At the end of the construction period, the Company determines if the transaction qualifies for sale-leaseback accounting treatment in regards to lease classification. If the Company receives a lease incentive payment from a landlord, the Company records the proceeds as a deferred lease incentive liability and amortizes the liability as a reduction in rent expense over the initial term of the respective lease if a new theatre, or over the remaining lease term if an existing theatre.
Deferred Revenues	Deferred Revenues — Advances collected on long-term screen advertising, concession and other contracts are recorded as deferred revenues. In accordance with the terms of the agreements, the advances collected on such contracts are recognized during the period in which the advances are earned, which may differ from the period in which the advances are collected. These advances are recognized on either a straight-line basis over the term of the contracts or as such revenues are earned in accordance with the terms of the contracts. The remaining amortization periods generally range from one to twenty years. See Note 2 for discussion of impact of new revenue recognition accounting pronouncement and Note 3 for discussion of deferred revenue – NCM.
Self-Insurance Reserves	Self-Insurance Reserves — The Company is self-insured for general liability claims subject to an annual cap. For the years ended December 31, 2015, 2016 and 2017, general liability claims were capped at $ 100, $100 and $250, respectively, per occurrence with annual caps of approximately $2,900, $3,350 and $3,900, respectively. The Company was fully insured for workers compensation claims during the years ended December 31, 2015 and 2016. During 2017, the Company implemented a fully-funded deductible workers compensation insurance plan under which the Company is responsible for pre-funding claims and is responsible for claims up to $250 per occurrence, with an annual cap of $5,000. The Company was also self-insured for medical claims up to $125, $150 and $250 per occurrence for the years ended December 31, 2015, 2016 and 2017, respectively. As of December 31, 2016 and 2017, the Company’s insurance reserves were $7,837 and $8,252, respectively, and are reflected in accrued other current liabilities in the consolidated balance sheets.
Revenue and Expense Recognition	Revenue and Expense Recognition — Revenues are recognized when admissions and concession sales are received at the box office. Other revenues include screen advertising and other ancillary revenues such as vendor marketing promotions, meeting rentals and electronic video games located in the Company’s theatres. Screen advertising revenues are recognized over the period that the related advertising is delivered on-screen or in-theatre. The Company records proceeds from the sale of gift cards and other advanced sale-type certificates in current liabilities and recognizes admissions or concession revenue when a holder redeems the card or certificate. The Company recognizes unredeemed gift cards and other advanced sale-type certificates as revenue only after such a period of time indicates, based on historical experience, the likelihood of redemption is remote, and based on applicable laws and regulations. In evaluating the likelihood of redemption, the Company considers the period outstanding, the level and frequency of activity, and the period of inactivity. As of December 31, 2016 and 2017, the Company’s liabilities for advanced sale-type certificates were approximately $70,247 and $77,623, respectively, and are reflected in accrued other current liabilities on the consolidated balance sheets. The Company recognized unredeemed gift cards and other advanced sale-type certificates as revenues in the amount of $11,786, $11,522 and $11,861 during the years ended December 31, 2015, 2016 and 2017, respectively. See Note 2 for discussion of impact of new revenue recognition accounting pronouncements. Film rental costs are accrued based on the applicable box office receipts and either firm terms or a sliding scale formula, which are generally established prior to the opening of the film, or estimates of the final settlement rate, which occurs at the conclusion of the film run, subject to the film licensing arrangement. Under a firm terms formula, the Company pays the distributor a percentage of box office receipts, which reflects either an aggregate rate for the life of the film or rates that decline over the term of the run. Under a sliding scale formula, film rental is paid as a percentage of box office revenues using a pre-determined matrix based upon box office performance of the film. The settlement process allows for negotiation of film rental fees upon the conclusion of the film run based upon how the film performs. Estimates are based on the expected success of a film. The success of a film can typically be determined a few weeks after a film is released when initial box office performance of the film is known. Accordingly, final settlements typically approximate estimates since box office receipts are known at the time the estimate is made and the expected success of a film can typically be estimated early in the film’s run. If actual settlements are different than those estimates, film rental costs are adjusted at the time of settlement.
Loyalty Programs	Loyalty Programs — The Company launched its app-based Connections loyalty program for its domestic markets in February 2016. Customers earn points for initial sign-up and for various transactions as tracked within the app. Points may be redeemed for concessions items, concession discounts and experiential rewards, each of which are offered for limited periods of time and at varying times during the year. The Company has determined that the values of the rewards offered to the customer are insignificant to the original transactions required to earn such rewards and has applied the incremental cost approach to accounting for the rewards earned. The Company also has loyalty programs in certain of its international markets, which generally consist of the customer paying a membership fee in exchange for discounts during the membership period. The Company had approximately $5,527 recorded in accrued other current liabilities for its loyalty programs as of December 31, 2017. See Note 2 for discussion of impact of new revenue recognition accounting pronouncements.
Accounting for Share Based Awards	Accounting for Share Based Awards — The Company measures the cost of employee services received in exchange for an equity award based on the fair value of the award on the date of the grant. The grant date fair value is estimated using a market observed price. Such costs are recognized over the period during which an employee is required to provide service in exchange for the award (which is usually the vesting period). At the time of the grant, the Company also estimates the number of awards that will ultimately be forfeited. See Note 12 for discussion of the Company’s share based awards and related compensation expense.
Income Taxes	Income Taxes — The Company participates in the consolidated return of Cinemark Holdings, Inc. However, the Company’s provision for income taxes is computed on a stand-alone basis. The Company uses an asset and liability approach to financial accounting and reporting for income taxes. Deferred income taxes are provided when tax laws and financial accounting standards differ with respect to the amount of income for a year and the basis of assets and liabilities. A valuation allowance is recorded to reduce the carrying amount of deferred tax assets unless it is more likely than not that such assets will be realized. Income taxes are provided on unremitted earnings from foreign subsidiaries unless such earnings are expected to be indefinitely reinvested. Income taxes have also been provided for potential tax assessments. The evaluation of an uncertain tax position is a two-step process. The first step is recognition: The Company determines whether it is more likely than not that a tax position will be sustained upon examination, including resolution of any related appeals or litigation processes, based on the technical merits of the position. In evaluating whether a tax position has met the more-likely-than-not recognition threshold, the Company should presume that the position would be examined by the appropriate taxing authority that would have full knowledge of all relevant information. The second step is measurement: A tax position that meets the more-likely-than-not recognition threshold is measured to determine the amount of benefit to recognize in the financial statements. The tax position is measured as the largest amount of benefit that is greater than 50 percent likely of being realized upon ultimate settlement. Differences between tax positions taken in a tax return and amounts recognized in the financial statements result in (1) a change in a liability for income taxes payable or (2) a change in an income tax refund receivable, a deferred tax asset or a deferred tax liability or both (1) and (2). The Company accrues interest and penalties on its uncertain tax positions as a component of income tax expense.
Segments	Segments — For the years ended December 31, 2015, 2016 and 2017, the Company managed its business under two reportable operating segments, U.S. markets and international markets. See Note 16.
Use of Estimates	Use of Estimates — The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires the use of estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the periods presented. The Company’s consolidated financial statements include amounts that are based on management’s best estimates and judgments. Actual results could differ from those estimates.
Foreign Currency Translations	Foreign Currency Translations — The assets and liabilities of the Company’s foreign subsidiaries are translated into U.S. dollars at current exchange rates as of the balance sheet date, and revenues and expenses are translated at average monthly exchange rates. The resulting translation adjustments are recorded in the consolidated balance sheets in accumulated other comprehensive loss. See Note 10 for a summary of the translation adjustments recorded in accumulated other comprehensive loss for the years ended December 31, 2015, 2016 and 2017. The Company recognizes foreign currency transaction gains and losses when changes in exchange rates impact transactions, other than intercompany transactions of a long-term investment nature, that have been denominated in a currency other than the functional currency.
Fair Value Measurements	Fair Value Measurements — According to authoritative guidance, inputs used in fair value measurements fall into three different categories; Level 1, Level 2 and Level 3. Level 1 inputs are quoted prices (unadjusted) in active markets for identical assets or liabilities that the reporting entity has the ability to access at the measurement date. Level 2 inputs are inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly. Level 3 inputs are unobservable inputs for the asset or liability. The Company had an interest rate swap agreement and investments in marketable securities that were adjusted to fair value on a recurring basis (quarterly). With respect to its interest rate swap agreement, the Company used the income approach to determine the fair value of its interest rate swap agreement and under this approach, the Company used projected future interest rates as provided by the counterparties to the interest rate swap agreement and the fixed rate that the Company was obligated to pay under the agreement. Therefore, the Company’s fair value measurements for its interest rate swap used significant unobservable inputs, which fall in Level 3. The interest rate swap agreement expired in April 2016. With respect to its investments in marketable securities, the Company used quoted market prices, which fall under Level 1 of the hierarchy. There were no changes in valuation techniques during the period and no transfers in or out of Level 1, Level 2 or Level 3 during the years ended December 31, 2015, 2016 and 2017. See Note 9 for further discussion of the Company’s fair value measurements. The Company also uses fair value measurements on a nonrecurring basis, primarily in the impairment evaluations for goodwill, intangible assets and other long-lived assets. See and included above for discussion of such fair value measurements.
Acquisitions	Acquisitions — The Company accounts for acquisitions under the acquisition method of accounting. The acquisition method requires that the acquired assets and liabilities, including contingencies, be recorded at fair value determined on the acquisition date and changes thereafter reflected in income. For significant acquisitions, the Company obtains independent third party valuation studies for certain of the assets acquired and liabilities assumed to assist the Company in determining fair value. The estimation of the fair values of the assets acquired and liabilities assumed involves a number of estimates and assumptions that could differ materially from the actual amounts realized. The Company provides assumptions, including both quantitative and qualitative information, about the specified asset or liability to the third party valuation firms. The Company primarily utilizes the third parties to accumulate comparative data from multiple sources and assemble a report that summarizes the information obtained. The Company then uses the information to record estimated fair value. The third party valuation firms are supervised by Company personnel who are knowledgeable about valuations and fair value. The Company evaluates the appropriateness of the assumptions and valuation methodologies utilized by the third party valuation firm.

SUMMARY OF SIGNIFICANT ACCOUN31

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)	12 Months Ended
	Dec. 31, 2017
Accounting Policies [Abstract]
Estimated Useful Life of Assets	Depreciation is provided using the straight-line method over the estimated useful lives of the assets as follows: Category Useful Life Buildings on owned land 40 years Buildings on leased land Lesser of lease term or useful life Land and buildings under capital lease (1) Lesser of lease term or useful life Theatre furniture and equipment 3 to 15 years Leasehold improvements Lesser of lease term or useful life (1)
Amortization Method Used for Intangible Assets	The table below summarizes the Company’s intangible assets and the amortization method used for each type of intangible asset: Intangible Asset Amortization Method Goodwill Indefinite-lived Tradename Indefinite-lived Vendor contracts Straight-line method over the terms of the underlying contracts. The remaining terms of the underlying contracts range from one to three years. Favorable/unfavorable leases Based on the pattern in which the economic benefits are realized over the terms of the lease agreements. The remaining terms of the lease agreements range from approximately two to nineteen years. Other intangible assets Straight-line method over the terms of the underlying agreement or the expected useful life of the intangible asset. The remaining useful lives of these intangible assets range from one to twelve years.

Investment in National CineMe32

Investment in National CineMedia LLC (Tables) - NCM	12 Months Ended
	Dec. 31, 2017
Summary of Common Units Received Under Common Unit Adjustment Agreement	Below is a summary of common units received by the Company under the Common Unit Adjustment Agreement during the years ended December 31, 2015, 2016 and 2017: Date Number Fair Value Common Units of Common Units of Common Units Event Received Received Received 2015 Annual common unit adjustment 3/31/2015 1,074,910 $ 15,421 2016 Annual common unit adjustment 3/31/2016 753,598 $ 11,111 2017 Annual common unit adjustment 3/31/2017 1,487,218 $ 18,363
Summary of Activity with NCM Included in Company's Consolidated Financial Statements	Below is a summary of activity with NCM included in the Company’s consolidated financial statements for the periods indicated. See Note 2 for discussion of impact of new revenue recognition accounting pronouncements. Investment Deferred Distributions from Equity in Other Other Comprehensive Cash in NCM Revenue NCM Earnings Revenue Loss Received Balance as of January 1, 2015 $ 178,939 $ (335,219 ) Receipt of common units due to annual common unit adjustment 15,421 (15,421 ) $ — $ — $ — $ — $ — Revenues earned under ESA (1) — — — — (11,330 ) — 11,330 Receipt of excess cash distributions (14,072 ) — (15,396 ) — — — 29,468 Receipt under tax receivable agreement (2,308 ) — (2,744 ) — — — 5,052 Equity in earnings 8,510 — — (8,510 ) — — — Equity in other comprehensive loss (2,735 ) — — — — 2,735 Amortization of deferred revenue — 8,506 — — (8,506 ) — — Balance as of and for the twelve months ended December 31, 2015 $ 183,755 $ (342,134 ) $ (18,140 ) $ (8,510 ) $ (19,836 ) $ 2,735 $ 45,850 Receipt of common units due to annual common unit adjustment 11,111 (11,111 ) $ — $ — $ — $ — $ — Revenues earned under ESA (1) — — — — (11,048 ) — 11,048 Receipt of excess cash distributions (11,233 ) — (11,483 ) — — — 22,716 Receipt under tax receivable agreement (2,985 ) — (3,173 ) — — — 6,158 Equity in earnings 9,347 — — (9,347 ) — — — Amortization of deferred revenue — 9,317 — — (9,317 ) — — Balance as of and for the twelve months ended December 31, 2016 $ 189,995 $ (343,928 ) $ (14,656 ) $ (9,347 ) $ (20,365 ) $ — $ 39,922 Receipt of common units due to annual common unit adjustment 18,363 (18,363 ) $ — $ — $ — $ — $ — Revenues earned under ESA (1) — — — — (11,274 ) — 11,274 Receipt of excess cash distributions (15,093 ) — (14,158 ) — — — 29,251 Receipt under tax receivable agreement (2,265 ) — (2,249 ) — — — 4,514 Equity in earnings 9,550 — — (9,550 ) — — — Amortization of deferred revenue — 10,585 — — (10,585 ) — — Balance as of and for the twelve months ended December 31, 2017 $ 200,550 $ (351,706 ) $ (16,407 ) $ (9,550 ) $ (21,859 ) $ — $ 45,039 (1) Amounts include the per patron and per digital screen theatre access fees due to the Company, net of amounts due to NCM for on-screen advertising time provided to the Company’s beverage concessionaire. The amounts due to NCM for on-screen advertising time provided to the Company’s beverage concessionaire were approximately $9,819, $10,523 and $11,110 for the years ended December 31, 2015, 2016 and 2017, respectively.
Summary Financial Information	The tables below present summary financial information for NCM for the periods indicated (financial information for NCM’s fiscal year ended December 29, 2017 is not yet available): Year Ended Year Ended Nine Months Ended December 31, 2015 December 29, 2016 September 28, 2017 Revenues $ 446,500 $ 447,600 $ 285,400 Operating income $ 140,500 $ 173,000 $ 83,700 Net income $ 87,500 $ 109,300 $ 44,800 As of As of December 29, 2016 September 28, 2017 Current assets $ 180,900 $ 130,100 Noncurrent assets $ 607,600 $ 776,900 Current liabilities $ 121,100 $ 96,700 Noncurrent liabilities $ 924,300 $ 910,800 Members' deficit $ (256,900 ) $ (100,500 )

Other Investments (Tables)

Other Investments (Tables)	12 Months Ended
	Dec. 31, 2017
Summary of Activity for Each of Company's Other Investments	Below is a summary of activity for each of the Company’s other investments for the periods indicated: DCIP RealD AC LLC DCDC Other Total Balance at December 31, 2014 $ 51,277 $ 14,429 $ 7,899 $ 2,438 $ 1,615 $ 77,658 Cash contributions 3,211 — — — 500 3,711 Equity in income 18,522 — 970 124 — 19,616 Equity in comprehensive loss (384 ) — — — — (384 ) Unrealized holding loss — (1,529 ) — — — (1,529 ) Sale of investment in Taiwan (1) — — — — (1,383 ) (1,383 ) Cash distributions received (1,047 ) — (1,600 ) — — (2,647 ) Other — — — — (69 ) (69 ) Balance at December 31, 2015 $ 71,579 $ 12,900 $ 7,269 $ 2,562 $ 663 $ 94,973 Cash contributions 717 — — — 415 1,132 Equity in income 21,434 — 311 870 — 22,615 Equity in comprehensive income 89 — — — — 89 Sale of investment (2) — (12,900 ) — — — (12,900 ) Cash distributions received (6,000 ) — (1,600 ) (98 ) — (7,698 ) Other — — — (584 ) 690 106 Balance at December 31, 2016 $ 87,819 $ — $ 5,980 $ 2,750 $ 1,768 $ 98,317 Cash contributions 1,112 — — — 2,603 3,715 Equity in income 22,900 — 2,336 1,199 — 26,435 Equity in comprehensive income 248 — — — — 248 Cash distributions received (5,864 ) — (2,400 ) (351 ) — (8,615 ) Other — — — — (55 ) (55 ) Balance at December 31, 2017 $ 106,215 $ — $ 5,916 $ 3,598 $ 4,316 $ 120,045 (1) (2) RealD, Inc
Transactions with DCIP	The Company had the following transactions with DCIP during the years ended December 31, 2015, 2016 and 2017: Year Ended December 31, 2015 2016 2017 Equipment lease payments $ 4,474 $ 5,217 $ 5,743 Warranty reimbursements from DCIP $ (4,329 ) $ (6,091 ) $ (8,511 ) Management services fees $ 825 $ 825 $ 823
Digital Cinema Implementation Partners
Summary Financial Information	Below is summary financial information for DCIP as of and for the years ended December 31, 2015, 2016 and 2017. Year ended December 31, 2015 2016 2017 Revenues $ 171,203 $ 178,836 $ 177,382 Operating income $ 103,449 $ 107,919 $ 106,687 Net income $ 79,255 $ 89,152 $ 93,103 As of December 31, 2016 December 31, 2017 Current assets $ 45,087 $ 56,296 Noncurrent assets $ 861,290 $ 772,438 Current liabilities $ 44,771 $ 59,153 Noncurrent liabilities $ 464,246 $ 296,889 Members' equity $ 397,360 $ 472,692

GOODWILL AND OTHER INTANGIBLE34

GOODWILL AND OTHER INTANGIBLE ASSETS - NET (Tables)	12 Months Ended
	Dec. 31, 2017
Goodwill And Intangible Assets Disclosure [Abstract]
Summary of Goodwill	The Company’s goodwill was as follows: U.S. Operating Segment International Operating Segment Total Balance at December 31, 2015 (1) $ 1,156,556 $ 90,992 $ 1,247,548 Acquisitions of theatres 7,607 — 7,607 Other acquisitions (2) — 1,410 1,410 Foreign currency translation adjustments — 6,398 6,398 Balance at December 31, 2016 (1) $ 1,164,163 $ 98,800 $ 1,262,963 Acquisitions of theatres (3) 9,878 13,211 23,089 Foreign currency translation adjustments — (1,973 ) (1,973 ) Balance at December 31, 2017 (1) $ 1,174,041 $ 110,038 $ 1,284,079 (1) Balances are presented net of accumulated impairment losses of $214,031 for the U.S. operating segment and $27,622 for the international operating segment. (2) (3) Acquisition of theatres in the U.S. and international markets.
Intangible Assets	As of December 31, intangible assets-net, consisted of the following: Balance at Balance at January 1, December 31, 2016 Additions (1) Amortization Other (2) 2016 Intangible assets with finite lives: Gross carrying amount $ 99,968 $ 503 $ — $ (675 ) $ 99,796 Accumulated amortization (59,706 ) ― (5,538 ) 638 (64,606 ) Total net intangible assets with finite lives $ 40,262 $ 503 $ (5,538 ) $ (37 ) $ 35,190 Intangible assets with indefinite lives: Tradename 299,382 ― ― 327 299,709 Total intangible assets — net $ 339,644 $ 503 $ (5,538 ) $ 290 $ 334,899 Balance at Balance at January 1, December 31, 2017 Additions (3) Amortization Other (2) 2017 Intangible assets with finite lives: Gross carrying amount $ 99,796 $ 11,584 $ — $ (5,485 ) $ 105,895 Accumulated amortization (64,606 ) — (5,563 ) 1,300 (68,869 ) Total net intangible assets with finite lives $ 35,190 $ 11,584 $ (5,563 ) $ (4,185 ) $ 37,026 Intangible assets with indefinite lives: Tradename 299,709 — — 26 299,735 Total intangible assets — net $ 334,899 $ 11,584 $ (5,563 ) $ (4,159 ) $ 336,761 (1) Activity for 2016 reflects addition of non-compete agreement and favorable lease associated with theatres acquired in the U.S. (2) Amounts represent foreign currency translation adjustments and the write-off of certain lease intangibles for theatre closures and lease amendments. (3) Amounts represent fair values allocated to intangible assets acquired as part of acquisitions of theatres in the U.S. and international markets.
Estimated Aggregate Future Amortization Expense for Intangible Assets	Estimated aggregate future amortization expense for intangible assets is as follows: For the year ended December 31, 2018 $ 5,725 For the year ended December 31, 2019 5,267 For the year ended December 31, 2020 5,535 For the year ended December 31, 2021 3,685 For the year ended December 31, 2022 3,280 Thereafter 13,534 Total $ 37,026

IMPAIRMENT OF LONG-LIVED ASSE35

IMPAIRMENT OF LONG-LIVED ASSETS (Tables)	12 Months Ended
	Dec. 31, 2017
Impairment Or Disposal Of Tangible Assets Disclosure [Abstract]
Long-Lived Asset Impairment Charges	The Company’s long-lived asset impairment losses are summarized in the following table: Year Ended December 31, 2015 2016 2017 U.S. theatre properties $ 7,052 $ 1,929 $ 5,227 International theatre properties 757 907 9,857 Subtotal 7,809 2,836 15,084 Intangible assets (1) 992 — — Impairment of long-lived assets $ 8,801 $ 2,836 $ 15,084 (1) Activity for 2015 was related to the impairment of a favorable lease for one theatre.

Deferred Charges and Other A36

Deferred Charges and Other Assets - Net (Tables)	12 Months Ended
	Dec. 31, 2017
Deferred Costs Capitalized Prepaid And Other Assets Disclosure [Abstract]
Deferred Charges and Other Assets Net	As of December 31, deferred charges and other assets — net consisted of the following: December 31, 2016 2017 Long-term prepaid rents $ 5,996 $ 7,762 Construction and other deposits 10,881 12,167 Equipment to be placed in service 12,856 13,868 Other 7,822 5,970 Total $ 37,555 $ 39,767

LONG-TERM DEBT (Tables)

LONG-TERM DEBT (Tables)	12 Months Ended
	Dec. 31, 2017
Debt Disclosure [Abstract]
Components of Long-Term Debt	As of December 31, long-term debt consisted of the following: December 31, 2016 2017 Cinemark USA, Inc. term loan $ 663,799 $ 659,517 Cinemark USA, Inc. 4.875% senior notes due 2023 755,000 755,000 Cinemark USA, Inc. 5.125% senior notes due 2022 400,000 400,000 Other (1) 4,167 2,778 Total long-term debt 1,822,966 1,817,295 Less current portion 5,671 7,099 Less debt issuance costs, net of accumulated amortization of $19,364 and $25,549, respectively 34,854 29,815 Long-term debt, less current portion $ 1,782,441 $ 1,780,381 (1) Primarily represents debt owed to NCM in relation to the recently-formed joint venture AC JV, LLC. See Note 4.
Amendment of Credit Agreement	Cinemark USA, Inc. amended its Credit Agreement as follows during 2016 and 2017: Debt Issue Loss on Debt Effective Date Nature of Amendment Costs Paid (1) Amendment (2) June 13, 2016 Reduced term loan interest rate by 0.25% $ 783 $ 249 December 15, 2016 Reduced term loan interest rate by 0.50% $ 2,446 $ 161 June 16, 2017 Reduced term loan interest rate by 0.25%; modified certain definitions and other provisions in the Credit Agreement $ 521 $ 190 November 28, 2017 Extended maturity of revolving credit line to December 2022; reduced the interest rate applicable to borrowings under the credit line $ 330 $ 331 (1) Reflected as a reduction of long term debt on the consolidated balance sheet as of December 31, 2016 and 2017.
Maturities of Long-Term Debt, Excluding Unamortized Debt Issuance Costs	The Company’s long-term debt, excluding unamortized debt issuance costs, at December 31, 2017 matures as follows: 2018 $ 7,099 2019 7,099 2020 5,710 2021 5,710 2022 1,036,677 Thereafter 755,000 Total $ 1,817,295

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	12 Months Ended
	Dec. 31, 2017
Fair Value Disclosures [Abstract]
Reconciliation of Beginning and Ending Balance for Liabilities Measured at Fair Value	Below is a reconciliation of the beginning and ending balance for liabilities measured at fair value on a recurring basis using significant unobservable inputs (Level 3): Liabilities Liabilities 2016 2017 Beginning balance - January 1 $ 373 $ — Total loss included in accumulated other comprehensive loss 71 — Settlements included in interest expense (444 ) — Ending balance - December 31 $ — $ —

FOREIGN CURRENCY TRANSLATION (T

FOREIGN CURRENCY TRANSLATION (Tables)	12 Months Ended
	Dec. 31, 2017
Fair Value Disclosures [Abstract]
Summary of Impact of Translating Financial Statements of Company's International Subsidiaries	Below is a summary of the impact of translating the financial statements of the Company’s international subsidiaries as of and for the years ended December 31, 2015, 2016 and 2017. Other Comprehensive Income (Loss) Exchange Rate as of December 31, For the Year Ended December 31, Country 2015 2016 2017 2015 2016 2017 Brazil 3.96 3.26 3.31 $ (74,559 ) $ 37,286 $ (4,567 ) Argentina 12.95 16.04 18.65 (30,520 ) (13,362 ) (8,200 ) Colombia 3,149.47 3,000.71 2,936.67 (8,043 ) 1,278 246 Chile 709.16 679.09 615.97 (6,572 ) 1,855 5,672 Peru 3.46 3.45 3.24 (4,882 ) 87 2,752 All other (898 ) (783 ) (869 ) $ (125,474 ) $ 26,361 $ (4,966 )

NONCONTROLLING INTERESTS IN S40

NONCONTROLLING INTERESTS IN SUBSIDIARIES (Tables)	12 Months Ended
	Dec. 31, 2017
Noncontrolling Interest [Abstract]
Noncontrolling Interests in Subsidiaries	Noncontrolling interests in subsidiaries of the Company were as follows at December 31: December 31, 2016 2017 Cinemark Partners II — 24.6% interest (in one theatre) $ 8,249 $ 8,795 Laredo Theatres – 25% interest (in two theatres) 1,695 1,746 Greeley Ltd. — 49% interest (in one theatre) 689 843 Other 509 509 Total $ 11,142 $ 11,893
Summary of Impact of Changes in Company's Ownership Interest in its Subsidiaries on its Equity	Below is a summary of the impact of changes in the Company’s ownership interest in its subsidiaries on its equity: Year ended December 31, 2015 2016 2017 Net income attributable to Cinemark USA, Inc. $ 218,532 $ 256,777 $ 265,643 Transfers from noncontrolling interests Decrease in Cinemark USA, Inc. additional paid-in-capital for the buyout of Flix Impirica non-controlling interest — (27 ) — Net transfers from non-controlling interests — (27 ) — Change from net income attributable to Cinemark USA, Inc. and transfers from noncontrolling interests $ 218,532 $ 256,750 $ 265,643

CAPITAL STOCK (Tables)

CAPITAL STOCK (Tables)	12 Months Ended
	Dec. 31, 2017
Summary of Restricted Stock Unit Financial Performance Thresholds and Vesting Rates	The financial performance factors and respective vesting rates for each of the 2015, 2016 and 2017 grants are as follows: Year Ended December 31, Percentage of Shares Vesting 2015 2016 2017 Threshold IRR 7.5% 6.0% 7.0% 33.3% Target IRR 9.5% 8.0% 9.5% 66.6% Maximum IRR 11.5% 10.0% 13.0% 100.0%
Number of Units Vested Under Restricted Stock Unit Awards	Below is a table summarizing the potential number of units that could vest under restricted stock unit awards granted during the years ended December 31, 2015, 2016 and 2017 at each of the three levels of financial performance (excluding forfeitures): Granted During the Year Ended December 31, 2015 2016 2017 Number of Value at Number of Value at Number of Value at Units Grant (1) Units Grant (1) Units Grant (1) at threshold IRR 47,640 $ 2,057 84,554 $ 2,522 58,545 $ 2,481 at target IRR 95,282 $ 4,115 169,107 $ 5,044 117,089 $ 4,961 at maximum IRR 142,917 $ 6,173 253,661 $ 7,568 175,634 $ 7,442 (1) The grant date fair values for units issued during the years ended December 31, 2015, 2016, and 2017 were $43.19, $29.83 and $42.37, respectively.
Restricted Stock
Summary of Restricted Stock Award Activity	Below is a summary of restricted stock award activity recorded for the periods indicated. Year Ended December 31, 2015 2016 2017 Compensation expense recognized by the Company during the period $ 8,715 $ 7,269 $ 7,528 Additional compensation expense recognized by Cinemark Holdings, Inc. during the period $ 885 $ 981 $ 856 Fair value of restricted shares held by Company employees that vested during the period $ 13,276 $ 13,739 $ 7,255 Fair value of restricted shares held by Cinemark Holdings, Inc.’s directors that vested during the period $ 1,148 $ 923 $ 917 Income tax benefit recognized upon vesting of restricted stock awards held by Company employees $ 3,341 $ 5,167 $ 2,281 Additional income tax benefit recognized upon vesting of restricted stock awards held by Cinemark Holdings, Inc.'s directors $ 482 $ 388 $ 386
Cinemark Holdings, Inc.
Summary of Restricted Stock Activity	Below is a summary of restricted stock activity for Cinemark Holdings, Inc. for the years ended December 31, 2015, 2016 and 2017: Year Ended Year Ended Year Ended December 31, 2015 December 31, 2016 December 31, 2017 Shares of Restricted Stock Weighted Average Grant Date Fair Value Shares of Restricted Stock Weighted Average Grant Date Fair Value Shares of Restricted Stock Weighted Average Grant Date Fair Value Outstanding at January 1 878,897 $ 24.92 757,775 $ 30.73 606,618 $ 33.51 Granted 226,212 $ 42.79 335,707 $ 30.98 246,534 $ 41.70 Vested (329,437 ) $ 23.72 (430,056 ) $ 26.60 (192,230 ) $ 36.26 Forfeited (17,897 ) $ 27.58 (56,808 ) $ 33.81 (10,341 ) $ 33.48 Outstanding at December 31 757,775 $ 30.73 606,618 $ 33.51 650,581 $ 35.81
Cinemark Holdings, Inc. | Restricted Stock Units (RSUs)
Summary of Restricted Stock Unit Award Activity	Below is a summary of activity for restricted stock unit awards for Cinemark Holdings, Inc. for the periods indicated: Year Ended December 31, 2015 2016 2017 Number of restricted stock unit awards that vested during the period 123,769 213,984 97,115 Fair value of restricted stock unit awards that vested during the period $ 5,483 $ 7,260 $ 4,155 Accumulated dividends paid upon vesting of restricted stock unit awards $ 442 $ 662 $ 558 Income tax benefit recognized upon vesting of restricted stock unit awards $ 2,303 $ 3,049 $ 1,745 Compensation expense recognized during the period $ 6,158 $ 5,144 $ 4,297

SUPPLEMENTAL CASH FLOW INFORM42

SUPPLEMENTAL CASH FLOW INFORMATION (Tables)	12 Months Ended
	Dec. 31, 2017
Supplemental Cash Flow Elements [Abstract]
Supplemental Information to Consolidated Statements of Cash Flows	The following is provided as supplemental information to the consolidated statements of cash flows: Year Ended December 31, 2015 2016 2017 Cash paid for interest $ 105,155 $ 108,101 $ 99,232 Cash paid for income taxes, net of refunds received $ 108,435 $ 93,368 $ 95,043 Noncash investing and financing activities: Change in accounts payable and accrued expenses for the acquisition of theatre properties and equipment (1) $ 2,491 $ (29,471 ) $ 9,349 Theatre properties and equipment acquired under capital lease $ 36,544 $ 33,282 $ 46,727 Investment in NCM - receipt of common units (see Note 3) $ 15,421 $ 11,111 $ 18,363 Noncash distributions to Cinemark Holdings, Inc. $ (17,935 ) $ — $ — Receipt of promissory note related to sale of investment in a Taiwan joint venture $ 2,304 $ — $ — (1) Additions to theatre properties and equipment included in accounts payable as of December 31, 2016 and 2017 were $40,625 and $31,276, respectively.

INCOME TAXES (Tables)

INCOME TAXES (Tables)	12 Months Ended
	Dec. 31, 2017
Income Tax Disclosure [Abstract]
Income Before Income Taxes	The Company’s provision for federal and foreign income tax expense for continuing operations consisted of the following: Year Ended December 31, 2015 2016 2017 Income before income taxes: U.S. $ 262,336 $ 277,474 $ 282,896 Foreign 88,015 85,890 64,842 Total $ 350,351 $ 363,364 $ 347,738
Current and Deferred Income Taxes	Current and deferred income taxes were as follows: Year Ended December 31, 2015 2016 2017 Current: Federal $ 72,185 $ 66,210 $ 55,224 Foreign 35,874 32,047 29,306 State 10,806 12,061 10,741 Total current expense $ 118,865 $ 110,318 $ 95,271 Deferred: Federal $ 10,420 $ (13,667 ) $ (14,046 ) Foreign (3,339 ) 1,674 (4,270 ) State 4,014 6,526 3,301 Total deferred taxes $ 11,095 $ (5,467 ) $ (15,015 ) Income taxes $ 129,960 $ 104,851 $ 80,256
Reconciliation Between Income Tax Expense and Taxes Computed	A reconciliation between income tax expense and taxes computed by applying the applicable statutory federal income tax rate to income before income taxes follows: Year Ended December 31, 2015 2016 2017 Computed statutory tax expense $ 122,623 $ 127,176 $ 121,708 Foreign inflation adjustments (1,295 ) (281 ) — State and local income taxes, net of federal income tax impact 9,640 12,081 12,857 Foreign losses not benefited and changes in valuation allowance (2,408 ) (34,757 ) 249 Foreign tax rate differential (2,660 ) (942 ) (245 ) Foreign dividends — 68,684 13,662 Foreign tax credits — (62,815 ) (21,647 ) Impacts related to 2017 Tax Act (1) — — (44,889 ) Changes in uncertain tax positions 3,717 921 983 Other — net 343 (5,216 ) (2,422 ) Income taxes $ 129,960 $ 104,851 $ 80,256 (1) Includes one-time benefit due to re-measurement of net deferred tax liabilities using a lower U.S. corporate tax rate and a reassessment of permanently reinvested earnings of ($79,834), a deemed repatriation tax of $14,512, and a reduction in deferred tax assets with regard to foreign tax credit carryforwards of $20,433.
Tax Effects of Significant Temporary Differences and Tax Loss and Tax Credit Carryforwards	The tax effects of significant temporary differences and tax loss and tax credit carryforwards comprising the net long-term deferred income tax liabilities as of December 31, 2016 and 2017 consisted of the following: December 31, 2016 2017 Deferred liabilities: Theatre properties and equipment $ 176,781 $ 147,208 Intangible asset — other 36,052 30,770 Intangible asset — tradenames 112,747 72,967 Investment in partnerships 107,066 67,449 Total deferred liabilities 432,646 318,394 Deferred assets: Deferred lease expenses 24,026 14,714 Exchange (gain) loss (731 ) 220 Deferred revenue - NCM 130,005 85,816 Capital lease obligations 85,721 67,369 Other tax loss carryforwards 15,883 15,564 Other tax credit carryforwards 48,033 38,436 Other expenses, not currently deductible for tax purposes 11,270 13,801 Total deferred assets 314,207 235,920 Net deferred income tax liability before valuation allowance 118,439 82,474 Valuation allowance against deferred assets – non-current 14,524 35,246 Net deferred income tax liability $ 132,963 $ 117,720 Net deferred tax liability — Foreign $ 7,571 $ 3,073 Net deferred tax liability — U.S. 125,392 114,647 Total $ 132,963 $ 117,720
Reconciliation of Total Amounts of Unrecognized Tax Benefits Excluding Interest and Penalties	The following is a reconciliation of the total amounts of unrecognized tax benefits excluding interest and penalties, for the years ended December 31, 2015, 2016 and 2017: Year Ended December 31, 2015 2016 2017 Balance at January 1, $ 16,515 $ 17,133 $ 17,403 Gross increases - tax positions in prior periods 40 13 92 Gross decreases - tax positions in prior periods — — (12 ) Gross increases - current period tax positions 2,112 923 265 Settlements (871 ) (924 ) (177 ) Foreign currency translation adjustments (663 ) 258 695 Balance at December 31, $ 17,133 $ 17,403 $ 18,266

COMMITMENTS AND CONTINGENCIES (

COMMITMENTS AND CONTINGENCIES (Tables)	12 Months Ended
	Dec. 31, 2017
Commitments And Contingencies Disclosure [Abstract]
Rent Expenses from Operating Leases	Theatre rent expense was as follows: Year Ended December 31, 2015 2016 2017 Fixed rent expense $ 240,057 $ 242,927 $ 247,908 Contingent rent and other facility lease expenses 79,704 78,367 80,289 Total facility lease expense $ 319,761 $ 321,294 $ 328,197
Estimated Future Minimum Lease Payments (Net of Noncancelable Sublease Rentals) Under Capital Leases	Future minimum lease payments under noncancelable operating and capital leases that have initial or remaining terms in excess of one year at December 31, 2017 are due as follows: Operating Capital Leases Leases 2018 $ 253,835 $ 42,832 2019 233,606 42,363 2020 215,265 41,543 2021 197,779 34,584 2022 171,486 32,383 Thereafter 675,567 182,027 Total $ 1,747,538 375,732 Amounts representing interest payments (99,070 ) Present value of future minimum payments 276,662 Current portion of capital lease obligations (25,511 ) Capital lease obligations, less current portion $ 251,151
Estimated Future Minimum Lease Payments (Net of Noncancelable Sublease Rentals) Under Operating Leases	Future minimum lease payments under noncancelable operating and capital leases that have initial or remaining terms in excess of one year at December 31, 2017 are due as follows: Operating Capital Leases Leases 2018 $ 253,835 $ 42,832 2019 233,606 42,363 2020 215,265 41,543 2021 197,779 34,584 2022 171,486 32,383 Thereafter 675,567 182,027 Total $ 1,747,538 375,732 Amounts representing interest payments (99,070 ) Present value of future minimum payments 276,662 Current portion of capital lease obligations (25,511 ) Capital lease obligations, less current portion $ 251,151

SEGMENTS (Tables)

SEGMENTS (Tables)	12 Months Ended
	Dec. 31, 2017
Segment Reporting [Abstract]
Selected Financial Information by Reportable Operating Segment	Below is a breakdown of select financial information by reportable operating segment: Year Ended December 31, 2015 2016 2017 Revenues U.S. $ 2,137,733 $ 2,230,693 $ 2,236,237 International 728,735 701,573 769,436 Eliminations (13,859 ) (13,501 ) (14,126 ) Total revenues $ 2,852,609 $ 2,918,765 $ 2,991,547 Adjusted EBITDA (1) U.S. $ 518,165 $ 550,150 $ 559,693 International 166,416 157,690 165,576 Total Adjusted EBITDA $ 684,581 $ 707,840 $ 725,269 Capital expenditures U.S. $ 223,213 $ 242,271 $ 321,040 International 108,513 84,637 59,822 Total capital expenditures $ 331,726 $ 326,908 $ 380,862 (1) Distributions from equity investees are reported entirely within the U.S. operating segment
Reconciliation of Net Income to Adjusted EBITDA	The following table sets forth a reconciliation of net income to Adjusted EBITDA: Year Ended December 31, 2015 2016 2017 Net income $ 220,391 $ 258,513 $ 267,482 Add (deduct): Income taxes 129,960 104,851 80,256 Interest expense (1) 112,741 108,313 105,918 Loss on debt amendments and refinancing 925 13,445 521 Other income (2) (20,041 ) (44,813 ) (43,121 ) Other cash distributions from equity investees (3) 19,027 21,916 25,973 Depreciation and amortization 189,206 209,071 237,513 Impairment of long-lived assets 8,801 2,836 15,084 Loss on sale of assets and other 8,143 20,459 22,812 Deferred lease expenses (1,806 ) (990 ) (1,268 ) Amortization of long-term prepaid rents 2,361 1,826 2,274 Share based awards compensation expense 14,873 12,413 11,825 Adjusted EBITDA $ 684,581 $ 707,840 $ 725,269 (1) Includes amortization of debt issue costs. (2) Includes interest income, foreign currency exchange gain (loss), and equity in income of affiliates and excludes distributions from NCM. (3) Includes distributions received from equity investees that were recorded as a reduction of the respective investment balances.
Selected Financial Information by Geographic Area	Below is a breakdown of select financial information by geographic area: Year Ended December 31, 2015 2016 2017 Revenues U.S. $ 2,137,733 $ 2,230,693 $ 2,236,237 Brazil 291,959 304,407 341,485 Other international countries 436,776 397,166 427,951 Eliminations (13,859 ) (13,501 ) (14,126 ) Total $ 2,852,609 $ 2,918,765 $ 2,991,547 December 31, 2016 December 31, 2017 Theatre Properties and Equipment-net U.S. $ 1,306,643 $ 1,439,168 Brazil 197,896 179,669 Other international countries 199,997 209,217 Total $ 1,704,536 $ 1,828,054

VALUATION AND QUALIFYING ACCO46

VALUATION AND QUALIFYING ACCOUNTS (Tables)	12 Months Ended
	Dec. 31, 2017
Valuation And Qualifying Accounts [Abstract]
Valuation Allowance for Deferred Tax Assets	The Company’s valuation allowance for deferred tax assets for the years ended December 31, 2015, 2016 and 2017 were as follows: Valuation Allowance for Deferred Taxes Balance at January 1, 2015 $ 52,873 Additions 437 Deductions (2,674 ) Balance at December 31, 2015 $ 50,636 Additions 483 Deductions (36,595 ) Balance at December 31, 2016 $ 14,524 Additions ( 1 ) 21,347 Deductions (625 ) Balance at December 31, 2017 $ 35,246 (1) A valuation allowance was provided against certain deferred tax assets arising from carryforwards of unused foreign tax credit benefits.

Condensed Consolidating Finan47

Condensed Consolidating Financial Information of Subsidiary Guarantors (Tables)	12 Months Ended
	Dec. 31, 2017
Statement Of Financial Position [Abstract]
Condensed Consolidating Balance Sheet Information	CONDENSED CONSOLIDATING BALANCE SHEET INFORMATION DECEMBER 31, 2016 Parent Subsidiary Subsidiary Company Guarantors Non-Guarantors Eliminations Consolidated (In thousands) Assets Current assets Cash and cash equivalents $ 146,855 $ 281,023 $ 133,260 $ — $ 561,138 Other current assets 62,425 15,098 71,706 (34,154 ) 115,075 Accounts receivable from parent or subsidiaries 76,550 121,478 (187,948 ) 10,080 Total current assets 285,830 417,599 204,966 (222,102 ) 686,293 Theatre properties and equipment - net 604,506 678,984 421,046 — 1,704,536 Investment in subsidiaries 1,570,592 132,892 — (1,703,484 ) — Other assets 1,409,320 134,284 488,535 (106,359 ) 1,925,780 Total assets $ 3,870,248 $ 1,363,759 $ 1,114,547 $ (2,031,945 ) $ 4,316,609 Liabilities and equity Current liabilities Current portion of long-term debt $ 4,282 $ — $ 1,409 $ (20 ) $ 5,671 Current portion of capital lease obligations 7,903 9,541 3,695 — 21,139 Accounts payable and accrued expenses 197,789 121,640 113,020 (16,457 ) 415,992 Accounts payable to parent or subsidiaries — — 187,948 (187,948 ) — Total current liabilities 209,974 131,181 306,072 (204,425 ) 442,802 Long-term liabilities Long-term debt, less current portion 1,879,663 — 12,600 (109,822 ) 1,782,441 Capital lease obligations, less current portion 124,944 71,228 38,109 — 234,281 Other long-term liabilities and deferrals 382,729 84,429 120,061 (14,214 ) 573,005 Total long-term liabilities 2,387,336 155,657 170,770 (124,036 ) 2,589,727 Commitments and contingencies Equity Cinemark USA, Inc.'s stockholder's equity: Common stock 49,543 457,368 10,239 (467,607 ) 49,543 Other stockholder's equity 1,223,395 619,553 616,324 (1,235,877 ) 1,223,395 Total Cinemark USA, Inc. stockholder's equity 1,272,938 1,076,921 626,563 (1,703,484 ) 1,272,938 Noncontrolling interests — — 11,142 — 11,142 Total equity 1,272,938 1,076,921 637,705 (1,703,484 ) 1,284,080 Total liabilities and equity $ 3,870,248 $ 1,363,759 $ 1,114,547 $ (2,031,945 ) $ 4,316,609 CONDENSED CONSOLIDATING BALANCE SHEET INFORMATION DECEMBER 31, 2017 Parent Subsidiary Subsidiary Company Guarantors Non-Guarantors Eliminations Consolidated (In thousands) Assets Current assets Cash and cash equivalents $ 130,590 $ 180,623 $ 211,202 $ — $ 522,415 Other current assets 59,661 17,841 76,789 (19,270 ) 135,021 Accounts receivable from parent or subsidiaries 117,972 119,616 — (223,007 ) 14,581 Total current assets 308,223 318,080 287,991 (242,277 ) 672,017 Theatre properties and equipment - net 650,783 765,500 411,771 — 1,828,054 Investment in subsidiaries 1,691,626 121,795 — (1,813,421 ) — Other assets 1,427,328 134,845 536,816 (113,720 ) 1,985,269 Total assets $ 4,077,960 $ 1,340,220 $ 1,236,578 $ (2,169,418 ) $ 4,485,340 Liabilities and equity Current liabilities Current portion of long-term debt $ 5,710 $ — $ 1,389 $ — $ 7,099 Current portion of capital lease obligations 9,532 11,124 4,855 — 25,511 Accounts payable and accrued expenses 215,580 116,409 110,089 (6,402 ) 435,676 Accounts payable to parent or subsidiaries — — 223,007 (223,007 ) — Total current liabilities 230,822 127,533 339,340 (229,409 ) 468,286 Long-term liabilities Long-term debt, less current portion 1,878,992 — 11,211 (109,822 ) 1,780,381 Capital lease obligations, less current portion 132,189 75,767 43,195 — 251,151 Other long-term liabilities and deferrals 426,355 60,567 93,871 (16,766 ) 564,027 Total long-term liabilities 2,437,536 136,334 148,277 (126,588 ) 2,595,559 Commitments and contingencies Equity Cinemark USA, Inc.'s stockholder's equity: Common stock 49,543 457,368 10,238 (467,606 ) 49,543 Other stockholder's equity 1,360,059 618,985 726,830 (1,345,815 ) 1,360,059 Total Cinemark USA, Inc. stockholder's equity 1,409,602 1,076,353 737,068 (1,813,421 ) 1,409,602 Noncontrolling interests — — 11,893 — 11,893 Total equity 1,409,602 1,076,353 748,961 (1,813,421 ) 1,421,495 Total liabilities and equity $ 4,077,960 $ 1,340,220 $ 1,236,578 $ (2,169,418 ) $ 4,485,340
Condensed Consolidating Statement of Income Information	CONDENSED CONSOLIDATING STATEMENT OF INCOME INFORMATION YEAR ENDED DECEMBER 31, 2015 Parent Subsidiary Subsidiary Company Guarantors Non-Guarantors Eliminations Consolidated (In thousands) Revenues $ 959,347 $ 1,178,873 $ 764,631 $ (50,242 ) $ 2,852,609 Cost of operations Theatre operating expenses 767,446 804,236 545,131 (50,242 ) 2,066,571 General and administrative expenses 16,152 81,240 56,660 — 154,052 Depreciation and amortization 59,759 73,708 55,739 — 189,206 Impairment of long-lived assets 6,445 1,600 756 — 8,801 (Gain) loss on sale of assets and other 6,191 3,728 (1,776 ) — 8,143 Total cost of operations 855,993 964,512 656,510 (50,242 ) 2,426,773 Operating income 103,354 214,361 108,121 — 425,836 Other income (expense) Interest expense (100,608 ) (8,500 ) (4,009 ) 376 (112,741 ) Loss on debt amendments and refinancing (925 ) — — — (925 ) Distributions from NCM 2,116 — 16,024 — 18,140 Equity in income of affiliates 217,567 55,082 27,262 (271,785 ) 28,126 Other income (expense) 200 20 (7,929 ) (376 ) (8,085 ) Total other income 118,350 46,602 31,348 (271,785 ) (75,485 ) Income before income taxes 221,704 260,963 139,469 (271,785 ) 350,351 Income taxes 3,172 79,131 47,657 — 129,960 Net income 218,532 181,832 91,812 (271,785 ) 220,391 Less: Net income attributable to noncontrolling interests — — 1,859 — 1,859 Net income attributable to Cinemark USA, Inc. $ 218,532 $ 181,832 $ 89,953 $ (271,785 ) $ 218,532 CONDENSED CONSOLIDATING STATEMENT OF INCOME INFORMATION YEAR ENDED DECEMBER 31, 2016 Parent Subsidiary Subsidiary Company Guarantors Non-Guarantors Eliminations Consolidated (In thousands) Revenues $ 1,014,713 $ 1,219,218 $ 737,981 $ (53,147 ) $ 2,918,765 Cost of operations Theatre operating expenses 804,041 828,905 540,310 (53,147 ) 2,120,109 General and administrative expenses 13,085 84,453 43,099 — 140,637 Depreciation and amortization 70,654 79,139 59,278 — 209,071 Impairment of long-lived assets 1,929 — 907 — 2,836 Loss on sale of assets and other 5,613 13,759 1,087 20,459 Total cost of operations 895,322 1,006,256 644,681 (53,147 ) 2,493,112 Operating income 119,391 212,962 93,300 — 425,653 Other income (expense) Interest expense (96,442 ) (7,538 ) (5,642 ) 1,309 (108,313 ) Loss on debt amendments and refinancing (13,445 ) — — — (13,445 ) Distributions from NCM 1,414 — 13,242 — 14,656 Equity in income of affiliates 245,010 58,528 30,370 (301,946 ) 31,962 Other income 351 19 13,790 (1,309 ) 12,851 Total other income (expense) 136,888 51,009 51,760 (301,946 ) (62,289 ) Income before income taxes 256,279 263,971 145,060 (301,946 ) 363,364 Income taxes (498 ) 52,277 53,072 — 104,851 Net income 256,777 211,694 91,988 (301,946 ) 258,513 Less: Net income attributable to noncontrolling interests — — 1,736 — 1,736 Net income attributable to Cinemark USA, Inc. $ 256,777 $ 211,694 $ 90,252 $ (301,946 ) $ 256,777 CONDENSED CONSOLIDATING STATEMENT OF INCOME INFORMATION YEAR ENDED DECEMBER 31, 2017 Parent Subsidiary Subsidiary Company Guarantors Non-Guarantors Eliminations Consolidated (In thousands) Revenues $ 1,013,960 $ 1,220,993 $ 807,350 $ (50,756 ) $ 2,991,547 Cost of operations Theatre operating expenses 795,976 834,135 591,223 (50,756 ) 2,170,578 General and administrative expenses 13,176 82,955 54,780 — 150,911 Depreciation and amortization 79,676 87,463 70,374 — 237,513 Impairment of long-lived assets 3,725 1,502 9,857 — 15,084 Loss on sale of assets and other 16,895 3,372 2,545 — 22,812 Total cost of operations 909,448 1,009,427 728,779 (50,756 ) 2,596,898 Operating income 104,512 211,566 78,571 — 394,649 Other income (expense) Interest expense (94,229 ) (7,675 ) (5,447 ) 1,433 (105,918 ) Loss on debt amendments and refinancing (521 ) — — — (521 ) Distributions from NCM — — 16,407 — 16,407 Equity in income of affiliates 255,594 16,838 33,742 (270,189 ) 35,985 Other income 2,475 1,040 5,054 (1,433 ) 7,136 Total other income 163,319 10,203 49,756 (270,189 ) (46,911 ) Income before income taxes 267,831 221,769 128,327 (270,189 ) 347,738 Income taxes 2,188 69,770 8,298 — 80,256 Net income 265,643 151,999 120,029 (270,189 ) 267,482 Less: Net income attributable to noncontrolling interests — — 1,839 — 1,839 Net income attributable to Cinemark USA, Inc. $ 265,643 $ 151,999 $ 118,190 $ (270,189 ) $ 265,643
Condensed Consolidating Statement of Comprehensive Income Information	CONDENSED CONSOLIDATING STATEMENT OF COMPREHENSIVE INCOME INFORMATION YEAR ENDED DECEMBER 31, 2015 Parent Subsidiary Subsidiary Company Guarantors Non-Guarantors Eliminations Consolidated (In thousands) Net income $ 218,532 $ 181,832 $ 91,812 $ (271,785 ) $ 220,391 Other comprehensive income (loss), net of tax Unrealized gain due to fair value adjustments on interest rate swap agreements, net of settlements, net of taxes of $1,562 2,636 — — — 2,636 Unrealized loss due to fair value adjustments on available-for-sale securities, net of taxes of $572 (957 ) — — — (957 ) Other comprehensive loss of equity method investments (3,119 ) — (3,086 ) 3,086 (3,119 ) Foreign currency translation adjustments (125,474 ) — (125,512 ) 125,474 (125,512 ) Total other comprehensive income, net of tax (126,914 ) — (128,598 ) 128,560 (126,952 ) Total comprehensive income, net of tax $ 91,618 $ 181,832 $ (36,786 ) $ (143,225 ) $ 93,439 Comprehensive income attributable to noncontrolling interests — — (1,821 ) — (1,821 ) Comprehensive income attributable to Cinemark USA, Inc. $ 91,618 $ 181,832 $ (38,607 ) $ (143,225 ) $ 91,618 CONDENSED CONSOLIDATING STATEMENT OF COMPREHENSIVE INCOME INFORMATION YEAR ENDED DECEMBER 31, 2016 Parent Subsidiary Subsidiary Company Guarantors Non-Guarantors Eliminations Consolidated (In thousands) Net income $ 256,777 $ 211,694 $ 91,988 $ (301,946 ) $ 258,513 Other comprehensive income, net of tax Unrealized gain due to fair value adjustments on interest rate swap agreements, net of settlements, net of taxes of $138 234 — — — 234 Other comprehensive income of equity method investments 89 — 89 (89 ) 89 Foreign currency translation adjustments 26,361 — 26,394 (26,361 ) 26,394 Total other comprehensive income, net of tax 26,684 — 26,483 (26,450 ) 26,717 Total comprehensive income, net of tax $ 283,461 $ 211,694 $ 118,471 $ (328,396 ) $ 285,230 Comprehensive income attributable to noncontrolling interests — — (1,769 ) — (1,769 ) Comprehensive income attributable to Cinemark USA, Inc. $ 283,461 $ 211,694 $ 116,702 $ (328,396 ) $ 283,461 CONDENSED CONSOLIDATING STATEMENT OF COMPREHENSIVE INCOME INFORMATION YEAR ENDED DECEMBER 31, 2017 Parent Subsidiary Subsidiary Company Guarantors Non-Guarantors Eliminations Consolidated (In thousands) Net income $ 265,643 $ 151,999 $ 120,029 $ (270,189 ) $ 267,482 Other comprehensive income (loss), net of tax Other comprehensive income of equity method investments 248 — 248 (248 ) 248 Foreign currency translation adjustments (4,966 ) — (4,966 ) 4,966 (4,966 ) Total other comprehensive loss, net of tax (4,718 ) — (4,718 ) 4,718 (4,718 ) Total comprehensive income, net of tax $ 260,925 $ 151,999 $ 115,311 $ (265,471 ) $ 262,764 Comprehensive income attributable to noncontrolling interests — — (1,839 ) — (1,839 ) Comprehensive income attributable to Cinemark USA, Inc. $ 260,925 $ 151,999 $ 113,472 $ (265,471 ) $ 260,925
Condensed Consolidating Statement of Cash Flows Information	CONDENSED CONSOLIDATING STATEMENT OF CASH FLOWS INFORMATION YEAR ENDED DECEMBER 31, 2015 Parent Subsidiary Subsidiary Company Guarantors Non-Guarantors Eliminations Consolidated (In thousands) Operating activities Net income $ 218,532 $ 181,832 $ 91,812 $ (271,785 ) $ 220,391 Adjustments to reconcile net income to cash provided by operating activities (142,602 ) 39,156 43,223 271,785 211,562 Changes in assets and liabilities 67,253 (67,850 ) 23,869 — 23,272 Net cash provided by operating activities 143,183 153,138 158,904 — 455,225 Investing activities Additions to theatre properties and equipment (98,193 ) (121,605 ) (111,928 ) — (331,726 ) Proceeds from sale of theatre properties and equipment and other 2,737 5,264 1,965 — 9,966 Acquisition of theatre in Brazil — — (2,651 ) — (2,651 ) Dividends received from subsidiaries 1,685 15 — (1,700 ) Intercompany note issuances (3,500 ) — (100,000 ) 103,500 — Investment in joint ventures and other (518 ) — (3,211 ) 18 (3,711 ) Net cash used for investing activities (97,789 ) (116,326 ) (215,825 ) 101,818 (328,122 ) Financing activities Dividends paid to parent (115,225 ) (1,700 ) — 1,700 (115,225 ) Repayments of long-term debt (8,385 ) — (35 ) — (8,420 ) Payments of debt issue costs (6,957 ) — — — (6,957 ) Payments on capital leases (5,389 ) (9,120 ) (2,004 ) — (16,513 ) Intercompany loan proceeds 100,000 — 3,518 (103,518 ) Other 2,421 (4,770 ) (1,045 ) — (3,394 ) Net cash provided by (used for) financing activities (33,535 ) (15,590 ) 434 (101,818 ) (150,509 ) Effect of exchange rate changes on cash and cash equivalents — — (26,932 ) — (26,932 ) Increase (decrease) in cash and cash equivalents 11,859 21,222 (83,419 ) — (50,338 ) Cash and cash equivalents: Beginning of year 129,505 74,643 434,693 — 638,841 End of year $ 141,364 $ 95,865 $ 351,274 $ — $ 588,503 CONDENSED CONSOLIDATING STATEMENT OF CASH FLOWS INFORMATION YEAR ENDED DECEMBER 31, 2016 Parent Subsidiary Subsidiary Company Guarantors Non-Guarantors Eliminations Consolidated (In thousands) Operating activities Net income $ 256,777 $ 211,694 $ 91,988 $ (301,946 ) $ 258,513 Adjustments to reconcile net income to cash provided by operating activities (189,223 ) 55,128 53,381 301,946 221,232 Changes in assets and liabilities 154,085 (164,005 ) (18,642 ) — (28,562 ) Net cash provided by operating activities 221,639 102,817 126,727 — 451,183 Investing activities Additions to theatre properties and equipment (108,439 ) (130,843 ) (87,626 ) — (326,908 ) Acquisition of theatres in the U.S. (15,300 ) — — — (15,300 ) Acquisition of screen advertising business — — (1,450 ) — (1,450 ) Proceeds from sale of theatre properties and equipment and other 2,912 374 284 — 3,570 Proceeds from sale of marketable securities 13,451 — — — 13,451 Intercompany note issuances (4,455 ) — — 4,455 Dividends received from subsidiaries 26,033 229,649 — (255,682 ) — Investment in joint ventures and other (1,000 ) — (132 ) — (1,132 ) Net cash provided by (used for) investing activities (86,798 ) 99,180 (88,924 ) (251,227 ) (327,769 ) Financing activities Dividends paid to parent (124,900 ) — (255,682 ) 255,682 (124,900 ) Proceeds from issuance of Senior Notes, net of discount 222,750 — — — 222,750 Retirement of Senior Subordinated Notes (200,000 ) — — — (200,000 ) Repayments of long-term debt (15,201 ) — (1,404 ) — (16,605 ) Payments of debt issue costs (7,217 ) — — — (7,217 ) Intercompany loan proceeds — — 4,455 (4,455 ) Payments on capital leases (6,645 ) (10,005 ) (2,693 ) — (19,343 ) Other 1,863 (6,834 ) (1,759 ) — (6,730 ) Net cash used for financing activities (129,350 ) (16,839 ) (257,083 ) 251,227 (152,045 ) Effect of exchange rate changes on cash and cash equivalents — — 1,266 — 1,266 Increase (decrease) in cash and cash equivalents 5,491 185,158 (218,014 ) — (27,365 ) Cash and cash equivalents: Beginning of year 141,364 95,865 351,274 — 588,503 End of year $ 146,855 $ 281,023 $ 133,260 $ — $ 561,138 CONDENSED CONSOLIDATING STATEMENT OF CASH FLOWS INFORMATION YEAR ENDED DECEMBER 31, 2017 Parent Subsidiary Subsidiary Company Guarantors Non-Guarantors Eliminations Consolidated (In thousands) Operating activities Net income $ 265,643 $ 151,999 $ 120,029 $ (270,189 ) $ 267,482 Adjustments to reconcile net income to cash provided by operating activities (123,080 ) 71,023 33,515 270,189 251,647 Changes in assets and liabilities 18,223 (35,138 ) 25,649 — 8,734 Net cash (used for) provided by operating activities 160,786 187,884 179,193 — 527,863 Investing activities Additions to theatre properties and equipment (146,385 ) (172,874 ) (61,603 ) — (380,862 ) Acquisition of theatres in the U.S. and international markets, net of cash acquired (12,500 ) — (28,497 ) — (40,997 ) Proceeds from sale of theatre properties and equipment and other 2,149 12,271 678 — 15,098 Dividends received from subsidiaries 127,600 1,873 — (129,473 ) — Investment in joint ventures and other — (104 ) (3,611 ) — (3,715 ) Net cash provided by (used for) investing activities (29,136 ) (158,834 ) (93,033 ) (129,473 ) (410,476 ) Financing activities Dividends paid to parent (134,500 ) (127,000 ) (2,473 ) 129,473 (134,500 ) Repayments of long-term debt (4,282 ) — (1,389 ) — (5,671 ) Payments on capital leases (7,952 ) (9,707 ) (4,066 ) — (21,725 ) Proceeds from financing lease — 10,200 — — 10,200 Other (1,181 ) (2,943 ) (1,088 ) — (5,212 ) Net cash used for financing activities (147,915 ) (129,450 ) (9,016 ) 129,473 (156,908 ) Effect of exchange rate changes on cash and cash equivalents — — 798 — 798 Increase (decrease) in cash and cash equivalents (16,265 ) (100,400 ) 77,942 — (38,723 ) Cash and cash equivalents: Beginning of year 146,855 281,023 133,260 — 561,138 End of year $ 130,590 $ 180,623 $ 211,202 $ — $ 522,415

Summary of Significant Accoun48

Summary of Significant Accounting Policies - Additional Information (Detail) $ in Thousands	12 Months Ended
	Dec. 31, 2017USD ($)UnitSegment	Dec. 31, 2016USD ($)UnitSegment	Dec. 31, 2015USD ($)UnitSegment
Summary Of Significant Accounting Policies [Line Items]
Approximate available remaining lease period for fee owned properties	20 years
Requirements to be classified as capital lease, minimum amount of present value of future minimum lease payments against estimated fair value, percentage	90.00%
Requirements to be classified as capital lease, minimum length of lease term against estimated useful life, percentage	75.00%
General liability claim per occurrence, cap	$ 250	$ 100	$ 100
Annual cap per policy year	3,900	3,350	2,900
Annual cap for self-insured workers compensation plan	5,000
Medical claim per occurrence, cap	250	150	125
Insurance Reserves	8,252	7,837
Unredeemed gift cards and other advances	77,623	70,247
Liabilities for advanced sale-type certificates	$ 11,861	$ 11,522	$ 11,786
Minimum Percentage for Tax position measure as largest amount of benefit	50.00%
Reportable operating segments | Segment	2	2	2
Interest Rate Swap
Summary Of Significant Accounting Policies [Line Items]
Derivative, expiration month and year	2016-04
Accrued Other Current Liabilities
Summary Of Significant Accounting Policies [Line Items]
Loyalty program liability, current	$ 5,527
Trade Names
Summary Of Significant Accounting Policies [Line Items]
Fair value in excess of carrying value percentage	10.00%
Rave Theatres | Trade Names
Summary Of Significant Accounting Policies [Line Items]
Fair value in excess of carrying value percentage		10.00%
U.S. Operating Segment
Summary Of Significant Accounting Policies [Line Items]
Number of reporting units | Segment	19
Multiplication Value to Cash flows for the determination of fair value of Reporting units | Unit	8	8	8
International Operating Segment
Summary Of Significant Accounting Policies [Line Items]
Number of reporting units | Segment	7
Minimum
Summary Of Significant Accounting Policies [Line Items]
Equity method investment, ownership percentage	20.00%
Amortization period of deferred charges and other assets	1 year
Remaining amortization period for deferred revenues	1 year
Minimum | U.S. Operating Segment
Summary Of Significant Accounting Policies [Line Items]
Reporting unit percentage of fair value in excesses of carrying value amount	10.00%		10.00%
Maximum
Summary Of Significant Accounting Policies [Line Items]
Equity method investment, ownership percentage	50.00%
Cost method investment, ownership Percentage	20.00%
Amortization period of deferred charges and other assets	15 years
Remaining amortization period for deferred revenues	20 years
Pre-funding claims and covers claims per occurrence	$ 250

Estimated Useful Lives of Asset

Estimated Useful Lives of Assets (Detail)	12 Months Ended
	Dec. 31, 2017
Buildings On Owned Land
Property, Plant and Equipment [Line Items]
Estimated useful life of assets	40 years
Buildings On Leased Land
Property, Plant and Equipment [Line Items]
Estimated useful life of assets	Lesser of lease term or useful life
Land and Buildings Under Capital Lease
Property, Plant and Equipment [Line Items]
Estimated useful life of assets	Lesser of lease term or useful life	[1]
Theatre furniture and equipment | Minimum
Property, Plant and Equipment [Line Items]
Estimated useful life of assets	3 years
Theatre furniture and equipment | Maximum
Property, Plant and Equipment [Line Items]
Estimated useful life of assets	15 years
Leasehold Improvements
Property, Plant and Equipment [Line Items]
Estimated useful life of assets	Lesser of lease term or useful life
[1]	Amortization of capital lease assets is included in depreciation and amortization expense on the consolidated statements of income. Accumulated amortization of capital lease assets as of December 31, 2016 and 2017 was $175,166 and $200,683, respectively.

Estimated Useful Lives of Ass50

Estimated Useful Lives of Assets (Parenthetical) (Detail) - USD ($) $ in Thousands	Dec. 31, 2017	Dec. 31, 2016
Property, Plant and Equipment [Line Items]
Accumulated depreciation and amortization	$ 1,500,535	$ 1,355,218
Property Under Capital Lease
Property, Plant and Equipment [Line Items]
Accumulated depreciation and amortization	$ 200,683	$ 175,166

Intangible Assets and Amortizat

Intangible Assets and Amortization Method (Detail)	12 Months Ended
	Dec. 31, 2017
Finite Lived Intangible Assets [Line Items]
Goodwill	Indefinite-lived
Tradename	Indefinite-lived
Vendor Contracts
Finite Lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets, Amortization Method	Straight-line method over the terms of the underlying contracts. The remaining terms of the underlying contracts range from one to three years.
Vendor Contracts | Minimum
Finite Lived Intangible Assets [Line Items]
Finite-Lived Intangible Asset, Useful Life	1 year
Vendor Contracts | Maximum
Finite Lived Intangible Assets [Line Items]
Finite-Lived Intangible Asset, Useful Life	3 years
Favorable/unfavorable leases
Finite Lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets, Amortization Method	Based on the pattern in which the economic benefits are realized over the terms of the lease agreements. The remaining terms of the lease agreements range from approximately two to nineteen years.
Favorable/unfavorable leases | Minimum
Finite Lived Intangible Assets [Line Items]
Finite-Lived Intangible Asset, Useful Life	2 years
Favorable/unfavorable leases | Maximum
Finite Lived Intangible Assets [Line Items]
Finite-Lived Intangible Asset, Useful Life	19 years
Other Intangible Assets
Finite Lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets, Amortization Method	Straight-line method over the terms of the underlying agreement or the expected useful life of the intangible asset. The remaining useful lives of these intangible assets range from one to twelve years.
Other Intangible Assets | Minimum
Finite Lived Intangible Assets [Line Items]
Finite-Lived Intangible Asset, Useful Life	1 year
Other Intangible Assets | Maximum
Finite Lived Intangible Assets [Line Items]
Finite-Lived Intangible Asset, Useful Life	12 years

New Accounting Pronouncements -

New Accounting Pronouncements - Additional Information (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2016	Jan. 01, 2018
ASU 2016-15
New Accounting Pronouncements Or Change In Accounting Principle [Line Items]
Reclassification of cash payments recorded in loss on debt amendments and refinancing from operating activities to financing activities	$ 9,519
Maximum | Subsequent Event
New Accounting Pronouncements Or Change In Accounting Principle [Line Items]
Cumulative effect of accounting change adjustment in retained earnings		$ 55,000

Investment in National CineMe53

Investment in National CineMedia LLC - Additional Information (Detail)	Feb. 13, 2007USD ($)	Dec. 31, 2017USD ($)$ / shares$ / Theatreshares	Dec. 31, 2016USD ($)	Dec. 31, 2015USD ($)	Dec. 31, 2014USD ($)
Schedule Of Equity Method Investments [Line Items]
Access fees per patron | $ / Theatre		0.07
Increase in percentage of payment per theatre patron		8.00%
Duration of percentage increase in theatre access fees per patron		5 years
Payment per digital screen	$ 800,000	$ 1,303,000	$ 1,241,000	$ 1,182,000
Percentage of annual increase in payment per digital screen		5.00%
Minimum percentage of aggregate advertising revenue for payment of fees		12.00%
Remaining term of exhibitor services agreement		19 years
Number of common units of NCM owned by Company | shares		27,871,862
Interest in common units of NCM owned by Company		18.00%
NCM
Schedule Of Equity Method Investments [Line Items]
Investment in NCM		$ 200,550,000	189,995,000
Impairment of investments		0
NCM | Theatre Properties and Equipment
Schedule Of Equity Method Investments [Line Items]
Payment for installation of certain equipment used for digital advertising		$ 102,000	49,000	50,000
Investment In NCM
Schedule Of Equity Method Investments [Line Items]
Common unit convertible into share of NCMI common stock, conversion ratio		1
Estimated fair value of investment using NCMI's stock price		$ 191,201,000
NCMI stock price | $ / shares		$ 6.86
Investment in NCM		$ 200,550,000	$ 189,995,000	$ 183,755,000	$ 178,939,000

Summary of Common Units Receive

Summary of Common Units Received Under Adjustment Agreement (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Schedule Of Equity Method Investments [Line Items]
Fair Value of Common Units Received	$ 18,363	$ 11,111	$ 15,421
Annual Common Unit Adjustment
Schedule Of Equity Method Investments [Line Items]
Date Common Units Received	Mar. 31, 2017	Mar. 31, 2016	Mar. 31, 2015
Number of Common Units Received	1,487,218	753,598	1,074,910
Fair Value of Common Units Received	$ 18,363	$ 11,111	$ 15,421

Summary of Activity with NCM In

Summary of Activity with NCM Included in Company's Consolidated Financial Statements (Detail) - USD ($) $ in Thousands		12 Months Ended
		Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Schedule Of Equity Method Investments [Line Items]
Equity in earnings		$ 35,985	$ 31,962	$ 28,126
Equity in other comprehensive loss		(248)	(89)	3,119
NCM
Schedule Of Equity Method Investments [Line Items]
Beginning Balance		189,995
Beginning Balance		(343,928)
Ending Balance		200,550	189,995
Ending Balance		(351,706)	(343,928)
Investment In NCM
Schedule Of Equity Method Investments [Line Items]
Beginning Balance		189,995	183,755	178,939
Receipt of common units due to annual common unit adjustment		18,363	11,111	15,421
Receipt of excess cash distributions		(15,093)	(11,233)	(14,072)
Receipt under tax receivable agreement		(2,265)	(2,985)	(2,308)
Equity in earnings		9,550	9,347	8,510
Equity in other comprehensive loss				(2,735)
Ending Balance		200,550	189,995	183,755
Deferred Revenue
Schedule Of Equity Method Investments [Line Items]
Beginning Balance		(343,928)	(342,134)	(335,219)
Receipt of common units due to annual common unit adjustment		(18,363)	(11,111)	(15,421)
Ending Balance		(351,706)	(343,928)	(342,134)
Deferred Revenue | NCM
Schedule Of Equity Method Investments [Line Items]
Amortization of deferred revenue		10,585	9,317	8,506
Distributions from NCM
Schedule Of Equity Method Investments [Line Items]
Beginning Balance		(14,656)	(18,140)
Receipt of excess cash distributions		(14,158)	(11,483)	(15,396)
Receipt under tax receivable agreement		(2,249)	(3,173)	(2,744)
Ending Balance		(16,407)	(14,656)	(18,140)
Equity in Earnings
Schedule Of Equity Method Investments [Line Items]
Beginning Balance		(9,347)	(8,510)
Ending Balance		(9,550)	(9,347)	(8,510)
Equity in Earnings | NCM
Schedule Of Equity Method Investments [Line Items]
Equity in earnings		(9,550)	(9,347)	(8,510)
Other Revenue
Schedule Of Equity Method Investments [Line Items]
Beginning Balance		(20,365)	(19,836)
Revenues earned under ESA	[1]	(11,274)	(11,048)	(11,330)
Ending Balance		(21,859)	(20,365)	(19,836)
Other Revenue | NCM
Schedule Of Equity Method Investments [Line Items]
Amortization of deferred revenue		(10,585)	(9,317)	(8,506)
Cash Received
Schedule Of Equity Method Investments [Line Items]
Beginning Balance		39,922	45,850
Revenues earned under ESA	[1]	11,274	11,048	11,330
Receipt of excess cash distributions		29,251	22,716	29,468
Receipt under tax receivable agreement		4,514	6,158	5,052
Ending Balance		$ 45,039	39,922	45,850
Other Comprehensive Loss
Schedule Of Equity Method Investments [Line Items]
Beginning Balance			$ 2,735
Ending Balance				2,735
Other Comprehensive Loss | NCM
Schedule Of Equity Method Investments [Line Items]
Equity in other comprehensive loss				$ 2,735
[1]	Amounts include the per patron and per digital screen theatre access fees due to the Company, net of amounts due to NCM for on-screen advertising time provided to the Company’s beverage concessionaire. The amounts due to NCM for on-screen advertising time provided to the Company’s beverage concessionaire were approximately $9,819, $10,523 and $11,110 for the years ended December 31, 2015, 2016 and 2017, respectively.

Summary of Activity with NCM 56

Summary of Activity with NCM Included in Company's Consolidated Financial Statements (Parenthetical) (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Equity Method Investments And Joint Ventures [Abstract]
Company's beverage concessionaire advertising costs	$ 11,110	$ 10,523	$ 9,819

Summary Financial Information f

Summary Financial Information for National CineMedia (Detail) - NCM - USD ($) $ in Thousands	9 Months Ended	12 Months Ended
	Sep. 28, 2017	Dec. 29, 2016	Dec. 31, 2015
Schedule Of Equity Method Investments [Line Items]
Revenues	$ 285,400	$ 447,600	$ 446,500
Operating income	83,700	173,000	140,500
Net income	44,800	109,300	$ 87,500
Current assets	130,100	180,900
Noncurrent assets	776,900	607,600
Current liabilities	96,700	121,100
Noncurrent liabilities	910,800	924,300
Members' deficit	$ (100,500)	$ (256,900)

Summary of Activity for Each of

Summary of Activity for Each of Company's Other Investments (Detail) - USD ($) $ in Thousands		1 Months Ended	12 Months Ended
		Dec. 31, 2013	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Schedule Of Equity Method Investments [Line Items]
Investments, beginning balance			$ 98,317
Equity in income			(35,985)	$ (31,962)	$ (28,126)
Cash distributions received	[1]		(25,973)	(21,916)	(19,027)
Investments, ending balance			120,045	98,317
AC JV, LLC
Schedule Of Equity Method Investments [Line Items]
Cash contributions		$ 268
Other Affiliates
Schedule Of Equity Method Investments [Line Items]
Investments, beginning balance			98,317	94,973	77,658
Cash contributions			3,715	1,132	3,711
Equity in income			26,435	22,615	19,616
Equity in comprehensive income (loss)			248	89	(384)
Unrealized holding loss					(1,529)
Sale of investment in Taiwan	[2]				(1,383)
Sale of investment	[3]			(12,900)
Cash distributions received			(8,615)	(7,698)	(2,647)
Other			(55)	106	(69)
Investments, ending balance			120,045	98,317	94,973
Other Affiliates | Digital Cinema Implementation Partners
Schedule Of Equity Method Investments [Line Items]
Investments, beginning balance			87,819	71,579	51,277
Cash contributions			1,112	717	3,211
Equity in income			22,900	21,434	18,522
Equity in comprehensive income (loss)			248	89	(384)
Cash distributions received			(5,864)	(6,000)	(1,047)
Investments, ending balance			106,215	87,819	71,579
Other Affiliates | RealD
Schedule Of Equity Method Investments [Line Items]
Investments, beginning balance				12,900	14,429
Unrealized holding loss					(1,529)
Sale of investment	[3]			(12,900)
Investments, ending balance					12,900
Other Affiliates | AC JV, LLC
Schedule Of Equity Method Investments [Line Items]
Investments, beginning balance			5,980	7,269	7,899
Equity in income			2,336	311	970
Cash distributions received			(2,400)	(1,600)	(1,600)
Investments, ending balance			5,916	5,980	7,269
Other Affiliates | Digital Cinema Distribution Coalition
Schedule Of Equity Method Investments [Line Items]
Investments, beginning balance			2,750	2,562	2,438
Equity in income			1,199	870	124
Cash distributions received			(351)	(98)
Other				(584)
Investments, ending balance			3,598	2,750	2,562
Other Affiliates | Other Investment
Schedule Of Equity Method Investments [Line Items]
Investments, beginning balance			1,768	663	1,615
Cash contributions			2,603	415	500
Sale of investment in Taiwan	[2]				(1,383)
Other			(55)	690	(69)
Investments, ending balance			$ 4,316	$ 1,768	$ 663
[1]	Includes distributions received from equity investees that were recorded as a reduction of the respective investment balances.
[2]	The Company sold its investment in a Taiwan joint venture for $2,634, resulting in a gain of $1,251, which is included in loss on sale of assets and other for the year ended December 31, 2015.
[3]	See further discussion of the sale of the investment held by the Company under RealD, Inc. below.

Summary of Activity for Each 59

Summary of Activity for Each of Company's Other Investments (Parenthetical) (Detail) $ in Thousands	12 Months Ended
	Dec. 31, 2015USD ($)
Equity Method Investments And Joint Ventures [Abstract]
Proceeds from sale of investment in joint venture	$ 2,634
Gain (loss) on sale of assets and other	$ 1,251

Other Investments - Additional

Other Investments - Additional Information (Detail)	Mar. 22, 2016USD ($)$ / shares	Dec. 31, 2013USD ($)	Mar. 31, 2011$ / shares	Dec. 31, 2017USD ($)RenewalOptionProjectionSystemshares	Dec. 31, 2016USD ($)	Dec. 31, 2015USD ($)	Dec. 31, 2013USD ($)	Dec. 31, 2011shares
Schedule Of Equity Method Investments [Line Items]
Number of shares owned in RealD | shares								1,222,780
Exercise price of options, shares | $ / shares			$ 0.00667
Number of shares owned in RealD | shares				1,222,780
Proceeds from sale of marketable securities					$ 13,451,000
Other Affiliates
Schedule Of Equity Method Investments [Line Items]
Cash contributions				$ 3,715,000	1,132,000	$ 3,711,000
Digital Cinema Implementation Partners
Schedule Of Equity Method Investments [Line Items]
Percentage of voting interest				33.00%
Economic interest in Digital Cinema Implementation Partners				24.30%
Digital Cinema Implementation Partners | Other Affiliates
Schedule Of Equity Method Investments [Line Items]
Digital projection systems leased under operating lease, initial term				12 years
Number of one-year fair value renewal options | RenewalOption				10
Minimum annual rent per digital projection system				$ 1,000
Number of equipment being leased under master equipment lease agreement | ProjectionSystem				3,805
Cash contributions				$ 1,112,000	717,000	3,211,000
RealD | Other Affiliates
Schedule Of Equity Method Investments [Line Items]
Purchase price per share | $ / shares	$ 11
Proceeds from sale of marketable securities	$ 13,451,000
Gain on investment					3,742,000
Unrealized holding gain previously recorded in AOCI					3,191,000
AC JV, LLC
Schedule Of Equity Method Investments [Line Items]
Ownership of class A units sold to Founding Members		97.00%
Cash contributions		$ 268,000
Ownership of class A units		1.00%
Ownership of class A units							31.00%
Aggregate value of Class A units							$ 25,000,000
Promissory note term							6 years
Original principal value of promissory note with NCM							$ 8,333,000
Annual interest rate on promissory note		5.00%					5.00%
Remaining outstanding balance of note payable				2,778,000
AC JV, LLC | Film rentals and advertising
Schedule Of Equity Method Investments [Line Items]
Event fees				$ 13,950,000	10,871,000	11,440,000
Digital Cinema Distribution Coalition
Schedule Of Equity Method Investments [Line Items]
Percentage of voting interest				14.60%
Payments for content delivery services				$ 848,000	$ 939,000	$ 807,000

Summary Financial Information61

Summary Financial Information for DCIP (Detail) - Other Affiliates - Digital Cinema Implementation Partners - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Schedule Of Equity Method Investments [Line Items]
Revenues	$ 177,382	$ 178,836	$ 171,203
Operating income	106,687	107,919	103,449
Net income	93,103	89,152	$ 79,255
Current assets	56,296	45,087
Noncurrent assets	772,438	861,290
Current liabilities	59,153	44,771
Noncurrent liabilities	296,889	464,246
Members' equity	$ 472,692	$ 397,360

Transactions with DCIP (Detail)

Transactions with DCIP (Detail) - Digital Cinema Implementation Partners - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Schedule Of Equity Method Investments [Line Items]
Equipment lease payments	$ 5,743	$ 5,217	$ 4,474
Warranty reimbursements from DCIP	(8,511)	(6,091)	(4,329)
Management services fees	$ 823	$ 825	$ 825

Summary of Goodwill (Detail)

Summary of Goodwill (Detail) - USD ($) $ in Thousands		12 Months Ended
		Dec. 31, 2017		Dec. 31, 2016
Goodwill [Line Items]
Beginning Balance	[1]	$ 1,262,963		$ 1,247,548
Acquisitions of theatres		23,089	[2]	7,607
Other acquisitions	[3]			1,410
Foreign currency translation adjustments		(1,973)		6,398
Ending Balance	[1]	1,284,079		1,262,963
U.S. Operating Segment
Goodwill [Line Items]
Beginning Balance	[1]	1,164,163		1,156,556
Acquisitions of theatres		9,878	[2]	7,607
Other acquisitions	[3]			0
Foreign currency translation adjustments		0		0
Ending Balance	[1]	1,174,041		1,164,163
International Operating Segment
Goodwill [Line Items]
Beginning Balance	[1]	98,800		90,992
Acquisitions of theatres		13,211	[2]	0
Other acquisitions	[3]			1,410
Foreign currency translation adjustments		(1,973)		6,398
Ending Balance	[1]	$ 110,038		$ 98,800
[1]	Balances are presented net of accumulated impairment losses of $214,031 for the U.S. operating segment and $27,622 for the international operating segment.
[2]	Acquisition of theatres in the U.S. and international markets.
[3]	Acquisition of screen advertising companies in Central America and Colombia.

Summary of Goodwill (Parentheti

Summary of Goodwill (Parenthetical) (Detail) $ in Thousands	Dec. 31, 2017USD ($)
U.S. Operating Segment
Goodwill [Line Items]
Accumulated impairment losses	$ 214,031
International Operating Segment
Goodwill [Line Items]
Accumulated impairment losses	$ 27,622

Intangible Assets -Net (Detail)

Intangible Assets -Net (Detail) - USD ($) $ in Thousands		12 Months Ended
		Dec. 31, 2017		Dec. 31, 2016
Intangible Assets Net Excluding Goodwill [Abstract]
Intangible assets with finite lives, Beginning balance		$ 99,796		$ 99,968
Accumulated amortization additions		11,584	[1]	503	[2]
Other, Gross carrying amount	[3]	(5,485)		(675)
Intangible assets with finite lives, Ending balance		105,895		99,796
Intangible assets with finite lives, Accumulated amortization, Beginning balance		(64,606)		(59,706)
Accumulated amortization additions		0	[1]	0	[2]
Accumulated amortization		(5,563)		(5,538)
Other Accumulated Amortization of Intangible Assets	[3]	1,300		638
Intangible assets with finite lives, Accumulated amortization, Ending balance		(68,869)		(64,606)
Net intangible assets with finite lives, Beginning balance		35,190		40,262
Amortization, intangible assets		(5,563)		(5,538)
Other, Finite lived intangible assets	[3]	(4,185)		(37)
Net intangible assets with finite lives, Ending balance		37,026		35,190
Indefinite-lived Intangible Assets, Tradename, Beginning Balance		299,709		299,382
Indefinite lived intangible assets, additions		0	[1]	0	[2]
Other, Tradename	[3]	26		327
Indefinite-lived Intangible Assets, Tradename, Ending Balance		299,735		299,709
Total intangible assets - net, Beginning balance		334,899		339,644
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles		11,584	[1]	503	[2]
Other, Total intangible assets - net	[3]	(4,159)		290
Total intangible assets - net, Ending balance		$ 336,761		$ 334,899
[1]	Amounts represent fair values allocated to intangible assets acquired as part of acquisitions of theatres in the U.S. and international markets.
[2]	Activity for 2016 reflects addition of non-compete agreement and favorable lease associated with theatres acquired in the U.S.
[3]	Amounts represent foreign currency translation adjustments and the write-off of certain lease intangibles for theatre closures and lease amendments.

Estimated Aggregate Future Amor

Estimated Aggregate Future Amortization Expense for Intangible Assets (Detail) - USD ($) $ in Thousands	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Finite Lived Intangible Assets Net [Abstract]
For the year ended December 31, 2018	$ 5,725
For the year ended December 31, 2019	5,267
For the year ended December 31, 2020	5,535
For the year ended December 31, 2021	3,685
For the year ended December 31, 2022	3,280
Thereafter	13,534
Total	$ 37,026	$ 35,190	$ 40,262

Long-Lived Asset Impairment Cha

Long-Lived Asset Impairment Charges (Detail) - USD ($) $ in Thousands		12 Months Ended
		Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Impaired Long-Lived Assets Held and Used [Line Items]
Theatre properties		$ 15,084	$ 2,836	$ 7,809
Intangible assets	[1]			992
Impairment of long-lived assets		15,084	2,836	8,801
U.S. Operating Segment
Impaired Long-Lived Assets Held and Used [Line Items]
Theatre properties		5,227	1,929	7,052
International Operating Segment
Impaired Long-Lived Assets Held and Used [Line Items]
Theatre properties		$ 9,857	$ 907	$ 757
[1]	Activity for 2015 was related to the impairment of a favorable lease for one theatre.

Impairment of Long-Lived Asse68

Impairment of Long-Lived Assets - Additional Information (Detail) $ in Thousands	12 Months Ended
	Dec. 31, 2017USD ($)
Impairment Or Disposal Of Tangible Assets Disclosure [Abstract]
Estimated aggregate remaining fair value of long-lived assets impaired during current period	$ 8,953

Deferred Changes and Other Asse

Deferred Changes and Other Assets (Detail) - USD ($) $ in Thousands	Dec. 31, 2017	Dec. 31, 2016
Deferred Costs Capitalized Prepaid And Other Assets Disclosure [Abstract]
Long-term prepaid rents	$ 7,762	$ 5,996
Construction and other deposits	12,167	10,881
Equipment to be placed in service	13,868	12,856
Other	5,970	7,822
Total	$ 39,767	$ 37,555

Long Term Debt (Detail)

Long Term Debt (Detail) - USD ($) $ in Thousands		Dec. 31, 2017	Nov. 28, 2017	[2]	Jun. 16, 2017	[2]	Dec. 31, 2016	Dec. 15, 2016	[2]	Jun. 13, 2016	[2]
Debt Instrument [Line Items]
Cinemark USA, Inc. term loan		$ 659,517					$ 663,799
Other	[1]	2,778					4,167
Total		1,817,295					1,822,966
Less current portion		7,099					5,671
Less debt issuance costs, net of accumulated amortization of $19,364 and $25,549, respectively		29,815	$ 330		$ 521		34,854	$ 2,446		$ 783
Long-term debt, less current portion		1,780,381					1,782,441
4.875 % Senior Notes Due May 2023
Debt Instrument [Line Items]
Senior notes		755,000					755,000
5.125% senior notes due 2022
Debt Instrument [Line Items]
Senior notes		$ 400,000					$ 400,000
[1]	Primarily represents debt owed to NCM in relation to the recently-formed joint venture AC JV, LLC. See Note 4.
[2]	Reflected as a reduction of long term debt on the consolidated balance sheet as of December 31, 2016 and 2017.

Long Term Debt (Parenthetical)

Long Term Debt (Parenthetical) (Detail) - USD ($) $ in Thousands	Dec. 31, 2017	Dec. 31, 2016
Debt Disclosure [Abstract]
Debt issue costs, accumulated amortization	$ 25,549	$ 19,364

Long Term Debt - Additional Inf

Long Term Debt - Additional Information (Detail) - USD ($)

Nov. 28, 2017

Jun. 16, 2017

Dec. 15, 2016

Jun. 13, 2016

May 21, 2016

May 16, 2016

May 08, 2015

May 24, 2013

Dec. 18, 2012

Jun. 03, 2011

Dec. 31, 2017

Dec. 31, 2016

Dec. 31, 2015

Dec. 31, 2012

Debt Instrument [Line Items]

Incurred debt issue costs

$ 1,146,000

$ 7,217,000

$ 6,957,000

Amount outstanding under the term loan

$ 659,517,000

663,799,000

Percentage voting stock of foreign subsidiaries

65.00%

Multiple consolidated interest expense under sub condition two of condition two under dividend restriction

1.75

Debt issuance costs

$ 330,000

[1]

$ 521,000

[1]

$ 2,446,000

[1]

$ 783,000

[1]

$ 29,815,000

34,854,000

Write off of unamortization of debt issuance cost

2,369,000

Loss on debt amendments and refinancing

$ 331,000

[2]

$ 190,000

[2]

$ 161,000

[2]

$ 249,000

[2]

521,000

13,445,000

925,000

Carrying value of long-term debt

1,817,295,000

1,822,966,000

Fair value of long-term debt

1,840,918,000

1,850,212,000

Amended Senior Secured Credit Facility

Debt Instrument [Line Items]

Quarterly principal payments due

$ 1,750,000

Last quarterly payment date

Mar. 31, 2022

Remaining principal

$ 635,250,000

Incurred debt issue costs

6,957,000

Loss on debt amendments and refinancing

$ 925,000

Amended senior secured credit facility, dividend that could have distributed

2,620,026,000

Senior Secured Credit Facility Agreement

Debt Instrument [Line Items]

Quarterly principal payments due

$ 1,427,000

Last quarterly payment date

Mar. 31, 2022

Remaining principal

$ 635,250,000

Remaining principal due date

May 8, 2022

Pre-payment of term loan

$ 13,451,000

First quarterly payment date

Jun. 30, 2017

4.875 % Senior Notes Due May 2023

Debt Instrument [Line Items]

Aggregate principal amount of Senior Notes

$ 530,000,000

Interest rate

4.875%

Debt instrument, maturity date

Jun. 1, 2023

Senior notes indenture, amount that could have distributed

$ 2,608,237,000

Price to repurchase the senior subordinated notes as a percentage of the aggregate principal amount outstanding plus accrued and unpaid interest in case of change of control

101.00%

Debt covenants, required minimum coverage ratio

200.00%

Actual coverage ratio

610.00%

4.875 % Senior Notes Due June 1, 2023

Debt Instrument [Line Items]

Aggregate principal amount of Senior Notes

$ 225,000,000

$ 755,000,000

Interest rate

4.875%

4.875%

Debt instrument, maturity date

Jun. 1, 2023

Price to repurchase the senior subordinated notes as a percentage of the aggregate principal amount outstanding plus accrued and unpaid interest in case of change of control

99.00%

Debt issuance costs

$ 3,702,000

3,702,000

Debt issue costs, discount

2,250,000

2,250,000

7.375% senior subordinated notes due 2021

Debt Instrument [Line Items]

Aggregate principal amount of Senior Notes

$ 200,000,000

$ 200,000,000

Interest rate

7.375%

7.375%

Debt instrument, maturity period

2,021

2,021

Percentage of debt repayment premium

104.00%

Write off of unamortization of debt issuance cost

$ 2,369,000

Early retirement of debt

$ 9,444,000

Loss on debt amendments and refinancing

$ 1,222,000

5.125% senior notes due 2022

Debt Instrument [Line Items]

Aggregate principal amount of Senior Notes

$ 400,000,000

Interest rate

5.125%

Debt instrument, maturity date

Dec. 15, 2022

Debt instrument, maturity period

2,022

Price to repurchase the senior subordinated notes as a percentage of the aggregate principal amount outstanding plus accrued and unpaid interest in case of change of control

101.00%

Debt covenants, required minimum coverage ratio

200.00%

Actual coverage ratio

610.00%

Description of debt Instrument frequency of periodic payment

Interest on the 5.125% Senior Notes is payable on June 15 and December 15 of each year.

Senior notes indenture, amount that could have distributed

$ 2,613,268,000

Term Loan Credit facility | Senior Secured Credit Facility

Debt Instrument [Line Items]

Aggregate principal amount of Senior Notes

$ 700,000,000

Maturity period

7 years

Term Loan Credit facility | Amended Senior Secured Credit Facility

Debt Instrument [Line Items]

Aggregate principal amount issued

$ 700,000,000

Remaining principal due date

May 8, 2022

Percentage of Variable rate added to federal funds effective rate

0.50%

Percentage of variable margin rate added to one-month Eurodollar rate

1.00%

Percentage of variable margin rate added to Eurodollar rate

2.00%

Debt instrument description of interest

A Eurodollar-based rate for a period of 1, 2, 3, 6, 9 or 12 months plus a margin of 2.00% per annum.

Amount outstanding under the term loan

$ 659,517,000

Average interest rate on outstanding borrowings

3.60%

Term Loan Credit facility | Amended Senior Secured Credit Facility | One Month Eurodollar Rate

Debt Instrument [Line Items]

Percentage of variable margin rate added to Eurodollar rate

1.00%

Revolving Credit Line | Senior Secured Credit Facility

Debt Instrument [Line Items]

Aggregate principal amount of Senior Notes

$ 100,000,000

Maturity period

5 years

Revolving Credit Line | Amended Senior Secured Credit Facility

Debt Instrument [Line Items]

Percentage of Variable rate added to federal funds effective rate

0.50%

Percentage of variable margin rate added to one-month Eurodollar rate

1.00%

Debt instrument description of interest

A Eurodollar-based rate for a period of 1, 2, 3, 6, 9 or 12 months plus a margin that ranges from 1.50% to 2.25% per annum.

Amount outstanding under the revolving credit line

$ 0

$ 0

Available borrowing capacity

$ 100,000,000

Revolving Credit Line | Amended Senior Secured Credit Facility | Minimum

Debt Instrument [Line Items]

Percentage of variable margin rate added to Eurodollar rate

1.50%

Revolving Credit Line | Amended Senior Secured Credit Facility | Maximum

Debt Instrument [Line Items]

Percentage of variable margin rate added to Eurodollar rate

2.25%

Revolving Credit Line | Amended Senior Secured Credit Facility | One Month Eurodollar Rate | Minimum

Debt Instrument [Line Items]

Percentage of variable margin rate added to Eurodollar rate

0.50%

Revolving Credit Line | Amended Senior Secured Credit Facility | One Month Eurodollar Rate | Maximum

Debt Instrument [Line Items]

Percentage of variable margin rate added to Eurodollar rate

1.25%

[1]

Reflected as a reduction of long term debt on the consolidated balance sheet as of December 31, 2016 and 2017.

[2]

Reflected as a loss on debt amendments and refinancing on the consolidated statement of income for the year in which the amendments were effective.

Long Term Debt - Amendment of C

Long Term Debt - Amendment of Credit Agreement (Detail) - USD ($) $ in Thousands	Nov. 28, 2017		Jun. 16, 2017		Dec. 15, 2016		Jun. 13, 2016		Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Debt Instrument [Line Items]
Debt Issue Cost Paid	$ 330	[1]	$ 521	[1]	$ 2,446	[1]	$ 783	[1]	$ 29,815	$ 34,854
Loss on Debt Amendment	$ 331	[2]	$ 190	[2]	$ 161	[2]	$ 249	[2]	$ 521	$ 13,445	$ 925
Amended Credit Agreement June 13, 2016
Debt Instrument [Line Items]
Nature of Amendment									Reduced term loan interest rate by 0.25%
Amended Credit Agreement December 15, 2016
Debt Instrument [Line Items]
Nature of Amendment									Reduced term loan interest rate by 0.50%
Amended Credit Agreement June 16, 2017
Debt Instrument [Line Items]
Nature of Amendment									Reduced term loan interest rate by 0.25%; modified certain definitions and other provisions in the Credit Agreement
Amended Credit Agreement November 28, 2017
Debt Instrument [Line Items]
Nature of Amendment									Extended maturity of revolving credit line to December 2022; reduced the interest rate applicable to borrowings under the credit line
[1]	Reflected as a reduction of long term debt on the consolidated balance sheet as of December 31, 2016 and 2017.
[2]	Reflected as a loss on debt amendments and refinancing on the consolidated statement of income for the year in which the amendments were effective.

Long Term Debt - Amendment of74

Long Term Debt - Amendment of Credit Agreement (Parenthetical) (Detail)	Nov. 28, 2017	Jun. 16, 2017	Dec. 15, 2016	Jun. 13, 2016
Debt Disclosure [Abstract]
Debt instrument, reduction in interest rate		0.25%	0.50%	0.25%
Debt instrument, extended maturity date	2022-12

Maturities of Long-Term Debt, E

Maturities of Long-Term Debt, Excluding Unamortized Debt Issuance Costs (Detail) - USD ($) $ in Thousands	Dec. 31, 2017	Dec. 31, 2016
Debt Disclosure [Abstract]
2,018	$ 7,099
2,019	7,099
2,020	5,710
2,021	5,710
2,022	1,036,677
Thereafter	755,000
Total	$ 1,817,295	$ 1,822,966

Fair Value Measurements - Addit

Fair Value Measurements - Additional Information (Detail) - USD ($)	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Fair Value Disclosures [Abstract]
Assets at fair value on recurring basis	$ 0
Liabilities at fair value on recurring basis	0
Fair value of assets transfers in or out, level 1 to level 2	0	$ 0	$ 0
Fair value of assets transfers in or out, level 2 to level 1	0	0	0
Fair value, asset transfers into Level 3	0	0	0
Fair value, asset transfers out of Level 3	$ 0	$ 0	$ 0

Reconciliation of Beginning and

Reconciliation of Beginning and Ending Balance for Liabilities Measured at Fair Value on Recurring Basis Unobservable Inputs (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016
Fair Value Disclosures [Abstract]
Beginning balances - Liabilities	$ 0	$ 373
Total loss included in accumulated other comprehensive loss	0	71
Settlements included in interest expense	0	(444)
Ending balances - Liabilities	$ 0	$ 0

Foreign Currency Translation -

Foreign Currency Translation - Additional Information (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016
Foreign Currency Translation [Line Items]
Accumulated other comprehensive income (loss)	$ 253,282	$ 247,013
Cumulative foreign currency adjustments	$ 253,565	$ 247,046
Cumulative inflation rate	100.00%
Cumulative inflation period	3 years
Reclassification of cumulative foreign currency translation adjustments	$ 1,551
Canada
Foreign Currency Translation [Line Items]
Reclassification of cumulative foreign currency translation adjustments	$ 1,551

Summary of Impact of Translatin

Summary of Impact of Translating Financial Statements of Company's International Subsidiaries (Detail) $ in Thousands	12 Months Ended
	Dec. 31, 2017USD ($)	Dec. 31, 2016USD ($)	Dec. 31, 2015USD ($)
Foreign Currency Translation [Line Items]
Other comprehensive Income (Loss)	$ (4,966)	$ 26,394	$ (125,512)
Brazil
Foreign Currency Translation [Line Items]
Exchange Rate	3.96	3.26	3.31
Other comprehensive Income (Loss)	$ (74,559)	$ 37,286	$ (4,567)
Argentina
Foreign Currency Translation [Line Items]
Exchange Rate	12.95	16.04	18.65
Other comprehensive Income (Loss)	$ (30,520)	$ (13,362)	$ (8,200)
Colombia
Foreign Currency Translation [Line Items]
Exchange Rate	3,149.47	3,000.71	2,936.67
Other comprehensive Income (Loss)	$ (8,043)	$ 1,278	$ 246
Chile
Foreign Currency Translation [Line Items]
Exchange Rate	709.16	679.09	615.97
Other comprehensive Income (Loss)	$ (6,572)	$ 1,855	$ 5,672
Peru
Foreign Currency Translation [Line Items]
Exchange Rate	3.46	3.45	3.24
Other comprehensive Income (Loss)	$ (4,882)	$ 87	$ 2,752
Other foreign countries
Foreign Currency Translation [Line Items]
Other comprehensive Income (Loss)	(898)	(783)	(869)
International Subsidiaries | Cinemark USA, Inc. Stockholder's Equity
Foreign Currency Translation [Line Items]
Other comprehensive Income (Loss)	$ (125,474)	$ 26,361	$ (4,966)

Non-controlling Interest in Sub

Non-controlling Interest in Subsidiaries (Detail) - USD ($) $ in Thousands	Dec. 31, 2017	Dec. 31, 2016
Noncontrolling Interest [Line Items]
Noncontrolling interests	$ 11,893	$ 11,142
Cinemark Partners II
Noncontrolling Interest [Line Items]
Noncontrolling interests	8,795	8,249
Laredo Theatre
Noncontrolling Interest [Line Items]
Noncontrolling interests	1,746	1,695
Greeley Ltd
Noncontrolling Interest [Line Items]
Noncontrolling interests	843	689
Other
Noncontrolling Interest [Line Items]
Noncontrolling interests	$ 509	$ 509

Non-controlling Interest in S81

Non-controlling Interest in Subsidiaries (Parenthetical) (Detail)	Dec. 31, 2017	Dec. 31, 2016
Cinemark Partners II
Noncontrolling Interest [Line Items]
Ownership share	24.60%	24.60%
Laredo Theatre
Noncontrolling Interest [Line Items]
Ownership share	25.00%	25.00%
Greeley Ltd
Noncontrolling Interest [Line Items]
Ownership share	49.00%	49.00%

Noncontrolling Interests in S82

Noncontrolling Interests in Subsidiaries - Additional Information (Detail) - USD ($) $ in Thousands	1 Months Ended	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2016	Dec. 31, 2017
Noncontrolling Interest [Line Items]
Percentage of remaining share purchased	25.00%
Purchase of noncontrolling interest	$ 450
Decrease in additional paid-in-capital		$ 450
Noncontrolling interests	$ 11,142	$ 11,142	$ 11,893
Ownership percentage	100.00%	100.00%
Flix Impirica S.A.
Noncontrolling Interest [Line Items]
Noncontrolling interests	$ 423	$ 423
Cinemark USA, Inc. Stockholder's Equity
Noncontrolling Interest [Line Items]
Decrease in additional paid-in-capital	$ 27	$ 27

Summary of Impact of Changes in

Summary of Impact of Changes in Company's Ownership Interest in Subsidiary (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Noncontrolling Interest [Line Items]
Net income attributable to Cinemark USA, Inc.	$ 265,643	$ 256,777	$ 218,532
Net transfers from non-controlling interests	0	(27)	0
Change from net income attributable to Cinemark USA, Inc. and transfers from noncontrolling interests	265,643	256,750	218,532
Chile
Noncontrolling Interest [Line Items]
Decrease in Cinemark USA, Inc. additional paid-in-capital for the buyout of Flix Impirica non-controlling interest	$ 0	$ (27)	$ 0

Capital Stock - Additional Info

Capital Stock - Additional Information (Detail) - USD ($) $ / shares in Units, $ in Thousands	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Stockholders Equity Note [Line Items]
Preferred stock, shares	1,000,000
Preferred stock, par value	$ 1
Preferred stock, issued	0
Preferred stock, outstanding	0
Restricted Stock
Stockholders Equity Note [Line Items]
Unrecognized compensation expense	$ 13,049
Remaining Compensation Expense recognition period (in years)	2 years
Restricted Stock | Cinemark Holdings, Inc.
Stockholders Equity Note [Line Items]
Shares of restricted stock, granted	246,534	335,707	226,212
Market value of common stock on the dates of grant	$ 41.70	$ 30.98	$ 42.79
Unrecognized compensation expense	$ 416
Restricted Stock | Cinemark USA Inc
Stockholders Equity Note [Line Items]
Unrecognized compensation expense	$ 12,633
Restricted Stock | Directors
Stockholders Equity Note [Line Items]
Award vesting period for restricted stock granted	1 year
Restricted Stock | Minimum
Stockholders Equity Note [Line Items]
Forfeiture rate for restricted stock awards	0.00%
Restricted Stock | Minimum | Cinemark Holdings, Inc.
Stockholders Equity Note [Line Items]
Market value of common stock on the dates of grant	$ 34.82
Restricted Stock | Minimum | Employees
Stockholders Equity Note [Line Items]
Award vesting period for restricted stock granted	1 year
Restricted Stock | Maximum
Stockholders Equity Note [Line Items]
Forfeiture rate for restricted stock awards	10.00%
Restricted Stock | Maximum | Cinemark Holdings, Inc.
Stockholders Equity Note [Line Items]
Market value of common stock on the dates of grant	$ 42.37
Restricted Stock | Maximum | Employees
Stockholders Equity Note [Line Items]
Award vesting period for restricted stock granted	4 years
Restricted Stock Units (RSUs)
Stockholders Equity Note [Line Items]
Market value of common stock on the dates of grant	$ 42.37	$ 29.83	$ 43.19
Unrecognized compensation expense	$ 6,820
Remaining Compensation Expense recognition period (in years)	2 years
Share-based compensation arrangement by share-based payment award, description	The financial performance factors are based on an implied equity value concept that determines an internal rate of return (“IRR”) for a two year measurement period, as defined in the award agreement, based on a formula utilizing a multiple of Adjusted EBITDA subject to certain specified adjustments (as defined in the restricted stock unit award agreement).
Share-based compensation arrangement by share-based payment award, vesting condition	All payouts of restricted stock units that vest will be subject to an additional service requirement and will be paid in the form of Cinemark Holdings, Inc.’s common stock if the participant continues to provide services through the fourth anniversary of the grant date.
Internal rate of return, performance period	2 years
Percentage of IRR expected	11.00%
Expected forfeiture rate	5.00%
Restricted Stock Units (RSUs) | Stock Grants 2016
Stockholders Equity Note [Line Items]
Actual IRR calculated for grant	8.00%
Restricted Stock Units (RSUs) | Stock Grants 2017
Stockholders Equity Note [Line Items]
Actual IRR calculated for grant	9.50%
Restricted Stock Units (RSUs) | Cinemark Holdings, Inc.
Stockholders Equity Note [Line Items]
Number of hypothetical shares of common stock	175,634	253,661	142,917
Number of hypothetical shares of common stock at maximum IRR level	628,189
Actual cumulative forfeitures (in units)	7,407
Restricted Stock Units (RSUs) | Cinemark Holdings, Inc. | Stock Grants 2013 and 2014
Stockholders Equity Note [Line Items]
Stock price at the date of modification			$ 33.02
Incremental compensation expense			$ 2,460
Restricted Stock Units (RSUs) | Cinemark Holdings, Inc. | Stock Grants 2015
Stockholders Equity Note [Line Items]
Stock price at the date of modification		$ 37.98
Incremental compensation expense		$ 562
Class A common stock
Stockholders Equity Note [Line Items]
Common stock, shares outstanding	1,500	1,500
Class B common stock
Stockholders Equity Note [Line Items]
Common stock, shares outstanding	182,648	182,648

Summary of Restricted Stock Act

Summary of Restricted Stock Activity (Detail) - Restricted Stock - Cinemark Holdings, Inc. - $ / shares	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Shares of Restricted Stock
Shares of Restricted Stock, Beginning balance	606,618	757,775	878,897
Shares of Restricted Stock, Granted	246,534	335,707	226,212
Shares of Restricted Stock, Vested	(192,230)	(430,056)	(329,437)
Shares of Restricted Stock, Forfeited	(10,341)	(56,808)	(17,897)
Shares of Restricted Stock, Ending balance	650,581	606,618	757,775
Weighted Average Grant Date Fair Value
Weighted Average Grant Date Fair Value Outstanding, Beginning	$ 33.51	$ 30.73	$ 24.92
Weighted Average Grant Date Fair Value, Granted	41.70	30.98	42.79
Weighted Average Grant Date Fair Value, Vested	36.26	26.60	23.72
Weighted Average Grant Date Fair Value, Forfeited	33.48	33.81	27.58
Weighted Average Grant Date Fair Value Outstanding, Ending	$ 35.81	$ 33.51	$ 30.73

Summary of Restricted Stock Awa

Summary of Restricted Stock Award Activity (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Restricted Stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Compensation expense recognized during the period	$ 7,528	$ 7,269	$ 8,715
Restricted Stock | Employees
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Fair value of restricted shares that vested during the period	7,255	13,739	13,276
Income tax benefit recognized upon vesting of share based awards	$ 2,281	$ 5,167	$ 3,341
Restricted Stock | Cinemark Holdings, Inc.
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of restricted stock unit awards that vested during the period	192,230	430,056	329,437
Compensation expense recognized during the period	$ 856	$ 981	$ 885
Restricted Stock | Cinemark Holdings, Inc. | Directors
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Fair value of restricted shares that vested during the period	917	923	1,148
Income tax benefit recognized upon vesting of share based awards	$ 386	$ 388	$ 482
Restricted Stock Units (RSUs) | Cinemark Holdings, Inc.
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of restricted stock unit awards that vested during the period	97,115	213,984	123,769
Fair value of restricted shares that vested during the period	$ 4,155	$ 7,260	$ 5,483
Accumulated dividends to be paid upon vesting of restricted stock unit awards	558	662	442
Income tax benefit recognized upon vesting of share based awards	1,745	3,049	2,303
Compensation expense recognized during the period	$ 4,297	$ 5,144	$ 6,158

Summary of Financial Performanc

Summary of Financial Performance Thresholds and Vesting Rates (Detail) - Restricted Stock Units (RSUs)	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Threshold IRR	7.00%	6.00%	7.50%
Target IRR	9.50%	8.00%	9.50%
Maximum IRR	13.00%	10.00%	11.50%
Threshold IRR
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Percentage of Shares Vesting	33.30%
Targeted IRR
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Percentage of Shares Vesting	66.60%
Maximum IRR
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Percentage of Shares Vesting	100.00%

Summary of Potential Number of

Summary of Potential Number of Units that Could Vest Under Restricted Stock Unit Awards (Detail) - USD ($) $ in Thousands		12 Months Ended
		Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Disclosure Of Restricted Stock Unit [Abstract]
Number of units at threshold IRR		58,545	84,554	47,640
Number of units at target IRR		117,089	169,107	95,282
Number of units at maximum IRR		175,634	253,661	142,917
Fair value of units at threshold IRR	[1]	$ 2,481	$ 2,522	$ 2,057
Fair value of units at target IRR	[1]	4,961	5,044	4,115
Fair value of units at maximum IRR	[1]	$ 7,442	$ 7,568	$ 6,173
[1]	The grant date fair values for units issued during the years ended December 31, 2015, 2016, and 2017 were $43.19, $29.83 and $42.37, respectively.

Summary of Potential Number o89

Summary of Potential Number of Units that Could Vest Under Restricted Stock Unit Awards (Parenthetical) (Detail) - $ / shares	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Restricted Stock Units (RSUs)
Schedule Of Restricted Stock Unit [Line Items]
Weighted Average Grant Date Fair Value, Granted	$ 42.37	$ 29.83	$ 43.19

Supplemental Information to Con

Supplemental Information to Condensed Consolidated Statements of Cash Flows (Detail) - USD ($) $ in Thousands		12 Months Ended
		Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Schedule Of Cash Flow Supplemental [Line Items]
Cash paid for interest		$ 99,232	$ 108,101	$ 105,155
Cash paid for income taxes, net of refunds received		95,043	93,368	108,435
Noncash investing and financing activities:
Change in accounts payable and accrued expenses for the acquisition of theatre properties and equipment	[1]	9,349	(29,471)	2,491
Theatre properties and equipment acquired under capital lease		46,727	33,282	36,544
Investment in NCM - receipt of common units (see Note 3)		$ 18,363	$ 11,111	15,421
Noncash distributions to Cinemark Holdings, Inc.				(17,935)
Receipt of promissory note related to sale of investment in a Taiwan joint venture				2,634
Other Affiliates | Taiwan Joint Venture
Noncash investing and financing activities:
Receipt of promissory note related to sale of investment in a Taiwan joint venture				$ 2,304
[1]	Additions to theatre properties and equipment included in accounts payable as of December 31, 2016 and 2017 were $40,625 and $31,276, respectively.

Supplemental Information to C91

Supplemental Information to Condensed Consolidated Statements of Cash Flows (Parenthetical) (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016
Supplemental Cash Flow Elements [Abstract]
Additions to theatre properties and equipment included in accounts payable	$ 31,276	$ 40,625

Income Taxes - Additional Infor

Income Taxes - Additional Information (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Income Taxes [Line Items]
Corporate income tax rate		35.00%
Income tax net one-time benefit		$ 44,889
Deemed reptriated foreign earnings		352,632
Additional net transition tax on deemed repatriated foreign earnings		14,512
Undistributed foreign earnings			$ 251,439	$ 316,346
Valuation allowance against deferred assets – non-current		35,246	14,524
Gross unrecognized tax benefits, including interest and penalties		20,232	18,190
Unrecognized tax benefit that if recognized would impact effective tax rate		20,232	18,190
Accrued for interest and penalties		$ 5,288	$ 4,111
Foreign | Minimum
Income Taxes [Line Items]
Tax credit carryforwards expiring year		2,024
State | Minimum
Income Taxes [Line Items]
Net operating losses carried forward expiring period		5 years
State | Maximum
Income Taxes [Line Items]
Net operating losses carried forward expiring period		20 years
Net operating losses carried forward expiring year		2,037
Scenario Forecast
Income Taxes [Line Items]
Corporate income tax rate	21.00%

Income Before Income Taxes (Det

Income Before Income Taxes (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Income Tax Disclosure [Abstract]
Income before income taxes, U.S.	$ 282,896	$ 277,474	$ 262,336
Income before income taxes, Foreign	64,842	85,890	88,015
Income before income taxes	$ 347,738	$ 363,364	$ 350,351

Current and Deferred Income Tax

Current and Deferred Income Taxes (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Current:
Federal	$ 55,224	$ 66,210	$ 72,185
Foreign	29,306	32,047	35,874
State	10,741	12,061	10,806
Total current expense	95,271	110,318	118,865
Deferred:
Federal	(14,046)	(13,667)	10,420
Foreign	(4,270)	1,674	(3,339)
State	3,301	6,526	4,014
Total deferred taxes	(15,015)	(5,467)	11,095
Income taxes	$ 80,256	$ 104,851	$ 129,960

Reconciliation Between Income T

Reconciliation Between Income Tax Expenses (Detail) - USD ($) $ in Thousands		12 Months Ended
		Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Income Tax Disclosure [Abstract]
Computed statutory tax expense		$ 121,708	$ 127,176	$ 122,623
Foreign inflation adjustments			(281)	(1,295)
State and local income taxes, net of federal income tax impact		12,857	12,081	9,640
Foreign losses not benefited and changes in valuation allowance		249	(34,757)	(2,408)
Foreign tax rate differential		(245)	(942)	(2,660)
Foreign dividends		13,662	68,684
Foreign tax credits		(21,647)	(62,815)
Impacts related to 2017 Tax Act	[1]	(44,889)
Changes in uncertain tax positions		983	921	3,717
Other — net		(2,422)	(5,216)	343
Income taxes		$ 80,256	$ 104,851	$ 129,960
[1]	Includes one-time benefit due to re-measurement of net deferred tax liabilities using a lower U.S. corporate tax rate and a reassessment of permanently reinvested earnings of ($79,834), a deemed repatriation tax of $14,512, and a reduction in deferred tax assets with regard to foreign tax credit carryforwards of $20,433.

Reconciliation Between Income96

Reconciliation Between Income Tax Expenses (Parenthetical) (Detail) $ in Thousands	12 Months Ended
	Dec. 31, 2017USD ($)
Income Tax Disclosure [Abstract]
One-time benefit due to re-measurement of net deferred tax liabilities	$ (79,834)
Deemed repatriation tax amount	14,512
Reduction in deferred tax assets with regard to foreign tax credit carryforwards	$ 20,433

Net Long-Term Deferred Income T

Net Long-Term Deferred Income Tax Liabilities (Detail) - USD ($) $ in Thousands	Dec. 31, 2017	Dec. 31, 2016
Schedule Of Deferred Income Tax Assets And Liabilities [Line Items]
Theatre properties and equipment	$ 147,208	$ 176,781
Intangible asset — other	30,770	36,052
Intangible asset — tradenames	72,967	112,747
Investment in partnerships	67,449	107,066
Total deferred liabilities	318,394	432,646
Deferred lease expenses	14,714	24,026
Exchange (gain) loss	220	(731)
Deferred revenue - NCM	85,816	130,005
Capital lease obligations	67,369	85,721
Other tax loss carryforwards	15,564	15,883
Other tax credit carryforwards	38,436	48,033
Other expenses, not currently deductible for tax purposes	13,801	11,270
Total deferred assets	235,920	314,207
Net deferred income tax liability before valuation allowance	82,474	118,439
Valuation allowance against deferred assets – non-current	35,246	14,524
Net deferred income tax liability	117,720	132,963
Foreign
Schedule Of Deferred Income Tax Assets And Liabilities [Line Items]
Net deferred income tax liability	3,073	7,571
U.S.
Schedule Of Deferred Income Tax Assets And Liabilities [Line Items]
Net deferred income tax liability	$ 114,647	$ 125,392

Reconciliation of Total Amounts

Reconciliation of Total Amounts of Unrecognized Tax Benefits Excluding Interest and Penalties (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Income Tax Disclosure [Abstract]
Beginning Balance	$ 17,403	$ 17,133	$ 16,515
Gross increases - tax positions in prior periods	92	13	40
Gross decreases - tax positions in prior periods	(12)
Gross increases - current period tax positions	265	923	2,112
Settlements	(177)	(924)	(871)
Foreign currency translation adjustments	695	258	(663)
Ending Balance	$ 18,266	$ 17,403	$ 17,133

Commitments and Contingencies -

Commitments and Contingencies - Additional Information (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016
Commitments and Contingencies Disclosure [Line Items]
Liability for deferred lease expenses	$ 40,929	$ 42,378
Employer matching contribution payments	6,380	$ 3,187
Liability recorded for employer contribution payments	$ 999
Tim Warner
Commitments and Contingencies Disclosure [Line Items]
Employment agreement termination date	Apr. 1, 2016
Other Employees Except Tim Warner
Commitments and Contingencies Disclosure [Line Items]
Employment agreements term extension	1 year
Robert Carmony
Commitments and Contingencies Disclosure [Line Items]
Employment agreement termination date	Jan. 2, 2018
Minimum
Commitments and Contingencies Disclosure [Line Items]
Operating and capital leases with terms generally ranging	10 years
Maximum
Commitments and Contingencies Disclosure [Line Items]
Operating and capital leases with terms generally ranging	25 years

Rent Expenses (Detail)

Rent Expenses (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Commitments And Contingencies Disclosure [Abstract]
Fixed rent expense	$ 247,908	$ 242,927	$ 240,057
Contingent rent and other facility lease expenses	80,289	78,367	79,704
Total facility lease expense	$ 328,197	$ 321,294	$ 319,761

Future Minimum Lease Payments u

Future Minimum Lease Payments under Noncancelable Operating and Capital Leases Remaining Terms in Excess of One Year (Detail) - USD ($) $ in Thousands	Dec. 31, 2017	Dec. 31, 2016
Commitments And Contingencies Disclosure [Abstract]
Future minimum operating lease payments, current	$ 253,835
Future minimum operating lease payments, in two years	233,606
Future minimum operating lease payments, in three years	215,265
Future minimum operating lease payments, in four years	197,779
Future minimum operating lease payments, in five years	171,486
Future minimum operating lease payments, thereafter	675,567
Future minimum operating lease payments, total	1,747,538
Future minimum capital leases payments, current	42,832
Future minimum capital leases payments, in two years	42,363
Future minimum capital leases payments, in three years	41,543
Future minimum capital leases payments, in four years	34,584
Future minimum capital leases payments, in five years	32,383
Future minimum capital leases payments, thereafter	182,027
Future minimum capital leases payments, total	375,732
Amounts representing interest payments	(99,070)
Present value of future minimum payments	276,662
Current portion of capital lease obligations	(25,511)	$ (21,139)
Capital lease obligations, less current portion	$ 251,151	$ 234,281

Selected Financial Information

Selected Financial Information by Reportable Operating Segment (Detail) - USD ($) $ in Thousands		12 Months Ended
		Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Segment Reporting Information [Line Items]
Revenues		$ 2,991,547	$ 2,918,765	$ 2,852,609
Adjusted EBITDA	[1]	725,269	707,840	684,581
Capital expenditures		380,862	326,908	331,726
Operating Segments | U.S. Operating Segment
Segment Reporting Information [Line Items]
Revenues		2,236,237	2,230,693	2,137,733
Adjusted EBITDA	[1]	559,693	550,150	518,165
Capital expenditures		321,040	242,271	223,213
Operating Segments | International Operating Segment
Segment Reporting Information [Line Items]
Revenues		769,436	701,573	728,735
Adjusted EBITDA	[1]	165,576	157,690	166,416
Capital expenditures		59,822	84,637	108,513
Eliminations
Segment Reporting Information [Line Items]
Revenues		$ (14,126)	$ (13,501)	$ (13,859)
[1]	Distributions from equity investees are reported entirely within the U.S. operating segment

Reconciliation of Net Income to

Reconciliation of Net Income to Adjusted EBITDA (Detail) - USD ($) $ in Thousands		Nov. 28, 2017	[2]	Jun. 16, 2017	[2]	Dec. 15, 2016	[2]	Jun. 13, 2016	[2]	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Segment Reporting [Abstract]
Net income										$ 267,482	$ 258,513	$ 220,391
Add (deduct):
Income taxes										80,256	104,851	129,960
Interest expense	[1]									105,918	108,313	112,741
Loss on debt amendments and refinancing		$ 331		$ 190		$ 161		$ 249		521	13,445	925
Other income	[3]									(43,121)	(44,813)	(20,041)
Other cash distributions from equity investees	[4]									25,973	21,916	19,027
Depreciation and amortization										237,513	209,071	189,206
Impairment of long-lived assets										15,084	2,836	8,801
Loss on sale of assets and other										22,812	20,459	8,143
Deferred lease expenses										(1,268)	(990)	(1,806)
Amortization of long-term prepaid rents										2,274	1,826	2,361
Share based awards compensation expense										11,825	12,413	14,873
Adjusted EBITDA	[5]									$ 725,269	$ 707,840	$ 684,581
[1]	Includes amortization of debt issue costs.
[2]	Reflected as a loss on debt amendments and refinancing on the consolidated statement of income for the year in which the amendments were effective.
[3]	Includes interest income, foreign currency exchange gain (loss), and equity in income of affiliates and excludes distributions from NCM.
[4]	Includes distributions received from equity investees that were recorded as a reduction of the respective investment balances.
[5]	Distributions from equity investees are reported entirely within the U.S. operating segment

Selected Financial Informati104

Selected Financial Information by Geographic Area (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Revenues from External Customers and Long-Lived Assets [Line Items]
Revenues	$ 2,991,547	$ 2,918,765	$ 2,852,609
Theatre Properties and Equipment - net	1,828,054	1,704,536
Reportable Geographical Components | U.S.
Revenues from External Customers and Long-Lived Assets [Line Items]
Revenues	2,236,237	2,230,693	2,137,733
Theatre Properties and Equipment - net	1,439,168	1,306,643
Reportable Geographical Components | Brazil
Revenues from External Customers and Long-Lived Assets [Line Items]
Revenues	341,485	304,407	291,959
Theatre Properties and Equipment - net	179,669	197,896
Reportable Geographical Components | Other international countries
Revenues from External Customers and Long-Lived Assets [Line Items]
Revenues	427,951	397,166	436,776
Theatre Properties and Equipment - net	209,217	199,997
Eliminations
Revenues from External Customers and Long-Lived Assets [Line Items]
Revenues	$ (14,126)	$ (13,501)	$ (13,859)

Related Party Transactions - Ad

Related Party Transactions - Additional Information (Detail)	12 Months Ended
	Dec. 31, 2017USD ($)TheatreFacilityLease	Dec. 31, 2016USD ($)	Dec. 31, 2015USD ($)
Related Party Transaction [Line Items]
Cash dividends paid to Cinemark Holdings, Inc.	$ 134,500,000	$ 124,900,000	$ 115,225,000
Noncash distribution to Cinemark Holdings, Inc.			17,935,000
Receivable from Cinemark Holdings, Inc.	$ 14,581,000	10,080,000
Laredo Theatre, Ltd
Related Party Transaction [Line Items]
Company's interest in Laredo	75.00%
Lone Star Theatre's interest in Laredo	25.00%
Ownership interest held by David Roberts	100.00%
Percentage of common stock held by Chairman of the Board of Directors	8.00%
Percentage of management fees based on theatre revenues	5.00%
Maximum amount of theater revenue used to calculate management fees	$ 50,000,000
Percentage of management fees based on theatre revenues in excess	3.00%
Minimum amount of theater revenue used to calculate management fees	$ 50,000,000
Management fee revenues	586,000	506,000	567,000
Copper Beech Capital LLC
Related Party Transaction [Line Items]
Amount paid for the use of aircraft	$ 131,000	110,000	410,000
Pinstack
Related Party Transaction [Line Items]
Amount paid for the event for employees and their families		70,000
Syufy Enterprises, LP
Related Party Transaction [Line Items]
Number of theatres leased | Theatre	14
Number of parking facilities leased | Facility	1
Total number of leases | Lease	15
Number of leases with minimum annual rent | Lease	14
Number of leases without minimum annual rent | Lease	1
Total rent paid to Syufy	$ 22,483,000	21,124,000	20,581,000
Cinemark Holdings, Inc.
Related Party Transaction [Line Items]
Cash dividends paid to Cinemark Holdings, Inc.	134,500,000	124,900,000	115,225,000
Noncash distribution to Cinemark Holdings, Inc.			$ 17,935,000
Receivable from Cinemark Holdings, Inc.	$ 14,581,000	$ 10,080,000

Valuation Allowance of Deferred

Valuation Allowance of Deferred Tax Assets (Detail) - Valuation Allowance of Deferred Tax Assets - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2017		Dec. 31, 2016		Dec. 31, 2015
Valuation and Qualifying Accounts Disclosure [Line Items]
Beginning Balance	$ 14,524		$ 50,636		$ 52,873
Additions	21,347		483		437
Deductions	(625)	[1]	(36,595)	[1]	(2,674)
Ending Balance	$ 35,246		$ 14,524		$ 50,636
[1]	A valuation allowance was provided against certain deferred tax assets arising from carryforwards of unused foreign tax credit benefits.

Condensed Consolidating Fina107

Condensed Consolidating Financial Information of Subsidiary Guarantors - Additional Information (Detail) $ in Thousands	Dec. 31, 2017USD ($)
5.125% Senior Notes Due 2022
Condensed Consolidating Financial Information [Line Items]
Outstanding aggregate principal amount of Senior Notes	$ 400,000
Interest rate	5.125%
4.875% Senior Notes Due 2023
Condensed Consolidating Financial Information [Line Items]
Outstanding aggregate principal amount of Senior Notes	$ 755,000
Interest rate	4.875%

Condensed Consolidating Balance

Condensed Consolidating Balance Sheet Information (Detail) - USD ($) $ in Thousands	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Current assets
Cash and cash equivalents	$ 522,415	$ 561,138	$ 588,503	$ 638,841
Other current assets	135,021	115,075
Accounts receivable from parent or subsidiaries	14,581	10,080
Total current assets	672,017	686,293
Theatre properties and equipment - net	1,828,054	1,704,536
Investment in subsidiaries	0	0
Other assets	1,985,269	1,925,780
Total assets	4,485,340	4,316,609
Current liabilities
Current portion of long-term debt	7,099	5,671
Current portion of capital lease obligations	25,511	21,139
Accounts payable and accrued expenses	435,676	415,992
Accounts payable to parent or subsidiaries	0	0
Total current liabilities	468,286	442,802
Long-term liabilities
Long-term debt, less current portion	1,780,381	1,782,441
Capital lease obligations, less current portion	251,151	234,281
Other long-term liabilities and deferrals	564,027	573,005
Total long-term liabilities	2,595,559	2,589,727
Commitments and contingencies
Cinemark USA, Inc.'s stockholder's equity:
Common stock	49,543	49,543
Other stockholder's equity	1,360,059	1,223,395
Total Cinemark USA, Inc.'s stockholder's equity	1,409,602	1,272,938
Noncontrolling interests	11,893	11,142
Total equity	1,421,495	1,284,080	1,113,251	1,136,723
Total liabilities and equity	4,485,340	4,316,609
Eliminations
Current assets
Cash and cash equivalents	0	0	0	0
Other current assets	(19,270)	(34,154)
Accounts receivable from parent or subsidiaries	(223,007)	(187,948)
Total current assets	(242,277)	(222,102)
Theatre properties and equipment - net	0	0
Investment in subsidiaries	(1,813,421)	(1,703,484)
Other assets	(113,720)	(106,359)
Total assets	(2,169,418)	(2,031,945)
Current liabilities
Current portion of long-term debt	0	(20)
Current portion of capital lease obligations	0	0
Accounts payable and accrued expenses	(6,402)	(16,457)
Accounts payable to parent or subsidiaries	(223,007)	(187,948)
Total current liabilities	(229,409)	(204,425)
Long-term liabilities
Long-term debt, less current portion	(109,822)	(109,822)
Capital lease obligations, less current portion	0	0
Other long-term liabilities and deferrals	(16,766)	(14,214)
Total long-term liabilities	(126,588)	(124,036)
Commitments and contingencies
Cinemark USA, Inc.'s stockholder's equity:
Common stock	(467,606)	(467,607)
Other stockholder's equity	(1,345,815)	(1,235,877)
Total Cinemark USA, Inc.'s stockholder's equity	(1,813,421)	(1,703,484)
Noncontrolling interests	0	0
Total equity	(1,813,421)	(1,703,484)
Total liabilities and equity	(2,169,418)	(2,031,945)
Parent Company
Current assets
Cash and cash equivalents	130,590	146,855	141,364	129,505
Other current assets	59,661	62,425
Accounts receivable from parent or subsidiaries	117,972	76,550
Total current assets	308,223	285,830
Theatre properties and equipment - net	650,783	604,506
Investment in subsidiaries	1,691,626	1,570,592
Other assets	1,427,328	1,409,320
Total assets	4,077,960	3,870,248
Current liabilities
Current portion of long-term debt	5,710	4,282
Current portion of capital lease obligations	9,532	7,903
Accounts payable and accrued expenses	215,580	197,789
Accounts payable to parent or subsidiaries	0	0
Total current liabilities	230,822	209,974
Long-term liabilities
Long-term debt, less current portion	1,878,992	1,879,663
Capital lease obligations, less current portion	132,189	124,944
Other long-term liabilities and deferrals	426,355	382,729
Total long-term liabilities	2,437,536	2,387,336
Commitments and contingencies
Cinemark USA, Inc.'s stockholder's equity:
Common stock	49,543	49,543
Other stockholder's equity	1,360,059	1,223,395
Total Cinemark USA, Inc.'s stockholder's equity	1,409,602	1,272,938
Noncontrolling interests	0	0
Total equity	1,409,602	1,272,938
Total liabilities and equity	4,077,960	3,870,248
Subsidiary Guarantors
Current assets
Cash and cash equivalents	180,623	281,023	95,865	74,643
Other current assets	17,841	15,098
Accounts receivable from parent or subsidiaries	119,616	121,478
Total current assets	318,080	417,599
Theatre properties and equipment - net	765,500	678,984
Investment in subsidiaries	121,795	132,892
Other assets	134,845	134,284
Total assets	1,340,220	1,363,759
Current liabilities
Current portion of long-term debt	0	0
Current portion of capital lease obligations	11,124	9,541
Accounts payable and accrued expenses	116,409	121,640
Accounts payable to parent or subsidiaries	0	0
Total current liabilities	127,533	131,181
Long-term liabilities
Long-term debt, less current portion	0	0
Capital lease obligations, less current portion	75,767	71,228
Other long-term liabilities and deferrals	60,567	84,429
Total long-term liabilities	136,334	155,657
Commitments and contingencies
Cinemark USA, Inc.'s stockholder's equity:
Common stock	457,368	457,368
Other stockholder's equity	618,985	619,553
Total Cinemark USA, Inc.'s stockholder's equity	1,076,353	1,076,921
Noncontrolling interests	0	0
Total equity	1,076,353	1,076,921
Total liabilities and equity	1,340,220	1,363,759
Subsidiary Non-Guarantors
Current assets
Cash and cash equivalents	211,202	133,260	$ 351,274	$ 434,693
Other current assets	76,789	71,706
Accounts receivable from parent or subsidiaries	0	0
Total current assets	287,991	204,966
Theatre properties and equipment - net	411,771	421,046
Investment in subsidiaries	0	0
Other assets	536,816	488,535
Total assets	1,236,578	1,114,547
Current liabilities
Current portion of long-term debt	1,389	1,409
Current portion of capital lease obligations	4,855	3,695
Accounts payable and accrued expenses	110,089	113,020
Accounts payable to parent or subsidiaries	223,007	187,948
Total current liabilities	339,340	306,072
Long-term liabilities
Long-term debt, less current portion	11,211	12,600
Capital lease obligations, less current portion	43,195	38,109
Other long-term liabilities and deferrals	93,871	120,061
Total long-term liabilities	148,277	170,770
Commitments and contingencies
Cinemark USA, Inc.'s stockholder's equity:
Common stock	10,238	10,239
Other stockholder's equity	726,830	616,324
Total Cinemark USA, Inc.'s stockholder's equity	737,068	626,563
Noncontrolling interests	11,893	11,142
Total equity	748,961	637,705
Total liabilities and equity	$ 1,236,578	$ 1,114,547

Condensed Consolidating Stateme

Condensed Consolidating Statement of Income Information (Detail) - USD ($) $ in Thousands		Nov. 28, 2017	[2]	Jun. 16, 2017	[2]	Dec. 15, 2016	[2]	Jun. 13, 2016	[2]	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Condensed Financial Statements, Captions [Line Items]
Revenues										$ 2,991,547	$ 2,918,765	$ 2,852,609
Cost of operations
Theatre operating expenses										2,170,578	2,120,109	2,066,571
General and administrative expenses										150,911	140,637	154,052
Depreciation and amortization										237,513	209,071	189,206
Impairment of long-lived assets										15,084	2,836	8,801
(Gain) loss on sale of assets and other										22,812	20,459	8,143
Total cost of operations										2,596,898	2,493,112	2,426,773
Operating income										394,649	425,653	425,836
Other income (expense)
Interest expense	[1]									(105,918)	(108,313)	(112,741)
Loss on debt amendments and refinancing		$ (331)		$ (190)		$ (161)		$ (249)		(521)	(13,445)	(925)
Distributions from NCM										16,407	14,656	18,140
Equity in income of affiliates										35,985	31,962	28,126
Other income (expense)										7,136	12,851	(8,085)
Total other income (expense)										(46,911)	(62,289)	(75,485)
Income before income taxes										347,738	363,364	350,351
Income taxes										80,256	104,851	129,960
Net income										267,482	258,513	220,391
Less: Net income attributable to noncontrolling interests										1,839	1,736	1,859
Net income attributable to Cinemark USA, Inc.										265,643	256,777	218,532
Eliminations
Condensed Financial Statements, Captions [Line Items]
Revenues										(50,756)	(53,147)	(50,242)
Cost of operations
Theatre operating expenses										(50,756)	(53,147)	(50,242)
General and administrative expenses										0	0	0
Depreciation and amortization										0	0	0
Impairment of long-lived assets										0	0	0
(Gain) loss on sale of assets and other										0	0
Total cost of operations										(50,756)	(53,147)	(50,242)
Operating income										0	0	0
Other income (expense)
Interest expense										1,433	1,309	376
Loss on debt amendments and refinancing										0	0	0
Distributions from NCM										0	0	0
Equity in income of affiliates										(270,189)	(301,946)	(271,785)
Other income (expense)										(1,433)	(1,309)	(376)
Total other income (expense)										(270,189)	(301,946)	(271,785)
Income before income taxes										(270,189)	(301,946)	(271,785)
Income taxes										0	0	0
Net income										(270,189)	(301,946)	(271,785)
Less: Net income attributable to noncontrolling interests										0	0	0
Net income attributable to Cinemark USA, Inc.										(270,189)	(301,946)	(271,785)
Parent Company
Condensed Financial Statements, Captions [Line Items]
Revenues										1,013,960	1,014,713	959,347
Cost of operations
Theatre operating expenses										795,976	804,041	767,446
General and administrative expenses										13,176	13,085	16,152
Depreciation and amortization										79,676	70,654	59,759
Impairment of long-lived assets										3,725	1,929	6,445
(Gain) loss on sale of assets and other										16,895	5,613	6,191
Total cost of operations										909,448	895,322	855,993
Operating income										104,512	119,391	103,354
Other income (expense)
Interest expense										(94,229)	(96,442)	(100,608)
Loss on debt amendments and refinancing										(521)	(13,445)	(925)
Distributions from NCM										0	1,414	2,116
Equity in income of affiliates										255,594	245,010	217,567
Other income (expense)										2,475	351	200
Total other income (expense)										163,319	136,888	118,350
Income before income taxes										267,831	256,279	221,704
Income taxes										2,188	(498)	3,172
Net income										265,643	256,777	218,532
Less: Net income attributable to noncontrolling interests										0	0	0
Net income attributable to Cinemark USA, Inc.										265,643	256,777	218,532
Subsidiary Guarantors
Condensed Financial Statements, Captions [Line Items]
Revenues										1,220,993	1,219,218	1,178,873
Cost of operations
Theatre operating expenses										834,135	828,905	804,236
General and administrative expenses										82,955	84,453	81,240
Depreciation and amortization										87,463	79,139	73,708
Impairment of long-lived assets										1,502	0	1,600
(Gain) loss on sale of assets and other										3,372	13,759	3,728
Total cost of operations										1,009,427	1,006,256	964,512
Operating income										211,566	212,962	214,361
Other income (expense)
Interest expense										(7,675)	(7,538)	(8,500)
Loss on debt amendments and refinancing										0	0	0
Distributions from NCM										0	0	0
Equity in income of affiliates										16,838	58,528	55,082
Other income (expense)										1,040	19	20
Total other income (expense)										10,203	51,009	46,602
Income before income taxes										221,769	263,971	260,963
Income taxes										69,770	52,277	79,131
Net income										151,999	211,694	181,832
Less: Net income attributable to noncontrolling interests										0	0	0
Net income attributable to Cinemark USA, Inc.										151,999	211,694	181,832
Subsidiary Non-Guarantors
Condensed Financial Statements, Captions [Line Items]
Revenues										807,350	737,981	764,631
Cost of operations
Theatre operating expenses										591,223	540,310	545,131
General and administrative expenses										54,780	43,099	56,660
Depreciation and amortization										70,374	59,278	55,739
Impairment of long-lived assets										9,857	907	756
(Gain) loss on sale of assets and other										2,545	1,087	(1,776)
Total cost of operations										728,779	644,681	656,510
Operating income										78,571	93,300	108,121
Other income (expense)
Interest expense										(5,447)	(5,642)	(4,009)
Loss on debt amendments and refinancing										0	0	0
Distributions from NCM										16,407	13,242	16,024
Equity in income of affiliates										33,742	30,370	27,262
Other income (expense)										5,054	13,790	(7,929)
Total other income (expense)										49,756	51,760	31,348
Income before income taxes										128,327	145,060	139,469
Income taxes										8,298	53,072	47,657
Net income										120,029	91,988	91,812
Less: Net income attributable to noncontrolling interests										1,839	1,736	1,859
Net income attributable to Cinemark USA, Inc.										$ 118,190	$ 90,252	$ 89,953
[1]	Includes amortization of debt issue costs.
[2]	Reflected as a loss on debt amendments and refinancing on the consolidated statement of income for the year in which the amendments were effective.

Condensed Consolidating Stat110

Condensed Consolidating Statement of Comprehensive Income Information (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Condensed Statement Of Income Captions [Line Items]
Net income	$ 267,482	$ 258,513	$ 220,391
Other comprehensive income (loss), net of tax
Unrealized gain due to fair value adjustments on interest rate swap agreements, net of settlements, net of taxes	0	234	2,636
Unrealized loss due to fair value adjustments on available-for-sale securities, net of taxes	0	0	(957)
Other comprehensive income (loss) in equity method investments	248	89	(3,119)
Foreign currency translation adjustments	(4,966)	26,394	(125,512)
Total other comprehensive income (loss), net of tax	(4,718)	26,717	(126,952)
Total comprehensive income, net of tax	262,764	285,230	93,439
Comprehensive income attributable to noncontrolling interests	(1,839)	(1,769)	(1,821)
Comprehensive income attributable to Cinemark USA, Inc.	260,925	283,461	91,618
Eliminations
Condensed Statement Of Income Captions [Line Items]
Net income	(270,189)	(301,946)	(271,785)
Other comprehensive income (loss), net of tax
Unrealized gain due to fair value adjustments on interest rate swap agreements, net of settlements, net of taxes		0	0
Unrealized loss due to fair value adjustments on available-for-sale securities, net of taxes			0
Other comprehensive income (loss) in equity method investments	(248)	(89)	3,086
Foreign currency translation adjustments	4,966	(26,361)	125,474
Total other comprehensive income (loss), net of tax	4,718	(26,450)	128,560
Total comprehensive income, net of tax	(265,471)	(328,396)	(143,225)
Comprehensive income attributable to noncontrolling interests	0	0	0
Comprehensive income attributable to Cinemark USA, Inc.	(265,471)	(328,396)	(143,225)
Parent Company
Condensed Statement Of Income Captions [Line Items]
Net income	265,643	256,777	218,532
Other comprehensive income (loss), net of tax
Unrealized gain due to fair value adjustments on interest rate swap agreements, net of settlements, net of taxes		234	2,636
Unrealized loss due to fair value adjustments on available-for-sale securities, net of taxes			(957)
Other comprehensive income (loss) in equity method investments	248	89	(3,119)
Foreign currency translation adjustments	(4,966)	26,361	(125,474)
Total other comprehensive income (loss), net of tax	(4,718)	26,684	(126,914)
Total comprehensive income, net of tax	260,925	283,461	91,618
Comprehensive income attributable to noncontrolling interests	0	0	0
Comprehensive income attributable to Cinemark USA, Inc.	260,925	283,461	91,618
Subsidiary Guarantors
Condensed Statement Of Income Captions [Line Items]
Net income	151,999	211,694	181,832
Other comprehensive income (loss), net of tax
Unrealized gain due to fair value adjustments on interest rate swap agreements, net of settlements, net of taxes		0	0
Unrealized loss due to fair value adjustments on available-for-sale securities, net of taxes			0
Other comprehensive income (loss) in equity method investments	0	0	0
Foreign currency translation adjustments	0	0	0
Total other comprehensive income (loss), net of tax	0	0	0
Total comprehensive income, net of tax	151,999	211,694	181,832
Comprehensive income attributable to noncontrolling interests	0	0	0
Comprehensive income attributable to Cinemark USA, Inc.	151,999	211,694	181,832
Subsidiary Non-Guarantors
Condensed Statement Of Income Captions [Line Items]
Net income	120,029	91,988	91,812
Other comprehensive income (loss), net of tax
Unrealized gain due to fair value adjustments on interest rate swap agreements, net of settlements, net of taxes		0	0
Unrealized loss due to fair value adjustments on available-for-sale securities, net of taxes			0
Other comprehensive income (loss) in equity method investments	248	89	(3,086)
Foreign currency translation adjustments	(4,966)	26,394	(125,512)
Total other comprehensive income (loss), net of tax	(4,718)	26,483	(128,598)
Total comprehensive income, net of tax	115,311	118,471	(36,786)
Comprehensive income attributable to noncontrolling interests	(1,839)	(1,769)	(1,821)
Comprehensive income attributable to Cinemark USA, Inc.	$ 113,472	$ 116,702	$ (38,607)

Condensed Consolidating Stat111

Condensed Consolidating Statement of Comprehensive Income Information (Parenthetical) (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Condensed Financial Information Of Subsidiaries Disclosure [Abstract]
Unrealized gain due to fair value adjustments on interest rate swap agreements, taxes	$ 0	$ 138	$ 1,562
Unrealized loss due to fair value adjustments on available-for-sale securities, taxes	$ 0	$ 0	$ 572

Condensed Consolidating Stat112

Condensed Consolidating Statement of Cash Flows Information (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Operating activities
Net income	$ 267,482	$ 258,513	$ 220,391
Adjustments to reconcile net income to cash provided by operating activities	251,647	221,232	211,562
Changes in assets and liabilities	8,734	(28,562)	23,272
Net cash provided by operating activities	527,863	451,183	455,225
Investing activities
Additions to theatre properties and equipment	(380,862)	(326,908)	(331,726)
Proceeds from sale of theatre properties and equipment and other	15,098	3,570	9,966
Acquisition of theatres in the U.S., Brazil and international markets, net of cash acquired	(40,997)	(15,300)	(2,651)
Acquisition of screen advertising business		(1,450)
Proceeds from sale of marketable securities		13,451
Dividends received from subsidiaries	0	0	0
Intercompany note issuances			0
Investment in joint ventures and other	(3,715)	(1,132)	(3,711)
Net cash used for investing activities	(410,476)	(327,769)	(328,122)
Financing activities
Dividends paid to parent	(134,500)	(124,900)	(115,225)
Proceeds from issuance of Senior Notes, net of discount		222,750
Retirement of Senior Subordinated Notes		(200,000)
Repayments of long-term debt	(5,671)	(16,605)	(8,420)
Payment of debt issue costs	(1,146)	(7,217)	(6,957)
Payments on capital leases	(21,725)	(19,343)	(16,513)
Proceeds from financing lease	10,200
Other	(5,212)	(6,730)	(3,394)
Net cash used for financing activities	(156,908)	(152,045)	(150,509)
Effect of exchange rate changes on cash and cash equivalents	798	1,266	(26,932)
Increase (decrease) in cash and cash equivalents	(38,723)	(27,365)	(50,338)
Cash and cash equivalents:
Beginning of period	561,138	588,503	638,841
End of period	522,415	561,138	588,503
Eliminations
Operating activities
Net income	(270,189)	(301,946)	(271,785)
Adjustments to reconcile net income to cash provided by operating activities	270,189	301,946	271,785
Changes in assets and liabilities	0	0	0
Net cash provided by operating activities		0	0
Investing activities
Additions to theatre properties and equipment	0	0	0
Proceeds from sale of theatre properties and equipment and other	0	0	0
Acquisition of theatres in the U.S., Brazil and international markets, net of cash acquired		0	0
Acquisition of screen advertising business		0
Proceeds from sale of marketable securities		0
Dividends received from subsidiaries	(129,473)	(255,682)	(1,700)
Intercompany note issuances		4,455	103,500
Investment in joint ventures and other	0	0	18
Net cash used for investing activities	(129,473)	(251,227)	101,818
Financing activities
Dividends paid to parent	129,473	255,682	1,700
Proceeds from issuance of Senior Notes, net of discount		0
Retirement of Senior Subordinated Notes		0
Repayments of long-term debt	0	0	0
Payment of debt issue costs		0
Payments on capital leases	0	0	0
Proceeds from financing lease	0
Intercompany loan proceeds		(4,455)	(103,518)
Other	0	0	0
Net cash used for financing activities	129,473	251,227	(101,818)
Effect of exchange rate changes on cash and cash equivalents	0	0	0
Increase (decrease) in cash and cash equivalents	0	0	0
Cash and cash equivalents:
Beginning of period	0	0	0
End of period	0	0	0
Parent Company
Operating activities
Net income	265,643	256,777	218,532
Adjustments to reconcile net income to cash provided by operating activities	(123,080)	(189,223)	(142,602)
Changes in assets and liabilities	18,223	154,085	67,253
Net cash provided by operating activities	160,786	221,639	143,183
Investing activities
Additions to theatre properties and equipment	(146,385)	(108,439)	(98,193)
Proceeds from sale of theatre properties and equipment and other	2,149	2,912	2,737
Acquisition of theatres in the U.S., Brazil and international markets, net of cash acquired	(12,500)	(15,300)	0
Acquisition of screen advertising business		0
Proceeds from sale of marketable securities		13,451
Dividends received from subsidiaries	127,600	26,033	1,685
Intercompany note issuances		(4,455)	(3,500)
Investment in joint ventures and other	0	(1,000)	(518)
Net cash used for investing activities	(29,136)	(86,798)	(97,789)
Financing activities
Dividends paid to parent	(134,500)	(124,900)	(115,225)
Proceeds from issuance of Senior Notes, net of discount		222,750
Retirement of Senior Subordinated Notes		(200,000)
Repayments of long-term debt	(4,282)	(15,201)	(8,385)
Payment of debt issue costs		(7,217)	(6,957)
Payments on capital leases	(7,952)	(6,645)	(5,389)
Proceeds from financing lease	0
Intercompany loan proceeds		0	100,000
Other	(1,181)	1,863	2,421
Net cash used for financing activities	(147,915)	(129,350)	(33,535)
Effect of exchange rate changes on cash and cash equivalents	0	0	0
Increase (decrease) in cash and cash equivalents	(16,265)	5,491	11,859
Cash and cash equivalents:
Beginning of period	146,855	141,364	129,505
End of period	130,590	146,855	141,364
Subsidiary Guarantors
Operating activities
Net income	151,999	211,694	181,832
Adjustments to reconcile net income to cash provided by operating activities	71,023	55,128	39,156
Changes in assets and liabilities	(35,138)	(164,005)	(67,850)
Net cash provided by operating activities	187,884	102,817	153,138
Investing activities
Additions to theatre properties and equipment	(172,874)	(130,843)	(121,605)
Proceeds from sale of theatre properties and equipment and other	12,271	374	5,264
Acquisition of theatres in the U.S., Brazil and international markets, net of cash acquired		0	0
Acquisition of screen advertising business		0
Proceeds from sale of marketable securities		0
Dividends received from subsidiaries	1,873	229,649	15
Intercompany note issuances		0	0
Investment in joint ventures and other	(104)	0	0
Net cash used for investing activities	(158,834)	99,180	(116,326)
Financing activities
Dividends paid to parent	(127,000)	0	(1,700)
Proceeds from issuance of Senior Notes, net of discount		0
Retirement of Senior Subordinated Notes		0
Repayments of long-term debt	0	0	0
Payment of debt issue costs		0	0
Payments on capital leases	(9,707)	(10,005)	(9,120)
Proceeds from financing lease	10,200
Intercompany loan proceeds		0	0
Other	(2,943)	(6,834)	(4,770)
Net cash used for financing activities	(129,450)	(16,839)	(15,590)
Effect of exchange rate changes on cash and cash equivalents	0	0	0
Increase (decrease) in cash and cash equivalents	(100,400)	185,158	21,222
Cash and cash equivalents:
Beginning of period	281,023	95,865	74,643
End of period	180,623	281,023	95,865
Subsidiary Non-Guarantors
Operating activities
Net income	120,029	91,988	91,812
Adjustments to reconcile net income to cash provided by operating activities	33,515	53,381	43,223
Changes in assets and liabilities	25,649	(18,642)	23,869
Net cash provided by operating activities	179,193	126,727	158,904
Investing activities
Additions to theatre properties and equipment	(61,603)	(87,626)	(111,928)
Proceeds from sale of theatre properties and equipment and other	678	284	1,965
Acquisition of theatres in the U.S., Brazil and international markets, net of cash acquired	(28,497)	0	(2,651)
Acquisition of screen advertising business		(1,450)
Proceeds from sale of marketable securities		0
Dividends received from subsidiaries	0	0	0
Intercompany note issuances		0	(100,000)
Investment in joint ventures and other	(3,611)	(132)	(3,211)
Net cash used for investing activities	(93,033)	(88,924)	(215,825)
Financing activities
Dividends paid to parent	(2,473)	(255,682)	0
Proceeds from issuance of Senior Notes, net of discount		0
Retirement of Senior Subordinated Notes		0
Repayments of long-term debt	(1,389)	(1,404)	(35)
Payment of debt issue costs		0	0
Payments on capital leases	(4,066)	(2,693)	(2,004)
Proceeds from financing lease	0
Intercompany loan proceeds		4,455	3,518
Other	(1,088)	(1,759)	(1,045)
Net cash used for financing activities	(9,016)	(257,083)	434
Effect of exchange rate changes on cash and cash equivalents	798	1,266	(26,932)
Increase (decrease) in cash and cash equivalents	77,942	(218,014)	(83,419)
Cash and cash equivalents:
Beginning of period	133,260	351,274	434,693
End of period	$ 211,202	$ 133,260	$ 351,274

Supplemental Schedules - Conden

Supplemental Schedules - Condensed Consolidating Balance Sheet (Detail) - USD ($) $ in Thousands	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Current assets
Cash and cash equivalents	$ 522,415	$ 561,138	$ 588,503	$ 638,841
Other current assets	149,602
Total current assets	672,017	686,293
Theatre properties and equipment - net	1,828,054	1,704,536
Other assets	1,985,269	1,925,780
Total assets	4,485,340	4,316,609
Current liabilities
Current portion of long-term debt	7,099	5,671
Current portion of capital lease obligations	25,511	21,139
Accounts payable and accrued expenses	435,676
Total current liabilities	468,286	442,802
Long-term liabilities
Long-term debt, less current portion	1,780,381	1,782,441
Capital lease obligations, less current portion	251,151	234,281
Other long-term liabilities and deferrals	564,027	573,005
Total long-term liabilities	2,595,559	2,589,727
Commitments and contingencies
Equity	1,421,495	1,284,080	$ 1,113,251	$ 1,136,723
Total liabilities and equity	4,485,340	4,316,609
Restricted Subsidiaries
Current assets
Cash and cash equivalents	461,518	559,964
Other current assets	276,373
Total current assets	737,891
Theatre properties and equipment - net	1,828,054
Other assets	1,823,787
Total assets	4,389,732
Current liabilities
Current portion of long-term debt	5,710
Current portion of capital lease obligations	25,511
Accounts payable and accrued expenses	435,951
Total current liabilities	467,172
Long-term liabilities
Long-term debt, less current portion	1,998,992
Capital lease obligations, less current portion	251,151
Other long-term liabilities and deferrals	501,030
Total long-term liabilities	2,751,173
Commitments and contingencies
Equity	1,171,387
Total liabilities and equity	4,389,732
Unrestricted Subsidiaries
Current assets
Cash and cash equivalents	60,897	$ 1,174
Other current assets	(126,494)
Total current assets	(65,597)
Other assets	488,501
Total assets	422,904
Current liabilities
Current portion of long-term debt	1,389
Accounts payable and accrued expenses	2
Total current liabilities	1,391
Long-term liabilities
Long-term debt, less current portion	1,389
Other long-term liabilities and deferrals	62,997
Total long-term liabilities	64,386
Commitments and contingencies
Equity	357,127
Total liabilities and equity	422,904
Eliminations
Current assets
Other current assets	(277)
Total current assets	(277)
Other assets	(327,019)
Total assets	(327,296)
Current liabilities
Accounts payable and accrued expenses	(277)
Total current liabilities	(277)
Long-term liabilities
Long-term debt, less current portion	(220,000)
Total long-term liabilities	(220,000)
Commitments and contingencies
Equity	(107,019)
Total liabilities and equity	$ (327,296)

Supplemental Schedules - Con114

Supplemental Schedules - Condensed Consolidating Statement of Income (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Condensed Financial Statements, Captions [Line Items]
Revenues	$ 2,991,547	$ 2,918,765	$ 2,852,609
Cost of operations
Theatre operating costs	2,170,578	2,120,109	2,066,571
General and administrative expenses	150,911	140,637	154,052
Depreciation and amortization	237,513	209,071	189,206
Impairment of long-lived assets	15,084
Loss on sale of assets and other	22,812	20,459	8,143
Total cost of operations	2,596,898	2,493,112	2,426,773
Operating income	394,649	425,653	425,836
Other income (expense)	(46,911)	(62,289)	(75,485)
Income before income taxes	347,738	363,364	350,351
Income taxes	80,256	104,851	129,960
Net income	267,482	258,513	220,391
Less: Net income attributable to noncontrolling interests	1,839	1,736	1,859
Net income attributable to Cinemark USA, Inc.	265,643	$ 256,777	$ 218,532
Restricted Subsidiaries
Condensed Financial Statements, Captions [Line Items]
Revenues	2,991,547
Cost of operations
Theatre operating costs	2,170,578
General and administrative expenses	150,896
Depreciation and amortization	237,513
Impairment of long-lived assets	15,084
Loss on sale of assets and other	22,812
Total cost of operations	2,596,883
Operating income	394,664
Other income (expense)	(123,960)
Income before income taxes	270,704
Income taxes	88,618
Net income	182,086
Less: Net income attributable to noncontrolling interests	1,839
Net income attributable to Cinemark USA, Inc.	180,247
Unrestricted
Cost of operations
General and administrative expenses	15
Total cost of operations	15
Operating income	(15)
Other income (expense)	77,049
Income before income taxes	77,034
Income taxes	(8,362)
Net income	85,396
Net income attributable to Cinemark USA, Inc.	$ 85,396

Supplemental Schedules - Con115

Supplemental Schedules - Condensed Consolidating of Comprehensive Income (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Net income	$ 267,482	$ 258,513	$ 220,391
Other comprehensive income (loss), net of tax
Other comprehensive income (loss) in equity method investments	248	89	(3,119)
Foreign currency translation adjustments	(4,966)
Total other comprehensive income (loss), net of tax	(4,718)	26,717	(126,952)
Total comprehensive income, net of tax	262,764	285,230	93,439
Comprehensive income attributable to noncontrolling interests	(1,839)	(1,769)	(1,821)
Comprehensive income attributable to Cinemark USA, Inc.	260,925	$ 283,461	$ 91,618
Restricted Subsidiaries
Net income	182,086
Other comprehensive income (loss), net of tax
Foreign currency translation adjustments	(4,966)
Total other comprehensive income (loss), net of tax	(4,966)
Total comprehensive income, net of tax	177,120
Comprehensive income attributable to noncontrolling interests	(1,839)
Comprehensive income attributable to Cinemark USA, Inc.	175,281
Unrestricted Subsidiaries
Net income	85,396
Other comprehensive income (loss), net of tax
Other comprehensive income (loss) in equity method investments	248
Total other comprehensive income (loss), net of tax	248
Total comprehensive income, net of tax	85,644
Comprehensive income attributable to Cinemark USA, Inc.	$ 85,644

Supplemental Schedules - Con116

Supplemental Schedules - Condensed Consolidating Statement of Cash Flows (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Operating activities
Net income	$ 267,482	$ 258,513	$ 220,391
Adjustments to reconcile net income to cash provided by operating activities	251,647	221,232	211,562
Changes in assets and liabilities	8,734	(28,562)	23,272
Net cash provided by operating activities	527,863	451,183	455,225
Investing activities
Additions to theatre properties and equipment and other	(380,862)	(326,908)	(331,726)
Acquisitions of theatres in the U.S. and international markets, net of cash acquired	(40,997)	(15,300)	(2,651)
Proceeds from sale of theatre properties and equipment and other	15,098	3,570	9,966
Investment in joint ventures and other	(3,715)	(1,132)	(3,711)
Net cash used for investing activities	(410,476)	(327,769)	(328,122)
Financing activities
Dividends paid to parent	(134,500)	(124,900)	(115,225)
Repayments of long-term debt	(5,671)	(16,605)	(8,420)
Payments on capital leases	(21,725)	(19,343)	(16,513)
Other	4,988
Net cash used for financing activities	(156,908)	(152,045)	(150,509)
Effect of exchange rate changes on cash and cash equivalents	798	1,266	(26,932)
Increase (decrease) in cash and cash equivalents	(38,723)	(27,365)	(50,338)
Cash and cash equivalents:
Beginning of period	561,138	588,503	638,841
End of period	522,415	561,138	$ 588,503
Restricted Subsidiaries
Operating activities
Net income	182,086
Adjustments to reconcile net income to cash provided by operating activities	246,820
Changes in assets and liabilities	34,233
Net cash provided by operating activities	463,139
Investing activities
Additions to theatre properties and equipment and other	(380,862)
Acquisitions of theatres in the U.S. and international markets, net of cash acquired	(40,997)
Proceeds from sale of theatre properties and equipment and other	15,098
Investment in joint ventures and other	(103)
Net cash used for investing activities	(406,864)
Financing activities
Dividends paid to parent	(134,500)
Repayments of long-term debt	(4,282)
Payments on capital leases	(21,725)
Other	4,988
Net cash used for financing activities	(155,519)
Effect of exchange rate changes on cash and cash equivalents	798
Increase (decrease) in cash and cash equivalents	(98,446)
Cash and cash equivalents:
Beginning of period	559,964
End of period	461,518	559,964
Unrestricted Subsidiaries
Operating activities
Net income	85,396
Adjustments to reconcile net income to cash provided by operating activities	4,827
Changes in assets and liabilities	(25,499)
Net cash provided by operating activities	64,724
Investing activities
Investment in joint ventures and other	(3,612)
Net cash used for investing activities	(3,612)
Financing activities
Repayments of long-term debt	(1,389)
Net cash used for financing activities	(1,389)
Increase (decrease) in cash and cash equivalents	59,723
Cash and cash equivalents:
Beginning of period	1,174
End of period	$ 60,897	$ 1,174